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Abstract 
Sample preparation has been described as the weak link in microfluidics. In 
particular, plasma has to be extracted from whole blood for many analysis 
including protein analysis, cell-free DNA detection for prenatal diagnosis and 
transplant monitoring. The lack of suitable devices to perform the separation at the 
microscale means that Lab On Chip (LOC) modules cannot be fully operated 
without sample preparation in a full-scale laboratory.  In order to address this 
issue, blood flow in microchannels has been studied, and red blood cells 
behaviours in different geometrical environments have been classified. Several 
designs have been subsequently proposed to exploit some natural properties of 
blood flow and extract pure plasma without disturbing the cells. Furthermore, a 
high-level modelling method was developed to predict the behaviour of passive 
microfluidic networks. Additionally, the technique proposed provides useful 
guidance over the use of systems in more complex external environments. 
Experimental results have shown that plasma could be separated from undiluted 
whole blood in 10µm width microchannels at a flow rate of 2mL/hr. Using slightly 
larger structures (20µm) suitable for mass-manufacturing, diluted blood can be 
separated with 100% purity efficiency at high flow rate. An extensive biological 
validation of the extracted plasma was carried out to demonstrate its quality. To 
this effect Polymerase Chain Reaction (PCR) was performed to amplify targeted 
human genomic sequence from cell-free DNA present in the plasma. Furthermore, 
the influence of the sample dilution and separation efficiency on the amplification 
was characterised. It was shown that the sample dilution does have an influence on 
the amplification of house-keeping gene, but that amplification can be achieved 
even on high diluted samples. Additionally amplification can also be obtained on 
plasma samples with a range of separation efficiencies from 100% to 84%. In 
particular, two main points have been demonstrated (i) the extraction of plasma 
using combination of constrictions and bifurcations, (ii) the biological validation of 
the extracted plasma.  
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Chapter 1: Introduction 
1.1 A revolution in point of care medicine ? 
In the 1990s was born a new field derived from microelectronics fabrication 
techniques, analytical chemistry and biological analysis. A number of scientists from all 
horizons joined this new and exciting route and contributed to establish the field to a 
strong hold in the scientific advances of the end of the 20th century and the beginning 
of the 21st.  The name of this field is Micro Total Analysis Sytem (µTAS). This field, 
derived or linked to MicroElectroMechanical System (MEMS), is also called BioMEMS 
or Lab-on-Chip (LOC). Although all these denominations might bear slight differences 
in the orientation of their science, the core of this activity deals with the 
miniaturisation of the analytical and diagnostic techniques. The application field is 
large. From core biological science to clinical diagnostic routine, pharmaceutical 
industry, analytical chemistry, cosmetics and on-site agricultural care, everyday human 
activity could potentially benefit from it. Toner and Irimia, for example, claimed in 
2005 that “bringing complete labs for blood analysis to the bedside […] is poised to 
reshape the delivery of health care” [1.1]. Although this assumption still remains true, 
Mariella asks three years later “why has it not progressed further?” *1.2].  
20 years on the field of µTAS has produced numerous prototypes for point-of-care or 
point-of-use devices. However, few of these prototypes have been commercialised 
yet. These devices are still expensive, sometimes complicated to run, or not handy 
enough [1.2]. Several reviews consider the “world-to-chip” interfacing as one of the 
major hurdles [1.2, 1.3, 1.4]. Still, some specific consumer applications have emerged 
early on and are now used all over the world. One could cite the insulin pump and the 
cardiac diagnostic kit. Nevertheless the revolution promised has not happened so far. 
Most probably it will never happen as such. It will most likely replace some obsolete 
conventional techniques, here and there, find its place in niche market and finally 
convince practioners of its good merits. 
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1.2 A success story 
The insulin pump and glucose meter provide two excellent examples of the 
miniaturisation of diagnostics or monitoring techniques. Due to the fatal nature of 
diabetic disease, on-site monitoring techniques had to be developed: the glucose 
meter was born [1.5]. The first example of portable glucose meter dates back to the 
60s with the use of urine strips that turn blue when the sugar levels were normal and 
orange when the levels were positive. In the late 60s, more accurate glucose metres 
were commercialised. They were portable, and miniaturised compared to a full 
laboratory procedure but still were quite bulky. In 1978 a new glucose reading was 
invented based on the monitoring of hematocrit. From then on, it was commonly 
accepted that rigorous glucose measurements were of utmost importance. Following 
this medical breakthrough, dedication to enhance the portability of glucose meter 
rose. From backpack size, it was transformed to thick credit-card size. Following closely 
this development, the miniaturisation of insulin pump has been at the forefront of 
bioMEMS development in the early 70s. The first pumps were syringe pumps that 
could deliver precise levels of insulin in the hospital bed-side use. By integrating silicon 
piezo-electric micropump, the insulin delivery was soon truly miniaturised in 1980 to 
the same extent as the glucose reader [8.6]. In 2007 the nanopump from Debiotech 
and STM was commercialised, a device which makes use of the latest MEMS 
technologies. Another new advance in the field was the creation of implantable insulin 
pumps. 30 years of effort from chemists, doctors and engineers was necessary to 
create a truly POC solution to diabetes.  
1.3 Establishment of the lab-on-chip field in industry and business 
The factors which led to the establishment of the academic lab on chip field are as 
follow. First of all, the need to miniaturise has driven many projects, followed by the 
need to improve performance and decrease the cost of devices [1.7]. The benefits of 
miniaturization are also helping to offer smaller response time and the ability to 
process many samples in parallel. 
Novel, more flexible, microfabrication techniques, such as soft lithography have helped 
researchers to lower the cost of prototype development and offered cheap, disposable 
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components. Along these new techniques came new developments in biocompatible 
polymer materials such as Polymdymethylsiloxane (PDMS) and SU8 [1.8] which offered 
great value to miniaturization. Figure 1.1 presents the breakdown of different 
materials used in the microfluidics system fabrication in the current market. As can be 
seem from this diagram, polymer is the material predominantly used in the field of 
interest in this study: Point of care devices and Clinical and veterinary diagnostics.   
 
Figure 1. 1: Material breakdown of microfluidic devices in the current market 
Adapted from [1.9] 
Breakthroughs in biology have triggered new routes for miniaturisation in a variety of 
fields. For example, the discovery of Polymerase Chain Reaction (PCR), cardiac markers 
or the Acquired Immuno Defficiency Syndrome (AIDS) has carried along the need for 
portable, miniaturized techniques to provide automated POC diagnosis and treatment.  
Social factors such the increase of the ageing population in developed countries and 
the subsequent increased cost of healthcare are also contributing to the fast 
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establishment of the lab on chip field. A trend towards personalized medicine and the 
appealing idea of self-diagnostics are driving research and industry to develop new 
smart tools. 
Microfluidic techniques for life-science is a fast-paced field and an emerging market. 
Microfluidic supply chains are beginning to be structured and the market of 
microfluidic devices exceeded 1 billion dollars in 2009 [1.9]. A regular growth has been 
observed in the last years (2005-2008). Moreover, as suggested by the graph in Figure 
1.2, the field is expected to grow up to $3 billion in 2014. Point of care applications 
represent today 15% of this market and is the one showing the largest growth.  
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Figure 1. 2: Microfluidic market in M$ adapted from Yole development August 
2009 [1.9] 
The microfluidic market is a rapidly moving field, and despite the growth predicted in 
microfluidic devices applications, some challenges remain in the commercialization 
route. The lack of metrics and standards is a serious obstacle to the development of 
new industries [1.7]. Manufacturing costs stay high for the moment as few devices are 
produced in high quantities [1.9]. In the same fashion, the conflicts between different 
manufacturing approaches (silicon vs polymer) and the lack of standardized 
micropackaging solutions hinders a faster growth in this field [1.7]. Most importantly, 
in the development of microfluidic systems, the sample preparation steps are often 
omitted in the development of products, making a “lab on chip” a “chip in the lab”. 
Finally microfluidics addresses important challenges to the healthcare system in terms 
of acceptance criteria and performance assessment. This step, as well as getting 
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practitioners and healthcare staff used to these new technologies, might take more 
time than the development of the systems themselves. 
1.4 The weak link: sample preparation 
Despite all the advances made in lab on chip, a major technical hurdle lies in the path 
of large scale commercialization and public access to point of care devices: sample 
preparation. With very few exceptions such as the pregnancy test kits for example, 
sample preparation comes with any diagnostic or analysis. It has been branded “the 
weak link in microfluidics-based biodetection” in *1.2+. Mariella gives several reasons 
for the lack of interest into sample preparation on-chip. The first reason is economical, 
Mariella believes that the emerging microfluidic has not triggered enough real 
commercial possibilities for sample preparation to be developed. Another financial 
reason is that the microfluidic technologies do not yet compete technically and cost-
effectively with the existing techniques. A social reason to explain the low number of 
sample preparation microtechniques is the “inertia” of the current techniques and the 
lack of will for trained staff to change the traditional way to prepare samples. Finally, 
and not the least, the integration of sample preparation technique is another issue, 
along with the use of disparate material, leakage problems, lack of generic solutions 
which explain the relative small interest for sample preparation. 
In two other reviews [1.3, 1.1] the challenges of “real” sample preparation, and in 
particular, of blood samples, were discussed. The complexity of the blood matrix is 
generally pointed out as the major hurdle towards on-chip blood preparation. The 
requirement for diverse blood sample pre-treatment is seen as one of the major 
hurdles towards miniaturization. It is observed that a significant part of the blood 
preparation is still handled manually in such conditions that may impair the collection 
of analytes of interest [1.1]. The need for low-cost systems reducing the time from 
blood collection to analysis is recognized.  
Blood plasma separation holds a strategic place in sample preparation, as most steps 
in biological analysis require analytes from the plasma portion or the cellular portion. 
Figure 1.3 summarizes the various elements of interest to be found in whole blood.  
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Figure 1. 3: Plasma and cellular portions found in whole blood, courtesy of 
Deirdre Kavanagh, Heriot-Watt University  
1.5 Non-invasive Prenatal Diagnosis     
This study is part of a larger project developed within the 3DMintegration Grand 
challenge. Prenatal diagnosis to determine the outcome of pregnancies and detect 
conditions that may affect future pregnancies has risen as another big issue among the 
broad public. Conventional prenatal tests are using invasive techniques, such as 
amniocentesis or chorionic villus sampling, which can result in abortion or growth 
abnormalities. Non-invasive prenatal diagnosis can be performed by separating rare 
foetal cells or cell-free foetal DNA from maternal blood, consequently avoiding the 
potential risk of amniocentesis. This project focuses on developing a Lab-on-chip 
device able to diagnose diverse prenatal pathologies within an hour at the doctor’s 
office. The concept of this idea is presented in figure 1.4. A star highlights the specific 
module developed in this work.   
1.6 Aim and scope of this thesis 
This thesis aims at addressing the lack of lab-on-chip modules for sample preparation 
by proposing a blood plasma separator based on hydrodynamic principles only. The 
system presented here has a high throughput and a high efficiency and resulted in the 
application for a British patent [1.10]. Our approach is truly continuous meaning that 
both separated collections, blood cells and plasma, can be recovered at the same time.  
Moreover, the material of the system was chosen carefully to ensure the bio-
compatibility, the ability to mass-manufacture, the disposability (ideally single-use to  
7 
 
Figure 1. 4: Concept of the lab-on-chip device for the diagnosis of prenatal 
pathologies at the doctor’s office. The star highlights the module developed i n 
this thesis.  
 
avoid contamination issues) and the low cost of the system. Additionally, another 
benefit of this microfluidic system is to have only one pressure source which eliminates 
the need for complex control systems. Unlike other microfluidic systems, this device 
can handle large (1-3mL) and complex (e.g. whole blood) samples. 
An extensive physical and biological characterization of the device is presented in this 
thesis. To biologically characterize the system, state-of-the-art and conventional 
biological techniques were used, such as flow cytometry, polymerase chain reaction 
and real time polymerase chain reaction. For the first time a PCR on cfDNA from on-
chip extracted plasma was performed without the need for further purification [1.11]. 
Most importantly, it was shown that the gentle separation of this system avoids RBCs 
lysis that would otherwise inhibit the PCR. 
All the experimental findings indicate that this continuous microfluidic separation 
system may be used as a preliminary module for a lab on-chip system. 
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1.7 Thesis organization  
Chapter two presents an extensive literature survey on particle separation at the 
microscale. The techniques specific to blood preparation before analysis are 
highlighted and polymer based passive separation techniques are found to be the best 
techniques to separate plasma from blood. In Chapter three the theory and design of a 
blood plasma separator is presented. The novel device will associate constrictions and 
bifurcations for enhanced yield and efficiency. Two generations of devices are 
presented. Chapter 4 is concerned with high-level simulation of the microfluidic 
separation network. It is found that the external connection might influence the 
internal separation of cells and plasma. Results are linked to the second generation 
device design. The rapid prototyping and fabrication routes for the microfluidic devices 
are presented in Chapter five alongside the experimental protocols developed for the 
testing of the blood plasma devices. In Chapter six, a hydrodynamic study of the 
biological samples is carried on the results obtained and the different effects of flow 
rate and entrance hematocrit levels on the system behavior are described. The results 
of two flow cytometric studies give detailed account on the separation characteristics. 
Molecular validation of the extracted plasma is presented in Chapter 7; this study is 
the first of its kind on non-purified cfDNA in plasma extracted on-chip. Influence of the 
separation efficiency and dilution levels on the polymerase chain reaction are 
discussed in this section. Chapter 8 presents the main conclusions and gives the future 
outlook of this research study. 
A diagram linking all chapters of this thesis is presented in Figure 1.5.  
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Figure 1. 5: Functional diagram of the thesis  
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Chapter 2: Literature review of 
continuous microscale separation 
techniques 
2.1 Introduction 
Recent techniques of micron-sized particle separation within microsystems are 
described with emphasis on five different categories: optical, magnetic, fluidic-only, 
electrical and other, minor separation methods. Examples from the growing literature 
are explained with insights into separation efficiency and microengineering challenges. 
Current applications of the techniques are discussed.  
Over the last ten years, point-of-use microreactors or point-of-care diagnostic tools 
have helped to reduce the need for intensive macrochemical plants or long diagnostic 
procedures. These so-called ‘lab-on-chip’ devices are built out of several different 
modules, each of them often achieving similar process functions as a macrochemical 
plant or a laboratory. Among these modules, the ‘separation module’, selectively sorts 
different kinds of particles, often immediately after synthesis or before analysis 
processes.  
Applications of separation techniques at the microscale are broad and versatile. 
Particle separation is a necessary preparation step in most biological microassays and 
common in microchemical processing. In the biomedical field, separation techniques 
are used for fundamental cell studies where the isolation of pure cell types is essential. 
Separation is a key activity of diagnostic and analysis tools.  
The aim of this chapter is to provide a critical review of the current technologies 
available for continuous microparticle separation within microchannels. Because of the 
growing rate of publications in the field, this review focuses mainly on advances in the 
last five years. This chapter describes radical new ways to separate particles, 
improvement of older methods and novel, cost-effective manufacturing methods. In 
comparison to recent reviews on particle separation, the emphasis given here is on 
continuous flow techniques. Although techniques such as electrical, optical or 
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magnetic separations are used in non-continuous flow, the main advantages of 
continuous-flow devices lie in profitability, minimum residence time under harmful 
conditions for separated particles, flexibility and integration of downstream functions. 
Special attention is given to a parallel, simultaneous separation of many 
subpopulations, providing potential high-throughput and high-recovery processes. This 
review focuses particularly on the passive separation of particles, not involving 
external decision making, and does not treat single-cell separation or trapping. Single-
cell separation or trapping is more relevant to an in-depth biological study of some 
specific cells rather than a bulk separation for a clinical diagnostic device. 
Different separation methods are highlighted and illustrated by relevant examples: (i) 
optical separation, (ii) magnetic separation, (iii) hydrodynamic separation, (iv) 
electrical separation and (v) other types of separation. 
This section describes different kinds of separation techniques within microchannels 
currently developed as prototypes or already commercially available. A chart 
summarising the techniques presented in this review is shown in Figure 2.1. 
 
Figure 2. 1: Chart summarising the different microparticle continuous 
separation techniques.  
13 
2.2 Optical separation 
A type of optical separation technique attracting attention is the new field of optical 
fractionation. Dholakia and coworkers [2.1,2] and Grier and coworkers [2.3,4,5] gave 
proof of the concept of optical fractionation. This method uses the recent advances in 
manipulation of optical tweezers. Optical tweezers is a manipulation tool developed by 
Ashkin, where a tightly focused single laser beam is used to trap a single particle 
[2.6,7]. Optical tweezers have been widely used since then to trap single particles in 
microfluidic systems. Advances in optical manipulation allowed the creation of three-
dimensional arrays of light traps (optical lattices) using holographic optical tweezers, 
generalised phase contrast or diffractive optical element and multi-beam interferences 
for example. In optical fractionation, these methods allow the generation of an optical 
gradient force called potential energy landscape, which can deflect particles from their 
natural pathway according to their size or intrinsic properties. Particles experiencing 
sufficient optical force are kinetically locked in arrays of optical tweezers, whereas 
other particles flow along the natural stream, as shown in Figure 2.2. Dholakia’s team 
reported with this method a sorting efficiency of up to 95% [2.1]. It was shown in 
[2.8,9] that flashing lattices, realised by amplitude modulation of the laser, can help to 
reduce the congestion of particles during the separation process. Optical fractionation 
is patented and yet commercially available from BioRyx200 by Arrys Inc [2.3]. In optical 
fractionation, the light patterns can easily be tuned making this method very flexible 
and responsive to new environments. On the other hand, the systems described are 
able to separate only one species from a mixture. In [2.10], however, separation of 
four different colloidal species is demonstrated using an optical lattice created with an 
acousto-optic deflector (AOD). An AOD is used to spatially control laser light and 
produce a complex potential energy landscape. In this experiment, a mixture of 
particles with four different diameters (2.3, 3.0, 5.17 and 6.84 mm), pumped through a 
microchannel is first focused into a single particle stream by an optical funnel. A 
following exit ramp with decreasing intensity releases the particles at different heights 
depending on their size. The smaller particles, which experience the weaker optical 
trapping force, leave the ramp first. Therefore a continuous parallel separation of four 
subpopulations is achieved. This method shows a near 100% pure sorting efficiency (all 
particles retrieved in their own specific group) and a throughput of 40 particles per 
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second. Although this throughput does not reach the throughput of conventional 
fluorescence-activated cell sorters (FACS), it is claimed that optical fractionation has 
the potential for higher throughput and might find niche application areas [2.11]. FACS 
is a common separation technique where particles are optically interrogated one by 
one and directed into different outlets depending on the interrogation result. 
However, FACS requires very expensive apparatus and fluorescence labelling. 
Optical separation presents for the most part major advantages in terms of sensitivity, 
selectivity as well as versatility and permits the sorting of particles in a continuous 
flow. However, the need for laser sources hinders the easy portability of such systems 
although the integration of vertical cavity surface emitting laser arrays offers real 
opportunity [2.12]. A real need for miniaturisation of the apparatus is necessary in this 
field. The scale up of such optical and fluidics microsystems is also a major issue. 
 
Figure 2. 2: Optical fractionation concept  3D optical lattice is introduced in the 
shared part of the chambers A, B,  C and D allowing the separation of species 
according to their size or optical properties 3D optical lattice is reconfigurable 
which allows an easy updating of  the selection criteria Scale bar is 40 mm long 
Reproduced with permission from [2.1] 
2.3 Magnetic separation 
2.3.1 Magnetophoresis 
Magnetism has many uses in biological and chemical assays such as in drug labelling 
and targeting, transport, mixing and also separation [2.13,14]. In the magnetic 
separation method, sorted particles have either intrinsic magnetic properties or are 
15 
labelled with magnetic beads. In the case of an immunological separation, coated 
antibodies bind specifically with antigens of the targeted cells in an operation called 
labelling. The concept of a conventional magnetic separation device is a 
straightforward and long-established process: a magnet is placed in the vicinity of a 
column containing the cells to be separated. Magnetically labelled cells are retained in 
the column, whereas non-labelled cells will be flushed with the buffer allowing the 
immunological separation of species. The column is removed from the magnet in a 
second step and flushed to allow the collection of the sorted particles.  This kind of 
separation is termed magnetic-activated cell sorting (MACS). MACS is also a method 
patented by Miltenyi Biotec but is widely available commercially under other names 
from manufacturers such as Dexter or StemCell [2.15,16]. The efficiency rate of the 
protocol is often better than 95% [2.17] and is used with success to isolate rare foetal 
cells [2.18]. The concept of MACS has been demonstrated at the microscale in order to 
reduce the volume of the apparatus and add other functions downstream. Benefits 
and drawbacks arise from the miniaturisation. Miniaturised magnets allow stronger 
and more precise magnetic fields because of the vicinity of magnets to the 
microchannels. On the other hand, the fabrication of integrated micromagnets 
requires numerous and expensive manufacturing steps [2.14,19]. The use of 
permanent magnets allows for portable (no electric connection) and autonomous 
devices; however, if the separation is not fully continuous, the removal of the magnet 
to flush the channel can cause difficulties. Electromagnets have the advantage to be 
easily switched on and off; however, their fabrication is more complicated and 
hampers the energetic autonomy of the system. An example of integrated microMACS 
was presented by Deng et al. [2.20], in which arrays of posts were manufactured on 
the bottom of a microchannel to trap magnetic particles. This device showed more 
efficiency compared with its macroequivalent. However, MACS is a batch process and 
might slow down further downstream analysis and limit the collection yield. Some 
attempts have been made to fabricate continuous flow magnetic separation devices. A 
technique called ‘on-chip free-flow magnetophoresis’ was demonstrated by Pamme et 
al. [2.21,22]. In this example, a mixture of different magnetic particles and non-
magnetic particles is aligned along the wall of a microchannel. A micromagnet placed 
upon the channel provides a non-homogeneous magnetic field gradient transverse to 
the laminar flow. Depending on their size and magnetic properties, particles are 
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deflected more or less from their path. The addition of spacers allows the collection of 
particles in separated outlets as shown in Figure 2.3. A continuous-flow, magnetic 
separation device for the enrichment of foetal cells from maternal blood has been 
described in a patent by Blankenstein [2.23]. This device uses the same working 
principles as the previous example although the cells require to be labelled.  
 
Figure 2. 3: Magnetic separation principle within a microchannel  Mixture of 
different magnetic and non-magnetic particles is injected in a microchannel  
Depending on their size and magnetic properties the particles will  be  more or 
less deflected from their natural path due to the magnetic field Non-magnetic 
particles will not be deflected Addition of spacers permits the independent 
recollection of different species [2.21] 
 
Figure 2. 4: Separation of red blood cells from white blood cells with  magnetic 
strips Superposed images showing the separation of a tagged leucocyte from  
untagged red blood cells using magnetic stripes  Reproduced with permission 
from reference [2.24] 
 
17 
2.3.2 Magnetic strips 
Another type of continuous magnetic separation was demonstrated by Inglis et al. 
[2.24]. In this example, some ferromagnetic strips fabricated in a microchannel provide 
an array-like magnetic field pattern at a given angle to flow direction. Cells selectively 
tagged with magnetic nanoparticles deflect from the flow path to follow the strips. 
This technique convincingly demonstrates the separation of white blood cells (WBCs) 
from human blood as shown in Figure 2.4. In another example, Han and Frazier [2.25] 
used an external magnetic field to activate a ferromagnetic wire integrated to a 
microchannel as shown in Figure 2.5. Depending on their internal properties, particles 
will be repelled or attracted by the wire and thus collected at different outlets.  
 
Figure 2. 5: Separation of red blood cells from white blood cells with a  
ferromagnetic wire Illustration of a magnetophoretic separator  Ferromagnetic 
wire is incorporated along the length of the microchannel  In the diamagnetic 
capture mode, an external magnetic field is applied normal to the x-axis of the 
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microchannel In this case the red blood cells will be deflected from the 
ferromagnetic wire and will flow through the outlets 1 and 3  In the 
paramagnetic mode, the external magnetic field is applied  normal to the y-
direction of the microchannel, which forces the  white blood cells to be deflected 
at this time from the ferromagnetic  wire.  
In one publication a magnetic blood plasma separation system was presented. 
However the system should be further miniaturized to be accepted as a microsystem 
[2.26]. 
Magnetic separation is very interesting in terms of portability and autonomy. Magnetic 
fields have never been reported to damage biological particles and therefore allow the 
gentle sorting of cells, especially between white blood cells and red blood cells. 
However, the manufacturability of the magnetic-activated separation mechanism can 
hamper the development of such devices. 
2.4 Electrical separation 
2.4.1 Dielectrophoresis and castellated electrodes 
Originally, most of the first separation techniques for microparticles used electrical 
forces. Indeed, electric-field-based manipulation is well suited at the microscale 
because of the ease with which high electric fields can be produced with micron size 
gaps and voltage of several volts only. Furthermore, in the last ten years, the 
diversification of micro-electromechanical systems into areas such as chemistry and 
biology has increased the tendency to combine electrical microsystems within 
microchannels. There are two main types of electric field-based manipulation, 
depending on the properties of the particles to be sorted. Electrophoresis, the 
movement of charged particles in a uniform electric field, is a very well known 
technique to separate and transport different kinds of charged particles. Detailed 
reviews on electrophoresis can be found in recent literature [2.27]. Dielectrophoresis, 
often confused with electrophoresis, is described by Pohl as ‘the translational motion 
of neutral matter caused by polarisation effects in a non-uniform electric field’ [2.28]. 
This technique has attracted scientific attention because of its ability to manipulate 
neutral–but polarisable–particles. Dielectrophoresis has first been applied to separate 
cells according to their size or dielectric properties. A number of early articles report 
the separation or the enrichment of particles using castellated or interdigitated planar 
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electrodes providing an inhomogeneous electric field [2.29,30]. These techniques, 
sometimes referred as stop-flow techniques, often relate to binary separation where a 
mixture is split into two subpopulations, one usually retained in the channel [2.31]. 
Sometimes particles approaching DEP affinities and size are difficult or impossible to 
separate. To overcome this limitation, Yang et al. [2.32] coupled an antibody 
recognition and a dielectrophoretic stop-flow technique. In this example, antibodies 
specific to the targeted bacterial cells are coated above interdigitated DEP arrays, 
isolated by a thin layer of SiO2. The mixture of bacterial cells is injected into the 
channel. When the DEP is actuated, all the cells are concentrated above the electrodes 
against the flow. During this time, the targeted cells bind themselves with the 
antibodies. When the DEP is deactivated, the unbound cells flow away, leaving the 
targeted cells separated in the channel. These techniques report high efficiencies, 
close to pure recollection of each type of particle and are adopted for high product 
value and low volume application. Some drawbacks can nevertheless be reported. 
First, cells are often trapped with positive dielectrophoresis (pDEP) and without careful 
control of the applied voltage and frequency, might experience very high electric 
fields, which can damage or destroy them.  A guide to the values of frequencies and 
applied electric fields affecting the viability of the cells is given in [2.33]. In [2.32], the 
cells trapped by pDEP stay viable, but an anomalous protein production is reported. 
Secondly, in general, only one subpopulation can be extracted from a heterogeneous 
mixture. Finally, even though fluid is continuously drawn through the chip, voltages 
often have to be turned on and off to collect the separated subpopulations, which can 
hamper the continuality of the process. Hydrodynamic forces have been coupled to 
dielectrophoresis to produce continuous particle separation. This technique uses 
electrodes to levitate particles to different heights depending on their dielectric 
properties. The addition of a parabolic flow allows the particles to be dragged away at 
different velocities. Separation of erythrocytes and latex beads was performed by 
Rousselet et al. [2.34]. The team of Gascoyne reported separation of different types of 
leucocytes with purity after separation up to 98% [2.35]. This technique uses negative 
dielectrophoresis to levitate particles above the electrodes and thus protects 
vulnerable biological particles from high electric fields. However, it has limitations in 
separation performance. Cells of one type can contaminate the cell population of 
another type [2.35]. 
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2.4.2 Isomotive electrode arrangements 
Other kinds of electrode arrangements have been successfully tested. Choi and Park 
[2.36] proposed a trapezoidal planar electrode array providing a specific electric field 
geometry in a microchannel. Particles focused on one side of the channel are deflected 
more or less by the electric field depending on their properties. At the end of the 
microchannel, the addition of spacers helps to collect different particles. Li and Kaler 
[2.37] reported an ingenious ‘isomotive’ electrode arrangement for continuous-flow 
separation. Isomotive refers to a specific electric field where a particle experiences a 
constant dielectrophoretic force everywhere in the field, a configuration described by 
Pohl and Pethig [2.38]. This geometry provides a better separation of species, based 
only on their dielectric properties.  
 
Figure 2. 6: DEP barriers used for cell dipping a Schematic diagram illustrating 
the concept of cell dipping Electrodes are mounted at the top and bottom of the 
microchannel Population of cells is introduced in one of the inlets  Electrodes, 
once activated, divert cells from their natural path  Cells are guided to the 
reagent and from the reagent back to the buffer  b Photograph of the experiment  
Transit time in the reagent is 0.3 s [2.39] 
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2.4.3 Dielectrophoresis barriers 
The use of dielectrophoretic barriers has also been widely and successfully 
demonstrated. A dielectrophoretic barrier refers to electrodes mounted at the top and 
bottom in a microchannel. This configuration creates an electrical field barrier which 
deflects particles from the direction of fluid flow. To separate two different species, 
the frequency and magnitude of the voltage is set such that one species exhibits 
dielectrophoretic forces and can be deflected, whereas the other species go through 
the electrical field barrier without experiencing any force. Fuhr and coworkers [2.40] 
were the first team to report such an arrangement in 1998 with serial and parallel non-
contact manipulation at high velocity. From 1998, several patents and articles have 
been published by the same team in collaboration with the German company Evotec 
Technologies and includes treatment, separating, sorting or confinement of diverse 
kinds of biological or synthetic particles [2.41,42,43]. In a publication by Schnelle, a 
particle separation is reported using dielectrophoretic forces engendered with curved 
electrodes and hydrodynamic forces [2.44]. In [2.45], a detailed experimental and 
theoretical study of DEP barriers shows a strong dependency between the channel 
height and the threshold velocity above which particles may penetrate the barrier. 
Decreasing the channel height leads to better separation efficiency. In [2.46], a system 
named NanoVirDetect is  described. This versatile module uses standardised biochips 
packaging and has individually tunable functions such as focusing, separation, holding 
of micron or submicron-sized particles and thus can be adaptable to a large number of 
different particles. Electrodes are made out of nanoporous materials to increase the 
electrode capacitance. This not only expands the frequency range of dielectrophoretic 
deflection but also allows the system to be used with higher conductivity medium 
which is of high interest especially with biological samples often flowing in relatively 
high conductivity liquids. Other teams report also the successful implementation of 
dielectrophoretic sorters, using improved DEP barriers [2.47,48,49]. Although the new 
configurations double the maximum flow speed compared to a classical strip-like 
electrode, plane electrodes show more temperature rise than the classical geometry, 
which is a major drawback for sensitive biological or chemical applications. A focusing 
device has been fabricated by Morgan et al. using a quadrupolar electrode 
arrangement [2.50]. In [2.51], a tripolar electrode arrangement for separation 
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purposes is demonstrated. In this application, two tripolar strip-like electrode 
arrangements are embedded on each side of the bottom of the channel. Thus, 
particles experiencing positive DEP are expected to flow near the electrodes, whereas 
particles with negative DEP affinity are focused along the central axis of the channel. 
This simple geometry might not be so proper for continuous flow, as particles with 
positive DEP will probably stick to the electrodes if the flow is too slow, hampering the 
collection of the species. A high speed cell-dipping system is proposed in [2.52] and 
shown in Figure 2.6. A classic pair of strip-like electrodes is mounted at the top and 
bottom of a 20 mm high microchannel. A large amount of particles is transferred from 
one reagent to the other in less than 0.5 s at a flow speed of 300 mm.s-1. A large 
diffusion of the dye shown as the second flow stream can be noticed after the first 
barrier and might be because of some electrokinetic forces or a perturbation in the 
flow caused by the accumulation of particles on the tip of the barrier. The addition of a 
spacer between the two streams, as stated in Fuhr’s patent, can help to avoid this 
perturbation [2.42].  
2.4.4 Improvements in  dielectrophoretic barriers 
In recent years, new ideas have been developed to enhance performance of DEP 
separations systems. A different channel geometry for dielectrophoretic focusing of 
particles is presented by Leu et al.[2.39]. In this device, a mixture of particles is 
separated in a single particle stream with a combination of DEP forces and 
hydrodynamic forces in a funnel-like channel. Although the result is obviously useful in 
term of particles analysis, the electrodes need to be embedded on the channel side 
walls, which is a laborious fabrication step. An interesting insight to improve 
separation is proposed by the team of Hu [2.53]. In this approach, labelling of cells 
with particles that differ in polarisation response enhances the sorting activity. A flow 
speed of 300 mm.s-1 in a 20 mm high channel can be obtained. However, this process 
requires a supplementary step of labelling. Park et al. [2.54] reported a fan-shaped like 
electrode geometry creating a unique asymmetric electric field gradient. In this 
concept, the applied fiel[2.39]d is continuously varied because of a half-circular type of 
microchannel and this geometry increases the discrimination power of the device. 
However, this approach leads to a higher temperature rise. The use of so-called 
electrodeless DEP was reported. In this method a homogeneous electric field is created 
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within a microchannel by introducing electrodes at the inlet and outlet. Insulating 
obstacles are placed within the channel rendering the electric field non-uniform, which 
leads to the creation of a dielectrophoretic force. Electrodeless DEP prevents electrode 
fouling and electrode destruction sometimes reported in DEP manipulation. Originally 
this principle was applied with arrays of insulating posts in a microchannel [2.55,56]. In 
this kind of arrangement, particles sensitive to DEP are trapped between posts, 
whereas others flow along. This results in a non-continuous system as the voltage has 
to be turned down to recollect the trapped particle. Using the same concept, 
Barbulovic-Nad et al. realised an original device incorporating an oil droplet at one 
point of the side wall of a microchannel. Particles approach the base of the droplet in 
the same fashion and are diverted more or less at the top of the bubble in the highest 
electric field zone. This allows the parallel collection of different particles [2.57]. The 
separation can be tuned by changing the size of the droplet. Renaud and coworkers 
[2.58] proposed recently a device embedding large electrodes insulated from the main 
microchannel by 5 thin, dead-end channels. These effective methods nevertheless 
require high voltages and create relatively high electric fields, sometimes exceeding 
the threshold of safe cell manipulation.  
2.4.5 Traveling wave dielectrophoresis 
Another kind of electrical separation, known as travelling-wave dielectrophoresis (TW-
DEP), has been demonstrated. In TW-DEP, particles are transported across arrays of 
interdigitated electrodes being energised with sinusoidal electric signals [2.31]. A 
travelling electric field, produced by phase shifting of the signals, induces a dipole 
moving in a direction perpendicular to the direction of the electrodes array. As the 
speed and direction of the motion depends on the particle’s dielectric properties, 
separation of different species can be achieved. Recently, Pethig et al. [2.59] 
demonstrated the separation of T-cells from monocytes with a superposition of TW-
DEP signals. The technique of signal superposition leads to a reduction in the length of 
the electrode array needed to achieve separation.  
To summarise, the use of an electric field for particle separation is a relatively old, 
established technique. Among the different kinds of microdevices using electric field-
based separation in continuous flow, examples include DEP fractionation, DEP barriers 
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and TW-DEP. Many different electrode arrangements related to these reliable and 
efficient techniques can be found in the literature. Moreover, it has been 
demonstrated that dielectrophoretic barriers have the potential for greater 
exploitation. Nevertheless, the use of electrodes introduces an important fabrication 
step which increases the cost of the microdevice and might hamper mass-
manufacturability. One publication reports on the use of electric field for blood plasma 
separation in a 10µL drop of diluted blood, however, no result is presented in this 
study [2.60].   
2.5 Fluidic-only separation 
2.5.1 Hydrodynamic separation 
To tackle the problem of outer force field requirement in separation devices, 
researchers proposed recently some techniques which can be termed ‘fluidic-only’ 
separation. In these separation methods, particles are sorted exclusively by size, often 
using only the geometries of microchannels and hydrodynamic forces. These 
techniques are particularly suitable for blood plasma separation as they can be 
developed using cheap disposable polymer-type of material. Moreover they are often 
gentle to cells (no electrical field for example), and do not require any outer field. 
2.5.1.1 Microcentrifugation 
Conventional techniques for blood plasma separation in traditional laboratories 
include centrifugation and filtration. Both methods are time-consuming, relatively 
expensive and might damage cells if not used carefully [2.61]. In the light of the 
disadvantages outlined above and the benefits that microscale techniques can provide 
in terms of volume of blood extracted, response time and portability, it is therefore 
unsurprising that the alternative blood-plasma separation on-chip has gained 
increasing interest over the last few years.  
In that respect, several broad avenues of research have been implemented that try to 
replicate the benefits of traditional centrifugation methods. The miniaturization of  
centrifugation has been the topic of many research groups. Ducrée and Madou, for 
example, have utilised centrifugal forces developed through the rotation of their lab-
on-CD devices to separate red blood cells from plasma [2.62,63]. Figure 2.7 illustrates 
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the concept of the lab-on-CD and a blood plasma separation using this tool.  Among 
the advantages of the lab-on-CD platform is the lack of clogging effect that might 
reduce the efficiency of separation in other devices. Centrifugation is often considered 
as “non-continuous”, however on Lab-on-CD devices, the samples might be processed 
in-line after the separation or other functions.  
  
Figure 2. 7: (a) Illustration of the concept of the “biodisk”. Courtesy of  IMTEC 
(b) Blood plasma separation in the lab-CD    
Using a mini-centrifugal effect, Blattert et al. proposed a bend structure to increase the 
plasma-free layer existing naturally in microchannels and extract plasma [2.64], in  that 
way the blood plasma separation is fully continuous. This device is shown in Figure 
2.8a. More recently, an original centrifugation device using a spiral design was 
proposed in [2.65] for blood plasma separation. A spiralling channel with a cross-
section of 200µm x200µm and 12cm long as shown in Figure 2.8b was used in an 
attempt to create high centrifuge acceleration. However, due to Dean vortices the 
efficiency of the system was limited. A 180 bend device was subsequently designed to 
reduce this side effect. Although this device was more efficient than the first one, 
significant haemolysis was observed. 
2.5.1.2Filtration 
Filtration is another conventional method to separate plasma from whole blood, and 
has also been miniaturized. Moorthy et al presented a device with an integrated 
membrane, or porous plug, allowing the filtration of cells greater than 3μm, however 
the device is easily clogged [2.66]. Cross-flow filtration has been implemented with 
more success by Vandelinder et al. and Chen et al. in Polydimethyloxane (PDMS)  
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Figure 2. 8: Development of centrifugal effects on-chip [2.64] (a) Bent channel 
and bifurcations (b) Spiral design[2.65]      
devices [2.67,68]. However, as pointed out by Becker, results obtained in PDMS 
devices are hardly reproducible on commercial chip applications [2.69]. Additionally, 
two original filtering geometries were proposed by Sollier et al [2.65]. A U-filter and 
Snake design (serpentine like) were manufactured to test the efficiency of hard beads 
and RBCs separation. These devices proved to have relatively good separation 
efficiency, at the expense of a small operation time, due to rapid clogging of the pores.      
2.5.1.3 Lateral displacement 
Some researchers have focused on the development of more continuous separation 
methods applicable to blood plasma separation using hydrodynamic forces. These 
methods, alongside centrifugal and filtration techniques, are sometimes labelled as 
“passive”, as they do not require any external force field but the force induced by the 
pumping of the fluid itself [2.65].   
In 2004, the team of Yamada and Seki proposed a pinched-flow separation device 
[2.70]. The concept is shown in Figure 2.9. A mixture of different-sized particles is 
injected into a buffer. With the help of another fluid, particles are aligned to a sidewall 
of a pinched segment, which is subsequently broadened; at this point, hydrodynamic 
forces act differently on particles, deflecting the small ones away from the big ones. 
Flow rates of the two inlets and the angle between the two segments are determining 
factors to sort the different sizes of particles. In 2005, Yamada et al. proposed a two-
step technique called ‘hydrodynamic filtration’ to get rid of the need of a second 
buffer to control the separation; concentration and classification are performed at the 
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same time [2.71]. A fluid containing particles is injected in the main microchannel 
having multiple branch points and side channels. Particles do not enter the 
subchannels when the relative flow rates at the branch point are low. This permits in a 
first step the withdrawal of the liquid and the concentration of the cells. Increasing 
stepwise the relative flow rates at each branch point allows the collection of firstly 
small particles and secondly large particles. The size limit of the sorted particles is 
determined by a precise distribution of the flow rate at each branch. This technique 
was proven by the enrichment of WBCs. Although, RBCs remain present in the fraction 
of interest, the relative concentration of WBCs in relation to RBCs was increased by 29 
times.  
 
Figure 2. 9: Separation of different-size particles in a pinched segment 
Schematic diagram illustrating the principle of pinched -flow fractionation a In 
the pinched segment, particles are aligned to one sidewall regardles s of their 
sizes by controlling the flow rates from two inlets  b Particles are separated 
according to their sizes by the spreading flow  profile at the boundary of the 
pinched and the broadened segments [2.70] Copyright 2004 American Chemical 
Society 
Other fluidic-only separation techniques emerged from preliminary work on 
microcirculation [2.72].  These techniques are particularly relevant in the case of blood 
plasma separation, where the axial migration of blood cells in microchannels below 
300µm is used for sorting [2.64,73,74]. A number of studies have been published by 
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different groups in the literature. Pharmaceuticals companies like Roche have 
published reports on the integration possibilities of such preliminary modules [2.75]. 
An example of blood plasma separation module manufactured by Roche is presented 
in Figure 2.10a. Faivre has used constrictions integrated before a bifurcation, as shown 
in Figure 2.10b, to increase the natural cell-free layer of blood flow at low Reynolds 
number using lateral migration [2.76]. A constriction integrated in a microchannel was 
demonstrated to enhance the cell free-layer up to 1 cm downstream. The addition of 
spacers near the channels walls allows the pure collection of plasma. Yang’s team 
presented a microfluidic network of T-channels to retrieve pure plasma with a series of 
10μm bifurcations in a 15μm main channel (Figure 2.10c) [2.74]. The same principle 
was used by Fan et al to extract plasma for protein analysis [2.77]. Effenhauser et al 
presented a 3D structure taking advantage of a high-aspect ratio with a single 
bifurcation to produce a better plasma yield [2.78].  Sollier et al, demonstrated 
recently a series of original structures to enhance the cell-free layer using constrictions 
and bifurcations (Figure 2.10.c) or ear-cavities and bifurcations and allowing up to 2x 
increase in extraction yield for 100% pure plasma [2.65,79] 
Lateral migration has also been demonstrated to extract plasma at higher Reynolds  
number and large flow rate by DiCarlo [2.81]. More recently, Rodríguez-Villarreal et al. 
have demonstrated a high flow rate blood plasma separation device using one 
constriction and one bifurcation [2.82]. The biological validation of the resulting 
extracted plasma in terms of contamination was however not presented in this article. 
An exhaustive comparison of passive blood plasma separation techniques has been 
presented by Sollier et al.[2.65].    
2.5.2 Deterministic lateral displacement 
Another technique called deterministic lateral displacement was set up and tested by 
Huang et al. [2.83]. In this method, microposts are placed in rows within a 
microchannel. Each row of posts is shifted from the other by a distance which partly 
sets the critical separating size. The asymmetric bifurcation of laminar flow around 
obstacles leads particle to choose their path deterministically on the basis of their size. 
A small particle will have a zigzag displacement path, whereas a large particle will tend 
to flow straight. After a number of rows, the particles can be collected separately. This 
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Figure 2. 10: Lateral displacement devices (a) Simple channel for the extraction 
of plasma from blood [2.75]. (b) Use of a constriction to enhance the natural 
cell-free layer in RBC flow [2.76]. (c) A more complex microfluidic network 
[2.74] (d) An example of enhancement of the cell free layer with the use of 
optimised constriction and bifurcations [2.80].  
method is cost effective and can separate in parallel a large number of different-sized 
particles with a precision of up to 10 nm. The method was successfully tested for the 
separation of WBCs and RBCs [2.84]. However, because of a high risk of clogging 
because of the numbers of posts employed and the narrow gaps between them, 
Huang and coworkers [2.85] presented later an optimised device including additional 
regions alongside the active sorting arrays. These additional regions collect the larger 
particles that have been sorted. Although these regions also contain pillars to maintain 
the same pressure drop across the system, the gaps between the pillars are made 
larger to avoid clogging. This device removed all the particles larger than 1 mm from 
whole blood, allowing the collection of pure undiluted plasma. The latest technique is 
patented in [2.86]. Recently Li et al. labelled CD4þ T helper lymphocytes with 25 mm 
polystyrene beads in a mixture of WBCs injected in a lateral displacement system 
[2.87]. Up to 91% of the specific lymphocytes were therefore separated from the other 
kind of WBCs. This article demonstrates the possibility of cell subtype sorting with the 
continuous-flow lateral displacement method.  
a b 
c d 
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2.5.3 Density based extraction  
Density based extraction, also known as ‘liquid–liquid extraction’ is another fluidic-only 
separation technique widely used in the chemical and biological industries. The 
concept exploits the preferential affinity or differential diffusion coefficients of solid 
compounds in a laminar flow of two liquid streams. H-filters developed by Yager et al. 
[2.88] have used this technique to extract molecular analytes from whole blood. Nam 
et al [2.89] proposed a microsystem incorporating this technique. In this device, the 
injection of cells in a thin stream between two phases allows the cells to partition in 
the preferred solvent. The sorting efficiency of the microdevice was reported to be 
97% which is higher than its macroscale counterpart. However, it is not a versatile 
technique, as only two types of particles can be sorted at the same time using 
sometimes very specific solvents. Liquid–liquid extraction is particularly adapted to 
chemical extraction, such as extraction of hydrocarbons from oil in the petrochemical 
industry or extraction of organic compounds from extraterrestrial dissolved minerals in 
space exploration [2.90,91]. In conclusion, these fluidic-only separation techniques 
have the great advantage of not requiring any outer field. Therefore the manufacturing 
of these devices relies only on microchannel networks. Manufacturing of these 
channels can be achieved via hot-embossing or microinjection moulding. This holds the 
potential for cheap and mass- manufacturable devices, which is particularly relevant in 
the case of point-of-care devices. However fluidic-only separation devices, with the 
exception of the last example, can separate particles by size only. 
2.6 Other types of separation 
2.6.1 Thermal separation 
A system using an outer thermal field is described in [2.92]. In this device, a 
temperature difference is applied across the microchannel. A separation between 
particles occurs because of the difference of thermal diffusion coefficient. In such a 
system, particles can react to a temperature gradient and will be displaced more or 
less rapidly, depending on their physical properties towards the cold wall of the 
microchannel across the flow. This technique does not have large separation efficiency 
and particles are not easily collectable from different outlets. However, it has been 
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recently observed that temperature modifies the separation parameters of cells in 
[2.82] and therefore might be applied in the future to enhance hydrodynamic blood 
plasma separation in some specific cases.   
2.6.2 Acoustic separation 
Acoustic separation can also be found in the literature [2.93,94,95]. The last reference 
demonstrates a separation efficiency near 100% which is comparable with 
conventional blood cell separation by centrifugation. The three-stage separation 
device is shown in Figure 2.11.  
 
Figure 2. 11: Sorting using ultrasonic field a Schematic of a three-stage 
microdevice Particle separation here occurs on each stage of the separator  On 
each stage, most of the particles in the solution being affected by  the ultrasonic 
standing waves are directed to the side channels of the  flow splitter, whereas 
the diluted solution flows via the central channel and passes to the second stage 
for further dilution and separation b Photograph of the experiment in a one-
stage microchannel Particle concentration is 7.5% in volume Scale bar is 100 
mm.[2.91] 
In another study, a transversal excitation was applied to an 8 branch system in order to 
separate cells from plasma [2.94]. The blood was undiluted, but four systems were 
needed to end up with a final contamination of the plasma inferior to 1%. The quality 
of the plasma was studied in a separate publication [2.93]. 
Acoustic separation techniques can offer continuous sorting of particles and is 
especially well adapted to blood plasma extraction as its best capability is a 
particle/medium type of separation.  
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2.6.3 Hybrid techniques 
Acoustic techniques can be adapted with other techniques to form hybrid systems. 
Indeed, Wiklund et al. [2.96] presented recently a device combining short-range DEP 
manipulation with long-range ultrasonic wave (USW) manipulation. In this device, a 
DEP force is induced by an electric field between co-planar electrodes at the bottom of 
the microchannel. A transducer made of a piezoceramic element and a 
polymethylmethacrylate (PMMA) refractive edge is placed on the glass cover of the 
chip. The two combined forces permit particle trapping, sorting, concentration and 
separation with selectivity up to 90%. This method had been previously described to 
some extent in a patent [2.97]. In the latter work, USW was also proposed as a means 
for transportation of particles. The DEP/USW manipulation looks promising for high-
throughput (because of the use of long-range USW forces) and high precision (because 
of the use of short-range DEP forces) applications.  
2.7 Applications of cell separation 
2.7.1 Blood plasma separation 
Blood separation is a strategic preliminary step in preparation for biological analysis 
on-chip. Polymerase Chain Reaction (PCR) can be performed on whole blood but the 
reaction is inhibited by components of blood such as haemoglobin (cellular portion) 
and IgG (plasma portion); therefore, by separating blood into its basic components of 
plasma and cells, the reaction can be optimised for better results [2.98,99].  
Blood plasma separation is particularly relevant in the field of theranostics, the new 
driver for bed-size diagnostic and treatment. Theranostics is defined as the 
combination of the diagnostics and therapeutic fields, whereby a disease could be 
screened daily such that the correct dose of medicine is administered to the patient as 
in the treatment of HIV [2.100]. Therefore it is necessary to get blood samples from 
patients once or several times on a daily basis. Microfluidics is particularly helpful in 
that respect, as it permits the analysis of few microlitres of biological samples, and 
avoids the painful blood extraction of several dozens of millilitres. Blood microsamples, 
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once extracted, are separated in most cases for downstream analysis. Theranostics is 
to grow by 20% until 2010 to reach a market estimated at 3.5 billions Euros [2.101].   
For point-of care diagnostics, it is well known that the sample preparation step is a 
serious bottleneck in microfluidics. The development of miniaturised modules capable 
of de-skilled blood separation would aid in the translation of this new technology. 
Optimum on-chip blood plasma separation techniques should have a large throughput, 
a high plasma yield and purity, with minimum cellular damage in order to prevent 
contamination of the plasma with cellular DNA and haemoglobin. Plasma yield is 
defined as the volume percentage of plasma that can be extracted from the device 
over the total volume of plasma in the blood.   
Blood plasma separation can however be applied to a variety of other fields, such as 
environmental pollution monitoring. Indeed, evidence shows that various sea shells 
and fishes indicate perturbed physiology in polluted areas [2.102,103]. The analysis of 
toxic compounds such as heavy metals in mussel haemolymph can potentially provide 
valuable environmental monitoring [2.104].    
2.7.2 Cell separation for HIV management 
The management of HIV disease in patients is a typical example of theranostics. 
Although HIV diagnostic relies on the separation of specific human T-lymphocytes from 
whole blood, its treatment is also adapted in function of the advancement of the 
disease. Therefore separation is continually needed through the length of the disease 
[2.100].  
2.7.3 Prenatal diagnosis 
Prenatal diagnosis to determine the outcome of pregnancies and detect conditions 
that may affect future pregnancies has risen as a big issue among the broad public. 
Conventional prenatal tests are using invasive techniques, such as amniocentesis or 
Chorionic Villus Sampling (CVS), which can result in abortion or growth abnormalities 
in up to 2% of the cases.  
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Non-invasive prenatal diagnosis can be performed by separating rare foetal cells from 
maternal blood, consequently avoiding the potential risk of amniocentesis and CVS 
[2.18,105].  Fetal target cells comprise: lymphocytes, nucleated erythrocytes and 
trophoblasts. Among the challenges identified in this field are the lack of gender-
independent fetal markers, the rarity of fetal cells, the reproducibility of results and 
the technology [2.18]. Although fetal cell recovery is still in its infancy and has to be 
greatly improved to meet clinical standards, this route has the potential for non-
invasive for early prenatal diagnosis.   
Circulating cell-free DNA in plasma and serum was first reported by Mandel and Metais 
in 1947. The correlation between levels of cfDNA and different pathologies was made 
three decades later with observations on cancer patients [2.106]. With new molecular 
technologies being developed, it resulted in an increasing interest in the detection and 
analysis of cfDNA [2.107,108,109,110]. However, it was not until 1997 that cell free 
foetal DNA, cffDNA, was detected in circulating maternal blood and arose as a mean to 
perform non invasive prenatal diagnosis [2.113]. cffDNA is not only used today to 
diagnose gender-linked conditions or foetal rhesus D status [2.114,115] but cffDNA is 
also employed as an indicator for pregnancy associated diseases such as pre-eclampsia 
and preterm labour [2.116]. The separation of plasma or serum from whole blood is a 
prerequisite to the analysis of cfDNA. Usually, purification is mostly required to remove 
the major inhibitors of the Polymerase Chain Reaction (PCR). These inhibitors include 
natural components such as heme and immunoglobulin G and exogenous components 
such as anticoagulants [2.117]. Furthermore, a plasma free of cells, reduces the 
contamination of the plasma with cellular DNA which can interfere with the accuracy 
of the DNA analysis. Traditionally plasma is separated from blood by centrifugation or 
filtration.  
Fetal RNA, like cfDNA, can be detected from the maternal plasma and necessitate the 
separation of plasma from whole blood. RNA has been found to be very stable at room 
temperature for up to 24h after the venipuncture, which makes it an ideal target 
[2.18]. Moreover it is thought that RNA might provide more information than cfDNA.  
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2.7.4 Cancer cell detection 
Microseparation techniques are also needed for the detection of cancer cells or the 
accumulation and counting of various types of cells and bacteria. As a particular 
example, testicular stem cell transplantation is a potential solution for the recovery of 
fertility in testicular cancer survivors [2.118]. However, the effectiveness of the 
transplantation is based on the number of stem cells transplanted. Testicular stem 
cells represent a very small fraction of testicular cells collected for this operation 
(0.03% in the mouse). Enrichment of stem cells is therefore highly desirable. 
Moreover, there is a risk of contamination by carcinogenic cells in a testicular cell 
suspension leading to a malignant relapse in the treated patient. Cell sorting is a 
solution to circumvent the contamination. Tournaye et al. show that the currently 
available macrotechniques do not allow the total depletion of malignant cells and 
subsequently illustrates the need for a finer gentle separation of cells [2.119]. 
Additionally, cfDNA detection allows the diagnosis and prognosis of various 
malignancies [2.107,108,110,111].  
2.7.5 Plasma viscometry 
Plasma viscometry is another application for cell separation from whole blood. Plasma 
viscometry is a technique competing with the more well-known ESR technique 
(Erythrocytes Sedimentation Rate). Plasma viscometry is a non-specific diagnostic test 
for a range of disorders. Patient plasma viscosity gives indication of several pathologies 
as indicated in Table 2.1. Plasma viscometry is used as a diagnostic tool in more than 
90% of myeloma cases. Additionally PV is also used to detect haematological cancers 
and cardiovascular diseases.  
2.7.6 Industrial applications 
For agrochemical, cosmetic and pharmaceutical companies, these techniques permit, 
the separation, at production level, of solid products for post-treatment. In the food 
industry, potentially harmful bacterial activity is carefully monitored. Separation and 
enrichment of bacteria is necessary preliminary to analysis [2.32]. Monitoring of 
biological weapons is an important activity in the defence sector. In this field, 
separation is required to detect threatening agents such as anthrax [2.120]. All these 
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examples account for the tremendous need of portable, low-cost separation 
microdevices in a wide range of fields.    
Plasma viscosity range Associated Pathology 
<1.40 
Found in infants under 3 years old and patients with low 
immunoglobulin or fibrinogen levels. 
1.40-1.75 None 
1.75-2 
Chronic disorders e.g. infection, malignancy, vascular 
disease. Autoimmune such as rheumatic diseases. 
2.01-3 
Suggestive of myeloma. IgG-paraproteins. High 
concentration of asymmetric paraproteins 
>3 
Suggestive of Waldenstrom’s macroglobulinaemia. 
Grossly raised IgM-paraproteins. 
Table 2.1: Associated pathologies versus plasma viscosities range. 
Adapted from www.benson viscometers.com  
2.8 Conclusions  
Recent advances in continuous microparticle separation have been presented in this 
chapter. The extensive literature in the field as well as the wide range of applications, 
illustrates the tremendous interest drawn by continuous microparticle separation. 
Separation is an important activity in the biological, medical and defence fields, to 
name but a few. Microparticle separation illustrates well the joined effort of different 
scientific communities that characterises the route towards integrated lab-on-a-chip 
devices. High throughput and high efficiency characterise optical fractionation in 
continuous flow. Magnetic separation is a gentle separation technique providing 
potential autonomy for a portable device if used with a permanent magnet. DEP 
separation is a well-established, robust and reliable technique applicable to a wide 
range of applications, not only separation but also focusing or dipping. Fluidic-only 
techniques are gentle, label-free techniques easily mass manufacturable. Other 
separation techniques such as thermal or acoustic separation can prove useful when 
coupled with other techniques to form hybrid systems which can manage a wide range 
of functions.  
All techniques presented in this review have the potential for immunological 
separation. The possibility to label cells with various kind of beads (magnetic, 
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polystyrene) using antibody recognition, opens up the future of immunological 
separation within microchannels. Some of these techniques already have commercial 
applications, whereas some of the others will undoubtedly find new applications. In 
general, lab-on-a-chip modules will not always replace conventional laboratories but 
might find niche markets. In this chapter, we have also highlighted new manufacturing 
trends such as the integration of optical components on a chip and development of 
cheap, highly mass-manufacturable components. The future of separation techniques 
may lie in hybrid techniques combining different methods for better accuracy, 
efficiency and versatility. Reducing the size of the apparatus surrounding the chip 
remains by itself a challenge to be overcome for separation applications to be 
commercially viable. 
In this study, we chose to tackle the issue of sample preparation in microfluidic system 
and in particular of blood plasma separation. Among the techniques presented in this 
review only one type allows a straightforward and cheap manufacturing process: 
hydrodynamic separation. Among others, this technique was chosen for its small 
footprint which increases its integrability in a more complex microsystem. The 
approach presented in this study differs from existing ones as it combines two 
separation mechanisms previously used separately, namely a constriction effect and a 
series of bifurcations. These mechanisms will be detailed in the next section. 
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Chapter 3: Theory and design 
3.1 Introduction 
Due to its particulate nature, blood is a complex fluid which can show specific behavior 
in a number of different situations. Still today, the theory of blood flow in various 
vessels is incomplete. This chapter presents the main theoretical ideas of blood flow in 
microvessels in order to explain the different effects involved into blood plasma 
separation at the microscale. Blood composition and the particular behavior of red 
blood cells which compose more than 40% of blood particulates are explained. The 
requirements for blood plasma separation are then detailed along with the 
delimitation of the study. An original rationale of red blood cells behavior in 
microchannels is presented in a chart format. The design of two generations of devices 
for the extraction of plasma are detailed towards the end of the chapter.  
3.2 Blood: a complex living fluid 
3.2.1 Blood composition 
Blood is a bodily fluid composed of several types of cells suspended in a fluid medium 
known as plasma. The cellular portion of the blood is divided between erythrocytes 
(red blood cells), leukocytes (white blood cells) and thrombocytes (platelets) as shown 
in figure 3.1. The normal blood pH range is 7.35-7.45 and the human blood bulk 
density at rest is around 1060 kg/m3. Humans are known to have approximately 5 litres 
of blood which consist of 7% of the total body weight.  
49 
 
Figure 3. 1: Artist’s view of blood composition. Courtesy of  Encyclopedia 
Britannica, Inc.  
The primary function of blood is the transport of oxygen which is necessary for the 
different body tissues. Additionally, blood transports proteins and antibodies. The 
blood circulation is activated through the organism via heart movement which initiates 
three distinct circuits:  
- the pulmonary circuit transports blood from the heart to the lungs,  
- the coronary circulation provides the heart network  
- the systemic circulation, is the circulation of blood through all the remaining 
vessels of the body.   
Blood cells originate from the bone marrow which produces stem cells common to all 
blood cells (pluripotential hematopoietic stem cells). Blood flows through vessels, 
flexible tubes of different shapes and constructions. Arteries, which branch out of the 
heart, need to pump a lot of fluid, and therefore can be larger than 10mm in diameter. 
Arterioles, a smaller kind of vessels branching out of arteries, subdivide into capillaries 
which can be as thin as diameter as a single cell, ie around 10m. The thin wall that 
forms the capillaries is called the endothelium and plays a major role in the absorption 
of oxygen and proteins delivered to the muscles and organs. The main vessel functions 
and dimensions are presented in Table 3.1 
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Name of vessel Function Dimensions 
arteries 
Wide and thick vessels that 
carry large quantities of 
blood away from the heart 
0.1-20mm 
arterioles 
Vessels that branch out 
from arteries 
15-100m 
capillaries 
Very narrow vessels with 
thin walls permeable to 
oxygen and carbon dioxide 
5-15m 
Table 3. 1: Main vessels function and dimensions  
The volume percentage of Red Blood Cells (RBCs), also called hematocrit, can vary 
between 35 to 55% depending on the age and sex of the individual. Red blood cells, or 
erythrocytes, which have a lifespan of around 120 days, are the particles transporting 
the oxygen to the body tissues from the heart to all limbs.     
RBCs get their red colour from the iron present in the hemoglobin molecules. As 
shown in Figure 3.2, RBCs have no nucleus; their biconcave shape changes depending 
on the characteristics of the buffer they are immersed in. Blood flow characteristics 
are dominated by the behaviour of these particles given their high concentration, 
about 5 millions cells per microlitre of blood.    
  
Figure 3. 2: (a) Red blood cells, courtesy of The Science museum 
(www.sciencemuseum.org.uk) (b) Red blood cells and white blood cells  [3.1]. 
White Blood Cells (WBCs), also called leucocytes, are the primary agents against 
infections. The number ratio of white blood cells against red blood cells is about 1 to 
1000, and the volume ratio is about 1 to 600. Therefore WBCs do not contribute 
greatly to the blood flow behaviour; although they are the biggest of blood particles 
(10-40µm), they have little influence on the blood viscosity [3.2]. However it has been 
suggested that white blood cells may contribute to microvascular network resistance 
[3.3]. The three main types of white blood cells are the granulocytes, lymphocytes and 
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monocytes a shown in figure 3.3. Leucocytes are mostly round cells and, in 
microvessels at low Reynolds number, they roll along the surface before being 
agglutinated and transported through the membrane during inflammatory response 
[3.1]. White blood cells have a lifespan ranging from a few days to years.   
Platelets, also called thrombocytes,, are the smallest of blood particles (2-3µm). They 
are responsible for blood clotting, a complex chain of reactions leading to the 
formation of a clot of blood over a wound. Platelets occupy 1/800 of the cell volume in 
blood [3.4]. Because of their small size, platelets do not play a considerable role into 
the blood flow behaviour at microscale. They do have, however, an important role into 
the blocking of vessels in-vivo and in-vitro. This role will be discussed to some extent in 
the results chapter. The lifespan of platelets is about 10 days.  
 
Figure 3. 3: Blood smear with staining showing the different types of white 
blood cells [3.1] 
Plasma is the water-based blood buffer and constitutes more than half of the blood. 
Plasma hosts many other components such as protein molecules, peptides and 
metabolites. Protein molecules are important indicators of various diseases and are 
one of the reasons why separating plasma from blood is of clinical importance.  
Proteins play a predominant part in most biological processes. Studying proteins may 
give clue to the health of cells as evidenced in oncological studies [3.5]. Sampling the 
blood is the easiest way to detect and monitor cancer without having to subject 
patients to clinical interventions in order to obtain cancerous tissues as illustrated in 
Figure 3.4. Instead of studying the tumours themselves, cancer can now be 
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characterized at the molecular level by the analysis of DNA copy number, patterns of 
gene expressions and changes in serum proteins. For the latter, blood plasma 
separation is vital as serum is obtained from pure plasma.   
 
Figure 3. 4: illustration of blood sampling vs tissue sampling, courtesy of 
Medscape.  
Cancer-associated proteins may be used not only to detect cancer tumours at an early 
stage of development but also to monitor the progression of cancer and the response 
to therapy [3.6]. Table 3.2 summarizes a list of cancer biomarkers and their location. 
Many cancer biomarkers approved by the US Food and Drugs Administration are to be 
found in plasma.   
Pregnancy-related biomarkers are present in the plasma of pregnant women. Human 
Chorionic Gonadotrophin (hCG) protein is a hormone produced during the pregnancy; 
hCG levels are undetectable in non-pregnant women but double every two days during 
early pregnancy. A blood hCG test is required to confirm if a woman is pregnant, but 
hCG levels are also monitored for prenatal diagnosis. A number of other markers 
including Pregnancy-Associated Plasma Protein A (PAPPA) and pregnancy specific β1-
glycoprotein (SP1) are used for prenatal diagnosis, in the latter case the detection of 
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Trisomy 18, or Edwards Syndrome, a serious chromosomal abnormality. Biomarkers 
are not necessarily proteins; they can also be Cell-free DNA, or cell-free RNA floating in 
the plasma. This topic will be discussed in chapter 7.   
 
Table 3. 2: List of cancer biomarkers approved by the US Food and Drugs 
Administration , courtesy of Medscape (Source: Nature Review Cancer 2005)  
3.2.2 Red blood cells characteristics  
The highly particular structure of RBCs is the key to understanding the behavior of 
blood flow. Red blood cells are extremely deformable particles and a precise 
determination of their geometry is not a straightforward task [3.2]. Additionally, in 
response to hydrodynamic situations, they can take up different shapes. Their volume 
also changes depending on the tonicity, the ratio of solutes to solvent, of the buffer 
solution.   
The degree of non-sphericity of particles can be expressed by the shape factor 
proposed by Wadell [3.7]:   
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A
As      (3.1) 
Where A is the actual surface area and As is the surface area of the sphere with the 
same volume (smallest possible area per unit volume) defined by: 
 3
2
3
1
6VAs                                    (3.2) 
RBC surface area is approximately 135mm2 and its volume 94mm3. In normal 
situations, the factor of non-sphericity of the red blood cell is around: 74.0 . 
Figures 3.5a and 3.5b present a normal RBC and a large RBC.  
 
 
 
 
 
Figure 3. 5: (a) Dimensions of a normal sized RBC at 300mosmol (b) Dimensions 
of a large sized RBC at 300mosmol. (c) Dimensions of a mean sized cell at 
217mosmol (d) Dimensions of a mean sized cell at 131mosmol.   
Table 3.3 contains experimental data from Evans and Fung [3.8] which demonstrates 
that the shape and dimensions of the RBC change with respect to the solution tonicity, 
the measure of the osmotic pressure1 between the cell and the solution, here plasma. 
                                                     
1
 Osmotic pressure is expressed in osmol or mosmol (=0.001osmol). The osmotic pressure is calculated 
as the number of moles times the number of solutes present in the solution. 
a
 
a 
 
d
 
a 
 
b
 
a 
 
c
 
a 
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In this case, when the solution is 290-300 mosmol, the solution is isotonic and the net 
flow of liquid into the RBC equals the net flow out.      
When the solution is decreased to 217 mosmol and below, the solution is hypotonic as 
fewer particles exist in the solution than in the RBCs. The fluid flows into the RBC 
causing it to expand. At 131 mosmol the RBCs become spherical. The volumes of the 
RBC in hypotonic case are shown in Figure 3.5a and b. 
Tonicity 
(mosmol) 
Diameter 
(µm) 
Minimum 
Thickness 
(µm) 
Maximum 
Thickness 
(µm) 
Surface Area 
(µm2) 
Volume 
(µm3) 
300 7.82 0.81 2.58 135 94 
217 7.59 2.10 3.30 135 116 
131 6.78 Appears spherical 145 164 
Table 3. 3: Experimental data from Evans and Fung [3.8].  
Red blood cells are also extremely deformable when subject to mechanical forces. A 
shear stress of the order of 0.02mbar can induce a deformation with a stretch ratio of 
up to 200% on the membrane [3.1]. The cell membrane is elastic and has a finite 
strength and, due to the absence of a nucleus, a red blood cell can squeeze itself into 
the smallest of blood vessels. A RBC can flow through microchannels of diameter as 
small as 2.3µm without hemolysis (death of the cell) [3.9]. This astonishing flexibility 
makes it the perfect particle to circulate in the entire body to deliver oxygen.   
Red blood cell 
characteristics 
Acronyms Values 
Mean Cell Volume MCV 80-100fL 
Mean Corpuscular 
Hemoglobin Concentration 
MCHC 32-36 g/dL 
Mean Corpuscular 
Hemoglobin 
MCH 27-31 pg/cell 
Red blood cell Distribution 
Width 
RDW 11.5-14.5% 
Table 3. 4: Characteristics of common human red blood cells. Values from the US 
national Libraries of Medecine website [3.10]. 
The geometrical and chemical parameters of RBCs can be used to detect blood 
disorders such as anemia and infections. Characteristics of common red blood cells 
indices include the mean corpuscular volume, which is a measurement of the average 
size of an RBC, the mean corpuscular hemoglobin which is the calculation of the 
average amount of oxygen in a RBC, the mean average concentration of hemoglobin 
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inside a cell and the red cell width distribution which is the variation in the size of 
RBCs. Such characteristics are shown in Table 3.4 for a normal human being.  
3.2.3 Properties of blood flow 
With a number density of 5 millions cells per mm3, red blood cells are found in great 
number in blood [3.9]. Red blood cells do not always float freely as individual particles 
in blood, they can form some complex structures called “rouleaux formation” as 
pictured in Figure 3.6.  
 
Figure 3. 6: Rouleaux formation, approximately 8 cells tall, three cells can be 
seen in the background joining the rouleaux formation in (E). (H) Only one cell 
remains out if  the structure [3.11].  
These formations are sometimes simply named blood aggregates and arise due to the 
interactions between individual red blood cells and the action of some plasma proteins 
like fibrinogen or globulin [3.9]. However this behavior only happens when blood is at 
rest. Blood aggregates are very sensitive to flow conditions such as  increased shear 
rate [3.9]. The shear rate is defined as the change of velocity of parallel planes in a 
flowing fluid (shear flow) separated by a distance. Shear stress is the force required to 
produce the shearing action. This stress acts tangentially on a surface and creates a 
deformation.  
A Newtonian fluid, which has a linear pressure-flow rate curve, obeys the Poiseuille 
equation and has a unique coefficient of viscosity. However in a non-Newtonian fluid 
such as blood, polymer or fluid suspensions, there is no unique coefficient of viscosity, 
as their structure depends on the flow [3.9].   
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Figure 3. 7: Viscosity-shear rate ratio in Newtonian and non-Newtonian fluid 
[3.9]. 
3.2.3.1 Blood flow viscosity 
The viscosity of blood is therefore dependant on shear conditions among others. In the 
case of blood, as shear rate increases, a progressive break-up of red blood cell 
aggregates is observed; leading to a decrease in viscosity. This behavior is typical of 
shear-thinning fluid. As shown in Figure 3.8, blood viscosity can change within a factor 
of 100 [3.9].  
Generally, the viscosity in blood depends on: 
- Shear rate 
- Hematocrit level 
- Temperature 
- Plasma viscosity2 
The measure of blood viscosity does not reflect its intrinsic properties but rather a 
property of the blood/vessel system under specific flow conditions [3.3].  Therefore a 
relative viscosity can be defined as the ratio of blood viscosity to that of plasma.  
A number of rheological equations describe the non-linear relationship of blood 
viscosity to the shear stress. One of the most well-known is the Casson equation, 
which is an empirical equation to characterize blood viscosity depending on the shear 
stress-shear rate relationship. For large values of shear rate the Casson equation 
should approach the asymptotic viscosity of a Newtonian fluid [3.12].  
                                                     
2
 Plasma is a Newtonian fluid and its viscosity is fixed 
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Figure 3. 8: Variation of the relative viscosity in function of shear rate for 
different suspensions (45% Hct blood, 11% Hct blood, 11% Hct hardened cells) 
[3.9] 
3.2.3.2 Blood flow laws in microvessels 
Most of the time, blood is considered to be a non-Newtonian fluid. At high shear rates 
however, blood can be considered as a Newtonian fluid [3.2]. In large channels it is 
acceptable to consider blood as a homogenous fluid as the size of the cells is not 
comparable to the size of the channel. However, for channel diameters of 500µm and 
below blood should be considered as a two-phase fluid: individual particles immersed 
in a Newtonian-type plasma.    
Fahraeus effect describes the tendency of red blood cells to migrate away from the 
tube walls, resulting in higher mean velocity of red blood cells compared to plasma.  
A related effect, named the Fahraeus-Lindqvist effect, describes the significant 
decrease in apparent viscosity of blood in channels of diameter less than 500µm. 
However these hemorheological laws appear at low Reynolds number, Re, defined as 
the ratio between viscous and inertial forces:  
                                                                               [3.3] 
For an assumed fixed viscosity μ=5.10-3 kg.m-1.s-1, a density ρ=1057 kg.m-3, a 
characteristic length l= 20μm and a flow velocity v = 2.10-6 m.s-1, the Reynolds number 
is 4.3, therefore laminar flow behaviour is expected. Laminar flow is common in most 
microfluidic system.  
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3.3 Behaviour of red blood cells in microchannels  
The understanding of the movement of a deformable asymmetric particle (such as a 
blood cell) in a laminar flow is the key to designing an efficient blood plasma 
separation microdevice. Although extensive studies of the behaviour of RBCs have 
been carried out over the last 50 years, there are still some unanswered questions 
about the movement of these cells [3.13,14]. In this section, an explanation of the 
fundamental mechanisms occurring in blood plasma separation in microchannels, will 
be given.  
3.3.1 Flow of red blood cells flow in straight microchannels 
Blood is known to be a non-Newtonian fluid. However, at the scale close to the 
microvascular network, blood can be considered as a suspension of RBCs in a 
Newtonian plasma. Plasma flow in a microchannel network of hydraulic diameters 
ranging from 10 to 500 µm is laminar, but the Reynolds number can vary greatly from 
0.01 to 100. RBCs are biconcave disks, reported to be extremely deformable. RBCs are 
known to exhibit different behaviours and even take different shapes depending on 
the Reynolds number and the degree of shear force.  
Under laminar flow, differentiation between the following cases is possible: 
- A rigid spherical particle 
- A flexible spherical particle 
- A rigid non-spherical particle 
- A flexible non-spherical particle. 
The red blood cell falls into the last category.  At a relatively high Reynolds number, 
but in the laminar regime, RBCs flip around themselves. This movement is often 
referred to as tumbling. At lower Reynolds number and higher shear stress however, 
they follow a tank-treading movement in which the membrane of the cell alone is 
rotating around its centre of mass. A cell, which tank-treads, maintains a stationary 
orientation with the flow. Finally a third transitional regime was found by Abkarian et 
al. and is named swinging [3.14]. In this regime the cell tank-treads but undergoes 
oscillations around its stationary orientation [3.14].   
60 
Tank-treading behaviour arises in the absence of inertia. In the presence of a wall, the 
asymmetry of the flow surrounding the cell leads to a net force creating a drift that 
pushes the cell to the centre of the channel. Due to this purely viscous lift force, a thin 
cell-free layer appears on the wall of the channel [3.15]. Faivre et al demonstrated that 
this movement depends on the magnitude of the shear force. Thus, the presence of a 
constriction leads to a local high shear stress zone, pushing the cells even more 
centrally. Faivre reported a cell free layer of two or three times larger than the straight 
channel case, the effect of which lasts for up to 1 cm after the constriction. The lift 
force is dependent on the shape of the particle, deformability of particle, density 
difference between the particle and the fluid and shear stress. Under these conditions 
spherical objects do not experience the lift force, although they have been reported to 
rotate.  
Contrary to common belief, inertial forces can overcome the viscous forces in 
microchannels in the laminar regime [3.16]. In this case, an axial migration effect, 
sometimes referred to as the tubular pinch effect, also applies to spherical and non-
spherical particles. The fact that a non-spherical particle rotates fast and thus exhibits 
the same mechanical characteristics as a spherical particle can explain that non-
spherical particles also experience the tubular pinch effect. The parameters affecting 
the migration of particles in this regime include the channel diameter-to-particle size 
ratio, the Reynolds number, the concentration of particles, the shape and 
deformability of the particle, the density difference between the particle and the fluid, 
and the presence or absence of particle rotation. In addition, the presence of other 
forces, such as the Saffman force at relatively high Reynolds number (but still in the 
laminar regime), acting on the spherical particles cannot be neglected if the rotation 
speed of the RBC is high enough. A pictorial summary of the different regimes of cell 
behaviour in microchannels is provided in Table 3.5. 
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Regime 
and 
reference 
Reynolds 
number 
Viscosity 
ratio 
between 
inner and 
outer fluids 
Movement 
of  cell 
Photographic evidence* 
Predominant 
lateral force 
Effect in microchannel 
A 
(tank-
treading 
[3.18]) 
Very Low 
(<1) 
Low 
Tank-
treading  
Viscous lift 
force 
 
B 
(Swinging 
[3.14]) 
Low Medium Swinging 
 
Transition 
regime 
The different effects on the cells are not 
known and therefore no drawing can be 
provided here. 
C 
(Tumbling 
[3.18]) 
Very low 
to Low 
(~1) 
High Tumbling 
 
Inertial lift 
force 
 
Table 3. 5: Different regimes of cell behaviour in a microchannel of diameter less than 300µm. *Photographs of the tank-treading and tumbling 
cell regimes have been reproduced from reference [3.18], by permission of the Royal Society of Chemistry. Photograph of the swinging regime 
has been reproduced from reference [3.14] with the authorisation of the authors             
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Axial migration is found in the two main regimes. In the absence of inertia, deformable 
asymmetric particles are pulled towards the centre of the channel, unlike the hard 
spheres which follow the streamlines. In the presence of inertia, the opposite scenario 
is more or less happening, although asymmetric particles have also been observed to 
move towards the centre of the channel. Both effects arise from the presence of a 
stationary wall and the interaction of a shear gradient on the particle. A transitional 
regime also exists where both effects may co-exist as discussed in [3.16,17]. The 
frontier between the two regimes has not been clearly established and this adds to the 
difficulty of predicting the behaviour of specific particles in microchannels. The cell-
free layer observed on the walls at certain conditions depends also on the particle-
particle interactions and the particle concentration. 
3.3.2 Behaviour of red blood cells at bifurcations  
Red blood cells exhibit a specific behaviour at bifurcations. Fung demonstrated 
empirically that RBCs have a tendency to travel to the highest flow rate daughter 
channel, providing that (a) the flow rate ratio between the daughter channel and the 
mother channel after the bifurcation is at least 2.5:1 and (b) the dimensions of the 
cells are comparable to the channel diameter. This effect is sometimes referred to as 
the Zweifach-Fung bifurcation law. Its origin is found in the asymmetrical distribution 
of pressure and shear forces on the cell at the bifurcation, pulling it to the channel 
with the highest flow as shown in figures 3.9 and 3.10 (left).   
Based on this law, a blood-plasma separation unit can be designed such that the 
daughter channels can maintain the prescribed flow rate ratio. This technique was 
indeed applied by Yang’s team in Pennsylvania and Yamada’s team in Japan [3.19,20]. 
The design can be facilitated by simulating the flow rate using high level behavioural 
simulation techniques based on lumped elements modeling. This design methodology 
will be described in the next chapter.    
The effect of bifurcations on the performance of the separation of plasma from blood 
has been discussed thoroughly through literature, but opinions still differ. Fung reports 
that the geometry of the bifurcation enhances the separation mechanism [3.2]. If the 
cell keeps a fixed orientation in the tank-treading regime, then it is easier for the cell to 
enter into a daughter channel as this one has the same orientation as the cell. Roberts 
63 
and Olbricht have carried out several experiments on bifurcations, as shown in Figure 
3.10 (right), to examine whether the angles made by the mother and daughter 
channels are influencing the separation. They demonstrated that the magnitude of the 
separation depends on the bifurcation geometry and the aspect ratio of the channel 
cross-section [3.21]. On the other hand,  Chien et al and Pries et al reported no 
appreciable effect of the branching angle on the particle distribution at bifurcations 
[3.3,22]. This contradiction illustrates the difficulty of predicting RBCs movement in 
microchannels. Microfluidic systems can nevertheless take advantage of RBCs specific 
behaviour to separate plasma from blood.  
 
Figure 3. 9: (a) Original illustration of Fung’s bifurcation law [3.2] 
3.4 Blood plasma separation   
Blood separation is a strategic preliminary step in the preparation for biological 
analysis on-chip. Polymerase Chain Reaction (PCR) can be performed on whole blood 
but the reaction is inhibited by components of blood such as hemoglobin (cellular 
portion) and IgG (plasma portion), therefore by separating blood into its basic 
components of plasma and cells the reaction can be optimised for better results.  
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Figure 3. 10: Left, Distributions of RBCs flowing through the bifurcation. RBCs 
are represented by black dots. In (a) the flow rate ratio is around 1 to 6.6 while 
in (b) the flow rate ratio is 1 to 2. [3.23]. Different channel geometries studied 
by Roberts and Olbricht [3.21].  
Centrifugation and filtration are the two conventional techniques for blood plasma 
separation in laboratories. Both methods are time-consuming, relatively expensive and 
might damage cells if not used carefully.  
In the light of the disadvantages outlined above and the benefits that microscale 
techniques can provide in terms of volume of blood extracted, response time and 
portability, the alternative blood-plasma separation on-chip has gained increasing 
interest over the last few years as shown in Chapter 2. Separation techniques using 
only hydrodynamic forces, channel geometries and bio-physical effects have lately 
been developed based on preliminary work on microcirculation [3.2]. New 
technologies like CD-like platform are complex and require expensive instrumentation. 
The approach chosen in this study uses the latest advances in hydrodynamic blood-
plasma separation techniques on-chip, which are passive by nature. The aim is to 
develop a system with a high plasma yield as well as a low processing time. Plasma 
yield is defined as the percentage volume of plasma that can be extracted from the 
device over the total volume of plasma in the blood. To allow mass-manufacturability 
of the device by high volume manufacturing techniques such as microinjection 
moulding, channel dimensions greater or equal to 20µm in the first designs were used. 
The separation method is continuous since no external force field need to be switched 
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on and off. Moreover the cell and plasma can be continuously collected or directed to 
in-line processing. The sample injection is kept straightforward and simple, with only 
one inlet needed for the entire system.  
The number of parameters affecting the flow of cells in a microchannel renders 
difficult the prediction of the behaviour of the RBCs in the separation system. The 
presence and effects of viscous and inertial lift forces which enable particles to be 
separated at the microscale has been discussed earlier [3.17].  
The designs presented here exploits two main hydrodynamic effects: the Zweifach-
Fung bifurcation law and the blood flow focusing effect occurring after a constriction. 
Although this law was first stated in the context of micro-circulation in the human 
body, it has also been exploited for in-vitro separation [3.24]. From a few cells in a 
microvessel, the law was generalised to accommodate the situation where populations 
of cells flow in microchannels several tens of microns wide. The Zweifach-Fung effect is 
commonly used in the design of micro-separators to set up a lower limit for flow rate 
ratio at a bifurcation. However, the physics which underpin the law and its limitations 
are not clearly understood yet. The second effect is the focusing of particles after a 
constriction. The design requirements for this device are summarised in Table 3.6.  
The overall aim of these systems is to reach maximum purity efficiency, Ep, preferably 
100%, defined as: 
 
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where cp and cf are the number of events (or presence of particles) per mL in the 
plasma collection outlet and in the feed inlet. 
In order to meet these requirements, two generations of blood plasma separation 
devices were designed as presented in Figure 3.7. The first generation devices were 
developed from two different approaches. The first integrating a single constriction 
with a series of bifurcations while the second model was integrating four bends with 
two constrictions. These devices will be presented in greater details in section 3.5. 
After some initial experiments results, the second module was abandoned because of 
poor results and especially clogging problems (data not shown in this thesis). Using  
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Design 
requirements 
in terms of: 
Solutions 
Manufacturing  Cost-effective 
Power None other than power to actuate the flow 
Physical forces used Viscous or inertial forces in flow 
Throughput Relatively high flow rates needed 
Separation mode Continuous 
Table 3. 6: Design requirements for the blood plasma separation device  
qualitative data from the modelling approach as presented in Chapter 4, and the first 
experimental results, the second generation device was based on T-channels and 
constrictions and is presented in section 3.6.  
 
 
 
 
 
 
 
Figure 3. 11: Design approach for the blood plasma separation modules  
 3.5 First generation devices 
In this section, two designs are presented, which use an original combination of the 
methods previously reported.  
3.5.1 T-junction channels and constriction 
As RBCs flowing through a bifurcating region of a capillary blood vessel have a 
tendency to travel into the vessel which has a higher flow rate, Yang et al. proposed a 
blood plasma separation device based on a T-shape configuration as shown in Figure 
2.10c [3.19]. T-channels for blood plasma separation manufactured by Roche are 
First Generation device  
T-channels and unique 
constriction  
Modelling 
qualitative 
data  
Second generation device  
T-channels and multiple 
constrictions  
Experimental 
Results  
First Generation device  
Bend channels and 
constrictions  
Literature references  
Design 
abandoned  
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presented in Figure 2.10b. Finally, Faivre et al reported that constrictions in 
microchannels increase the natural cell-free layer over a distance of up to 1 cm after 
the constriction [3.15]. The first design produced in this study, integrates a constriction 
and a series of bifurcations. 
The principle of the microfluidic blood plasma separation module is shown in figure 
3.11. This design should theoretically work at both low and medium Reynolds number 
which is regulated by the flow rate used (respectively 0.01 and 1). The configuration of 
the separation module is as follows. Firstly, the use of micrometre dimensions ensures 
laminar flow and the presence of a particle-free layer. Secondly, a constriction in the 
main channel induces a high-shear stress zone pulling the particles even more 
centrally. Thirdly, 20 bifurcation channels are placed on each side of the main channel 
to enhance the plasma yield. In the basic design, the width of the main channel is 
100µm and the plasma channels are 20µm wide. The constriction width and length are 
respectively 25 and 300µm. The height of all channels is 20μm. The drift induced on 
the cells by the single constriction has been calculated as [3.15]:   
2
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d  ,                                                                   [3.4] 
Here L, w, h are the length, width and height of the constriction. R is the radius of a 
sphere having the same radius as a cell and  is a dimensionless parameter equal to 
0.45. Using Eq.(3.4) the drift induced by the constriction is estimated to be around 
27.5µm. The constriction width and length, and the main channel width have been 
used as variable parameters and change from one design to another. The external 
connection consists of only one inlet to introduce the blood and three outlets. One of 
these outlets collects the cells and the other two collect the plasma. The length of 
capillaries connected to the outlets can easily be tuned to change the flow rate ratios 
at the outlets. The length ratio between the plasma outlet capillaries and the cell 
outlet capillary will also be used as a variable parameter.  
The change of purity efficiency might be achieved by varying the following parameters: 
main channel width (MCW), buffer type (BT), outlet length ratio (OLR) and flow rate 
(FR). 
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Figure 3. 12: Principles of the hydrodynamic blood plasma separation. The use 
of laminar flow ensures a particle free layer on the walls of the main channel, a 
constriction pulls the cells even more centrally. Finally the cells and plasma are 
separated at the bifurcations using the Zweifach -Fung bifurcation law. 
Dimensions are given in mm. 
3.5.2 Bends and constrictions 
Blattert et al introduced a bend structure for blood plasma separation and released 
optimised devices later on [3.25]. This structure is combining two principles: a 
centrifugal force field and a “plasma skimming effect”. The plasma skimming effect 
exists naturally in microchannels. An axial accumulation of RBCS has been observed 
along a microchannel. This has the consequence of leaving a “cell-free layer” or 
“plasma-rich layer” near the microchannel walls. A bend in the microchannel induces a 
variation of the flow profile and results in an increased width of the “cell-free layer”. A 
sub-microchannel is placed downstream on the inner wall of the bend to collect the 
plasma. It was observed that thinner is the sub-microchannel, better is the efficiency. 
However, a thinner plasma collection channel induces a poor plasma yield. A bend 
changes the velocity profile in the microchannel with the faster flow layers tending to 
migrate slightly on the outer wall of the bend. It implies another drift on the blood 
cells. Blattert found this drift proportional to the density difference of the particle and 
the medium.  
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Figure 3.12 shows a “bend” design of the blood plasma separation device. The 
microsystem is composed of a constriction in each of the two whole blood inlet 
channels, followed by two bends in each channel, several bifurcating plasma sub-
channels and an oulet channel for the blood cells. Geometrical features contributing to 
the separation are the chosen dimensions of the microchannels, the constrictions, the 
bends and the bifurcations. The separation of red blood cells from plasma is made 
possible by the presence of bio-physical effects within the microchannel structure, the 
Zweifach-Fung bifurcation law and a centrifugal effect.  
However, the centrifugal effect has been later found to provide a minimal contribution 
on the separation process. In the light of the small affect produced by the bends, it was 
decided to abandon this bend structure and to focus more on the bifurcation and flow 
rate ratio effect.   
 
Figure 3. 13: Four bends design 
3.6 Second generation device  
Subsequently to the simulation results presented in Chapter 4 and the tests performed 
on the first generation devices and presented in Chapter 6, a second series of device 
was designed. The aim of this second iteration was to redesign the device in order to 
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improve the plasma purity, or separation efficiency as defined in Equation (3.5) and 
reduce the back flow observed in the last channels.   
As shown in Figure 3.13, the second generation device has four connections, a single 
inlet for whole blood, one outlet for the concentrated cells and two outlets for the 
extracted plasma, as for the first generation T-channel device.  Four plasma channels 
of 5.5mm in length are placed on each side of a 100µm wide main channel at a 45º 
angle. Meanders are used to minimize the area occupied by the eight plasma channels 
and keep the footprint of the chip low. A constriction has been placed before each of 
the plasma channels in order to create a cell-free zone from which the plasma is 
extracted. A set of chips has 20μm wide plasma channels while another has 10μm wide 
plasma channels. The depth of the microchannel networks is 20μm for all structures.  
 
Figure 3. 14: Schematic of a 20µm wide microchannels blood plasma separator. 
The flow of plasma is indicated by the yellow arrows.  
The plasma channels due to their geometrical features (length and width) have a 
higher fluidic resistance value, whereas the main channel segment, of broader width 
and shorter length, has lower resistance. This difference in resistance value at each 
bifurcation is proportional to the flow rate ratio. The value of the fluidic resistance of 
the main channel decreases after each bifurcation.  Since the plasma channels have 
the same lengths the flow rate ratios are expected to be different at each bifurcation. 
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The flow rate ratios can be roughly calculated by the Saber(TM) microfluidic applications 
software (CoventorWare) with the methodology detailed in chapter 4. Flow rate ratios 
have been calculated as approximately 17.8, 22.6, 31.8 and 55.6 for the left hand side 
of the chip (bifurcations 1, 3, 5, 7) and 19.2, 25.7,  40.1,  and 94.5 for the right hand 
side of the chip (bifurcations 2, 4, 6, 8) with 20µm plasma channels. The side having 
the highest flow rate ratios is expected to perform better, this will be verified in 
Chapter 6. Theoretically, the design should extract 30% of plasma for the 20µm design 
and 7% for the 10µm design.    
3.7 Conclusions 
In this chapter, the blood has been presented as a complex living fluid. The theoretical 
blocks have been assembled allowing the understanding of red blood cells behaviour 
in microchannels. Two generations of T- junction microdevices for blood plasma 
separation have been detailed. The main differences between these devices are 
highlighted in Table 3.7. Chapter 4 will present a simulation model to allow for better 
control of the system while Chapters 6 and 7 will discuss the results obtained by the 
two generations of devices.  
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First Generation T-channel 
design 
 
Second Generation T-channel 
design  
 
Main channel width  100 or 200µm 100µm 
Plasma channel width 20µm 10 or 20µm 
Plasma channel length 0.5mm 5.5mm   
Number of plasma 
channels 
30  8  
Geometry Symmetric Asymmetric 
Overall footprint of the 
chip  
1.8x2.3cm 1.8x2.3cm  
Number of 
constrictions 
One single constriction 
A constriction before each 
bifurcation 
Constriction 
dimensions (length x 
width) 
300µm x 25µm   
Table 3. 7: Main physical differences between the two devices chosen for testing.  
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Chapter 4: System-level simulation of 
microfluidic networks   
4.1 Introduction 
4.1.1 Motivations 
The goal of the present modeling study is to assess the performance of the microfluidic 
network using a full Newtonian approach, to evaluate the initial design and observe 
the effects of design variations on the flow rate ratios at each bifurcation. 
The chosen simulation approach of the microfluidic device is a system-level simulation, 
which allows the simulation of not only the critical part of the system where 
separation takes places, but also the surrounding microchannels which are ancillary to 
the operation of the system. There are several advantages at taking a holistic 
approach, as all the resistances in the system are interdependent. System level 
modeling allows faster design iterations than Computational Fluid Dynamics (CFD) and 
offers a means to evaluate an initial design and observe the effects of design 
variations. 
The external surroundings of the chip itself, which include the pump, board, plugs and 
capillary fittings, can play a considerate role on the actual performance of the device in 
terms of separation efficiency and yield. This influence has to be controlled and 
integrated into the design not only to avoid perturbation during the test procedures, 
but also to ensure robustness of performance during device operation. 
Although an experimental validation  approach was not undertaken, the information 
determined from the simulation contributed to the development of the second 
generation  device which resulted in a 30% increase in  performance. 
 
4.1.2 Blood flow modeling in literature: Computational Fluid Dynamics 
vs System-level modelling 
The computational analysis of blood flow in microvessels is a long-sought goal in both 
(1) clinical research, for the understanding of specific disease such as the presence of 
stenosis in the circulation and (2) in new biomedical applications, such as the 
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separation of cells from plasma at the microscale. Blood flow modelling is particularly 
difficult and computationally expensive due to the unusual contribution of the red 
blood cells, these highly deformable particles, to the physical model. Apart from RBCs, 
the rest of the particulates form less than 1% of the total volume. Several strategies 
have been developed to model blood flow in microvessels. Computational Fluid 
Dynamic (CFD) is the common tool for modelling microfluidic flow. The meshing 
requirements for a microfluidic network are very important to obtain results close to 
experimental data. CFD simulations are computationally expensive, and, without the 
use of powerful computers, these simulations would be useful only for the 
determination of the flow at localised points rather than through the entire system. 
However, biophysical analysis can often be enhanced by CFD modelling. For example, 
CFD was employed for the study of the flow around a stenosis [5.1].  In other cases, 
such as in ref [5.2] simple structures have been simulated to predict the relationship 
between pressure and flow rates in different geometrical situations.  In another 
original study, a flow of RBCs in a straight microchannel, was simulated using a 2D 
particulate model [5.3]. As shown in Figure 4.1a, the model is composed of 1200 
individual RBC, initially organized in 10 rows and 120 columns in a microchannel with a 
width of 75µm. Each RBC is itself modeled by 100 particles, allowing the model to 
account for deformability. The flow of multiple RBCs over a length of 200µm in this 
channel was been successfully simulated as shown in Figure 4.1b, and predicted the 
aggregation of RBCs at the centre of the channel. This simulation however, required 
the computational power of 80 processors and 12 hours in real time (960 hours in CPU 
time). 
In another example, Barber et al presents a model for the behaviour of RBCs at 
microvessel bifurcations, using a two-dimensional, flexible-particle model [5.4]. The 
model accounts for the effects of flexibility of RBCs and asymmetry of the bifurcations. 
The model does not incorporate a larger and more complex microfluidic network other 
than a single bifurcation. Other studies have focused on the behaviour of one or 
several red blood cells in a straight, bent, constricted microchannel or at bifurcations 
[5.5].  
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Figure 4. 1: Tsubota’s red blood cell flow model resulted in these accurate 
rendering of blood flow in a channel but necessitate 80 processors to compute 
just a straight channel segment [5.3].  
System-level fluidic modelling is more adapted to the case of microfluidic networks if 
rapid conclusions need to be made for the manufacturing of such a system. In this 
approach, also named lumped parameters model, the microfluidic network is broken 
down into several elements, each having a different function [5.6]. A brief description 
of the basic building lumped parameters is given below. 
Poiseuille flow is known as the steady-state flow of incompressible fluid into 
microchannels [5.7]. In this case a constant pressure drop, P, results in a constant 
flow rate, Q. This law is known as the Hagen-Poiseuille law: 
QRP hyd          [4.1]
 
Where Rhyd is the hydraulic resistance. This law is analogous to Ohm’s law. The concept 
exploits the analogy of microfluidic networks to electrical circuits and an equivalent to 
Kirchhoff laws can be used to compute the response of the system [5.8]. The concept 
of hydraulic resistance is essential for the characterization of microchannel network as 
presented in this study [5.7]. 
Figure 4.2 presents the different models that can be used in microfluidic analysis. 
78 
 
Figure 4. 2: Comparison between CFD and system-level modeling, adapted from 
[5.9].   
The aim of this study is to find solutions for an efficient design of microfluidic networks 
for the passive separation of plasma from blood using the Zweifach-Fung bifurcation 
law. This chapter demonstrates that, not only the chip itself but also its surroundings 
can affect the overall performance of the device. This study also aims at examining the 
validity and usefulness of a system-level approach for general modelling of microfluidic 
network. Only Newtonian fluids and particle-free fluids have been considered for this 
study although improvement on the existing model could be carried out at the 
expense of computational time.  
The model presented incorporates the Zweifach-Fung bifurcation law in the simulation 
of a Microfluidic network. In the first section, the design is presented in detail and the 
algorithm for the simulation of the microfluidic network is described. The second 
section introduces the numerical verification of the algorithm using the software 
package CoventorWare. In the third section we discuss the results and the limitations 
of the model.  
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4.2 Separation of plasma from blood 
4.2.1 System design  
The principle of the microfluidic blood plasma separation module has been presented 
in Chapter 3 [5.10]. This design can work both at low (around 0.01) and medium 
(around 1) Reynolds number which is regulated by the flow rate used.   
The configuration of the separation module is as follows. Firstly, the use of microscale 
dimensions ensures laminar flow and the presence of a cell-free layer. Secondly, a 
constriction in the main channel induces a high-shear stress zone pulling the particles 
even more centrally [5.11]. Thirdly, in the first generation device, 15 bifurcation 
channels are placed on each side of the main channel to enhance the plasma yield, as 
defined in Chapter 3. In the basic design, the width of the main channel is 100μm and 
the plasma channels are 20μm wide. The constriction width and length are 
respectively 25 and 300μm. The depth of the entire structure is 20μm. As shown in 
Figure 4.3, the chip sits on a platform which routes the fluid from the chip to fluid 
adaptors. Standard microfluidic connectors with capillaries (or tubing) are plugged to 
the fluid adaptors. The fluid adaptors are shown in green on Figure 4.3, and the 
capillaries plugged to the holder is presented in Figure 4.4. Capillaries are required to 
bring the blood from the syringe to the platform itself. In the same way, for the 
outlets, capillaries bring the blood from the platform to Eppendorf tubes for collection. 
The length of capillaries connected to the outlets can easily be tuned to change the 
flow rate ratios at the outlets. The length ratio between the plasma outlet capillaries 
and the cell outlet capillary will also be used as a variable parameter. 
The separation at each bifurcation is based on the Zweifach-Fung principle. In the 
design figure 3.11, the flow rate ratio cannot be the same at each bifurcation as the 
flow rate in the main channel reduces after each bifurcation, but the plasma channel 
length remains the same. This potentially induces different separation efficiency at 
each bifurcation if the efficiency at the last bifurcation is below 100%. It is of interest 
to regulate the flow to get the same ratio at each bifurcation in order to avoid either 
red blood cells entering the plasma channels or the lysis of the cells if the flow rate is 
too high. Such design iteration can make the system stronger and more reliable. In the  
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Figure 4. 3: The physical design comprises a bifurcation to focus the flow of red 
blood cells and 15 bifurcations situated on each side  of the main channel to 
extract the plasma. Platform schematic, courtesy of Epigem Ltd.  
 
Figure 4. 4: (a) Photograph of the chip on the chip holder, or platform,  
connected to standard microfluidic capillaries. (b) Schematic of the 
experimental set-up detailing the chip on the holder and the capillaries 
connected from the chip to the collecting tubes  
context of these simulation, the level of hematocrit used is considered very low (in the 
order of 3%), which allows us to model the flow of plasma as a Newtonian fluid 
without any particles.  
In this case, there are several advantages at taking a holistic approach, as all the 
resistances are interdependent. System level modelling allows faster design iterations 
a b 
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than CFD and offers a means to evaluate an initial design and observe the effects of 
design variations. 
4.2.2 Hypothesis and major assumptions 
In this model, the liquid is assumed to be driven at a constant flow rate by a syringe 
pump. The three outlets are connected to hydraulic ground, at a pressure nil. 
The microfluidic network designed in this study can be described as an assemblage of 
straight segments with hydraulic resistances and nodes (or bifurcations) as shown in 
Figure 4.5. Unlike in some other lumped parameter models, the hydraulic equivalents 
of capacitance and inductance have been considered as negligible [5.12]. This is a valid 
assumption as the elastic capacity of the channel and inertia of the flow of blood are 
small. Each segment of the network is therefore considered as a pure hydraulic 
resistance. 
 
Figure 4. 5:  The microfluidic network can be seen as an assembly of straights 
channels linked by nodes. The inlet is fed with a constant flow rate  Q0 . The 
outlets are connected to the hydraulic ground. In this figure only four plasma 
branches on each side of the main channel have been considered.  
The following assumptions have been made for the development of the analytical 
equations describing the flow of liquid in each segment: 
- The flow is considered Newtonian, incompressible and laminar; 
- The flow is considered set and stable at the time of the analysis, meaning that 
entry and exit effects are neglected; 
- The effect constriction is ignored, as the system is flow rate driven; 
- Channels have been manufactured using SU8 (epoxy based photoresist) by 
photolithography and have a rectangular cross-section; 
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- The fluid used in the model is water and 
- The system is flow rate driven. 
The design requirements to be met by the model are: (i) The flow rate ratio between 
mother and daughter channel should be equal at each bifurcation (ii) The total depth 
of the microfluidic channels is 20µm (iii) The plasma channel has a width of 20µm.  
The model will calculate the required lengths for plasma channels lengths to get 
constant flow rate ratios at each bifurcation. 
The goal of the present modeling study is to assess the performance of the microfluidic 
network, evaluate the initial design and observe the effects of design variations.  
Figure 4.6 details the flow chart used for the modelling process. A model producing a 
set of internal and external parameters based on initial conditions is solved 
analytically. A numerical model is built using the internal and external parameters 
given by the analytical model as inputs. By comparing the compilation results, the 
match between the two models is checked. We have now the chip completely 
designed and ready for the manufacturing and testing. As it is often found, the chip has 
to be connected to external devices or capillaries for either test purpose of for 
operation. These changes are not always foreseen during the design step. The second 
half of the modelling proposes to investigate changes occurring in the flow distribution 
inside the chip after the manufacturing when changes are impossible.   
4.2.3 Algorithm  
The algorithm has been constructed that is based on the lumped element model 
developed by Berthier [5.13].   
The algorithm is built using the basic laws of conservation of mass and energy. The first 
step of the algorithm is the calculation of flow rates; the second step deal with the 
calculation of the associated resistances. Finally the third step is the extraction of the 
channel length.  
Looking at the first node, let  be the constant flow rate ratio between the flow rate 
in the plasma channels and the flow rate in the main channel after the bifurcation. At  
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Figure 4. 6: Typical simulation flow chart. This diagram is detailing the 
relationships between the analytical and numerical model .  
the first node, the sum of the flows entering and leaving each node must sum to zero 
such that: 
0112 QFF MP   ,                                                 [4.2] 
Where FP1 and FM1 are the flow rates of the two plasma channels and of the main 
channel at the first node, respectively. As =FP1/FM1,  
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Using a recurrence relationship we obtain, the flow rates at the nth are: 
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The continuity equation for an incompressible fluid is directly linked to mass 
conservation can be checked by verifying the following expression [5.7]: 
  02 QFPk      [4.5] 
The plasma channels join together on both side of the main channel to form side 
channels, or daughter channels. The flow rates for these channels are as follow:  
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The flow resistances can now be calculated by determining all the possible paths that 
the flow will follow. As the design of the first prototype is symmetric with respect to 
the main channel, half the system with four branches is considered as shown in Figure 
4.7. Five independent paths can be distinguished and are represented by different 
colours. 
Remembering the generic equation [4.1], the microfluidic network can be modeled as 
a set of linear equations. Each equation uses the generic equation [4.1] for each of the 
individual paths:   
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Figure 4. 7: Five independent flow paths, represented by different colours, exist 
for the half network. The unknowns in the system are highlighted in bold and 
italic. Compared to Figure 4.4 , all the channels branches are identical such that 
RM1=RM2=RM3=RM . All the side channels are also equal. Here, the flow resistances 
of the end branches on the cell and plasma sides are equal, ie: RS 4=RM 4=Re nd.   
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Where Pi is the inlet pressure and FMi is the flow rate in the main channel after the ith 
bifurcation. 
We know the values of 
SR  and 0MR , so: 
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The system can be solved step by step to obtain the hydraulic resistances of the 
plasma channels as well as the resistance of the end channel: 
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This algorithm can be implemented and solved using the software package by 
MatlabTM. To get the length of the channels out of their resistance values, the 
Washburn law and Bahrami’s expression are used for the pressure drop in a channel 
with a rectangular cross-section [5.14]: 
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Where P  is the difference of pressure between the entrance and the exit of the 
channel, w is the width of the channel, d is the depth of the structure, µ is the viscosity 
of the liquid and U is the mean velocity of the liquid in the channel.  
Finally, the length of the last cell channel and the length of the plasma channel are 
solved by using a set of input parameters. The list of parameters is given in Table 4.1 
alongside their symbol, value and dimension.  
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Parameter 
Parameter 
symbol 
Value Dimension 
Pressure at the entrance Pi varying
 Pa 
Flow rate at the entrance Q0 1.6.10
-7 m3.s-1 
Depth of the structure d 20 µm 
Length RM0 LRM0 2000 µm 
Width RM0 WRM0 100 µm 
Length side channel Rs LRS varying µm 
Width side channel Rs WRS 80 µm 
Length main channel sections LRM varying µm 
Width Main channel section WRM 100 µm 
Width plasma channels WRP 20 µm 
Width end channels WRend 100 µm 
Viscosity of the fluid µ 0.0012 Pa.s 
Flow rate ratio  varying - 
Table 4. 1: List of parameters name, symbol, value and dimensions.  
 
Table 4.1 shows the parameters of the computation.  A number of parameters have 
been varied to study their influence on the length of the channels. The channel lengths 
resulting from the compilation for three characteristic parameter sets are presented in 
Table 4.2. In the two first cases,  is set to 0.1 which corresponds to a flow rate ratio 
(1/) of 10. The length of the main channels has to be greater or equal to 400µm to 
allow for the future integration of constriction before each bifurcation. The length of 
the side channel is arbitrarily set to 200µm in case 1 and doubled in case 2. The 
equality of the length of the side and main channel leads to a reduction in the plasma 
channel length span. In case 3 the flow rate ratio is set to 20, which results in larger 
plasma channel lengths as expected. These channel lengths can be manufactured. The 
end plasma and main channel lengths are set-up to a fixed value (here 1063 µm for   
= 0.1).  
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 Case 1 
LRs(w)=200µm 
LRm(w)=400µm 
 = 0.1 
P=11.05 MPa 
Case 2 
LRs(w)=400µm 
LRm(w)=400µm 
 = 0.1 
P=11.05 MPa 
Case 3 
LRs(w)=200µm 
LRm(w)=400µm 
 = 0.05 
P=11.05 MPa 
LRP1 1124 989 2574 
LRP2 912 781 2005 
LRP3 695 604 1409 
LRP4 478 478 787 
LRend 1063 1063 528 
Table 4. 2: This table presents the length of plasma channels a nd end channel 
for three different situations. The common parameters used are; Q0=2.77.10 -
9m3 .s -1; µ=1.2.10 -3 . All the dimensions of the channel lengths are in microns.  
4.3 Optimisation of the algorithm  
4.3.1 Microfluidic platform and capillaries 
In the results presented in the preceding section, only the structure of the chip has 
been taken into account for the calculation of the microfluidic performance of the 
device. The modeling fails to account for the microfluidic connectors linking the chip 
itself to the outside equipment such as the chip holder, or platform. The chip is indeed 
plugged to a chip holder. From the same platform, capillaries are branched to direct 
the fluids from the outlet to collecting Eppendorf tubes. This microfluidic manifold is 
shown in the schematic, Figure 4.4 and the photograph, Figure 4.5.  The length of the 
fluidic path, which can be calculated by adding the length of each channel, 
microchannel and capillary section, is now taken into account.  
These new parameters are introduced in the model. The algorithm is also slightly 
changed to set the lengths of the end plasma and main (cell outlet) channels and 
deduce the required length of the main channel segments (LRM). Table 4.3 presents the 
new dimensions obtained when taking into account the extra length of the fluidic path 
off-chip. 
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 LRM0=6.6cm 
LRPend=9.6cm 
LRMend=6.6cm 
LRs=400 µm 
 = 0.1 
P=341.6.106 Pa 
LRM0=6.6 cm 
LRPend=9.6 cm 
LRMend=6.6 cm 
LRs=400 µm 
 = 0.1 
P=399.106 Pa 
LRp1 14520 85038 
LRp2 14323 84940 
LRp3 14158 84893 
LRp4 14047 84909 
LRM 2714 4053 
Table 4. 3: For P=341.6.106Pa, FRe=5mL/h; µ=1.2.10 -3Pa.s; α=0.1; Q0=1.6.10 -
7m3 .s -1 . Channel lengths are expressed in microns.  
The differences in the length of the plasma channels to be applied to get the same flow 
rate ratios at each bifurcation is not as large as in the previous example. In the first 
example of Table 4.2 with an ideal set-up, the mean size reduction between each 
channel is approximately 41% from one bifurcation to another. In Table 4.3 the mean 
size reduction is about 1.13%. Therefore it can be concluded that the external chip 
board and capillaries significantly attenuate the geometrical differences at each 
bifurcation. 
4.3.2. Asymmetrical design 
The same modeling methodology was applied in the case of a new design presented in 
Figure 4.8. The design cannot be considered as symmetric anymore. A new algorithm is 
therefore developed.          
 
Figure 4. 8: The design comprising asymmetric branches. The n umber of plasma 
channels stays the same, but channel are not placed anymore in front of each 
other alongside the main channel.  
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At the entrance node the sum of the flow rates is now expressed as: 
011 QFF MP           [4.12] 
The introduction of , the flow rate ratio provides the expressions of the main channel 
and plasma flow rates: 
1
1
0
1
0
1







Q
F
Q
F
P
M
          [4.13] 
The recurrence relationship becomes:  
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The flow rates of the side channels become 
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There are now 9 different flow paths, resulting in a system of 9 relationships for the 8 
different flow resistances of the plasma channels and of the back segments. The 
former algorithm can be easily adapted to this new configuration. Table 4.4 details the 
results for two different parameter settings with the new asymmetric configuration. To 
simplify, the external contribution is as follows: at the main entrance and cell outlet, 
channels are 66mm in length with a width of 100 µm; at the plasma outlet a channel is 
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chosen of 96mm in length with a width of 100µm. The 20µm depth in these channels is 
the same as in the whole structure. A example of a Matlab code for this part can be 
found in Appendix A. 
In this new model the differences of plasma channel lengths to get a constant flow rate 
ratio exist but are not large compared to the total length of the channels. One can 
imagine keeping the same length to simplify the design. This situation will be 
highlighted in the numerical verification using CoventorWare. 
 Case 1 Case 2 
 Rs(L,w)=1000µm,80µm 
 = 0.1 
P=350MPa 
Rs(L,w)=1000µm,80µm 
 = 0.05 
P=420MPa 
LRp1 13695 92361 
LRp2 15915 92692 
LRp3 12352 89785 
LRp4 15038 90150 
LRp5 10911 87098 
LRp6 14161 87501 
LRp7 9390 84305 
LRp8 13323 84749 
LRM 1949 2914 
 
Table 4. 4: This table presents the length of plasma channels and end channel 
for three different situations. In every case P=15.104mPa, FRe= 5mL/h;  µ=10-
3Pa.s. Channel lengths are expressed in microns.  
4.4 Numerical verification & Network behaviour  
4.4.1. Numerical verification 
CoventorWareTM and in particular, its Architect Parametric Fluidics Library can be used 
to design and simulate microfluidic networks. Here we use CoventorWareTM mainly to  
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Figure 4. 9: CoventorWareT M model for the symmetrical configuration built using the Architect SaberSketch Schematic Editor , with the 
collaboration of David Bease. .  
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verify the analytical solution. The channel lengths, outputs of the analytical solution 
are used as parameters in the model of the software package. 
The circuit is broken down into very simple straight channel elements, as no other 
passive or active component is present in the network. The network is composed of an 
assemblage of straight segments. At each bifurcation there is a corresponding node. In 
this model, to verify the algorithm calculated in Matlab, we consider just 4 channels on 
each side of the main channel. 
The same assumptions have been made for the numerical model in CoventorWare as 
for the analytical development. The model is a flow-rate driven system. This model is 
based on the assumption that the outlets wells are at a pressure nil and room 
temperature. The cross-sections are assumed to have assuming perfectly rectangular 
shapes with the general etch depth of 20μm throughout the structure.   
A schematic is created using the Saber tool of CoventorWareTM. The hydrodynamic 
source at the start of the network is a constant flow rate source. At the end of the two 
plasma and the cell branches a hydraulic reservoir with a pressure of zero is set. The 
rest of the fluidic elements are all passive components. This model is shown in Figure 
4.9.  
The validity of the analytical approach can be studied by comparing the flow rate 
obtained at each bifurcation in each case. Figure 4.10 shows a close match between 
the flow rate obtained through the analytical development and obtained in the 
numerical analysis. In the same figure, the Bahrami’s fluidic resistance equation is 
compared to the more common Bruus’ resistance.  Fluidic resistance equation is used 
to obtain the plasma channel lengths which build the numerical model. The use of the 
Bahrami’s resistance shows a better fit with the analytical model.   
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Figure 4. 10: Comparisons between the analytical and numerical computation 
for the Bahrami and Bruus resistance. The graph shows the flow rate in the 
plasma channels at each bifurcation versus channel index.  
CoventorWare model validates the analytical development and can also be used on its 
own to optimize a given design.    
4.4.2. Network behaviour 
Particularities of the network behaviour are investigated using the Coventor model. 
The influence of the entrance parameters is studied. As expected, flow rate ratios are 
independent of the entrance flow rate as illustrated in Figure 4.11. More generally 
flow rate ratios are independent of all entrance parameters such as the width and 
length of the entrance channel.  
Having validated the analytical model, the parameters from this model are used as 
input parameters for the CoventorWareTM model. “External” parameters such as the 
entrance and outlet channels lengths, or entrance flow rate are then modified. The 
internal geometry of the chip cannot be changed but external capillaries can be 
plugged into the inlet and outlets or the entrance flow rate can be changed. Therefore, 
by varying these external parameters, we can study the response of the performance 
the network, notably, the changes in flow rate ratios at each bifurcation.  
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Figure 4. 11: Comparison of flow rate ratios for different entrance flow rates 
(numerical results). This graph shows the flow rates and flow rate ratios of the 
system for two cases versus the bifurcation index. Flow rate ratio are the same 
in both cases as shown in the figure on the right .  
To start with, the influence on the cell and plasma outlets, of the lengths of the end 
channels, in fact, any capillaries plugged to the outlets.  These output lengths are 
doubled and quadrupled onto two different Coventor models for two different values 
of the initial flow rate ratio, FRR. The first model is the symmetrical, and chip isolated 
model presented in the first part and the second model more realistic model takes into 
account the chip board. Figure 4.12 shows the main channels and plasma channels 
flow rates at each bifurcation as well as the corresponding flow rate ratios (FRR) for 
two values of an initial FRR of 10 on the chip and platform model and chip only. In 
every case but the control (normal output length, first network diagram), a rapid 
decrease of the flow rate ratio is observed.  A greater decrease is witnessed in when 
the chip is isolated.  It can be concluded that any capillaries or other devices plugged 
downstream the system will greatly affect the performance of the chip itself.   
The situation worsens with a larger flow rate ratio. Figure 4.13 shows the flow rates 
and flow rate ratios for an initial FRR of 20. The separation efficiency being 
theoretically coupled with the flow rate ratio, the system efficiency is therefore 
dependent on the downstream microfluidic network. The continuous separation 
system is meant to be part of a modular system that incorporates further microfluidic 
modules downstream. The strong dependence of the separation efficiency on 
downstream device eventually means that a downstream system of valves and 
reservoirs will be needed to restore the initial flow rate ratio.    
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Figure 4. 12: Influence of the external microfluidic devices on  the internal flow 
rate ratios at  an initial FRR=10. These graphs illustrate the flow rates of the 
main and plasma channels and the corresponding flow rate ratios at each 
bifurcation. The diagrams are obtained using the parameters given by the 
analytical computation in the CoventorWare TM model. Two models are used, the 
first one is the real model with the chip embedded on the board  (left column), 
the second is the ideal chip on its own (right column). For each of these models, 
the outlet lengths are multiplied by two (in red on second inset diagram) and 
four (in green on third inset diagram).  
 
Figure 4. 13: Influence of the external microfluidic circuitry on the internal flow 
rate ratios at an initial FRR=20. This graph illustrates the flow rates of the 
main and plasma channels and the corresponding flow r ate ratios at each 
Main channel 
Plasma channel 
Main channel 
Plasma channel 
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bifurcation. Two models are used, the first one is real life model with the chip 
embedded on the board, the second is the ideal chip on its own. For each of  
these models, the outlet lengths are multiplied by two  (red curves) and four 
(green curves).  
Alternatively the flow rate ratios can be tuned by externally adapting the output 
lengths.  We define an Outlet Length Ratio, OLR as : 
RPend
RMend
L
L
OLR         [4.6] 
Where LRMend and LRPend are the lengths of the output lengths on the main channel 
and plasma channel, respectively. In the optimised symetrical model designed with an 
initial FRR of 10, the attainement of a FRR of 20 from the first bifurcation necessitates 
an OLR of at least 10. However an OLR of 10 set-up a back flow in the fourth and last 
channel (FP4=-0.3123) as illustrated in Table 4.5. Although an OLR of 9 provides a FRR 
of 19.8 at the first bifurcation, and a positive flow rate in the fourth and last 
bifurcation the flow rate is really small in the last channels. Clearly from the table, the 
rise in the FRR is not directly proportional to the rise in the corresponding OLR, it is 
therefore hard to predict during the experiment the consequence of additional pieces 
of tubing being plugged to the device. The design methodology outlined above 
therefoare helps in predicting quickly the performance the overall system when 
additional microfluidic circuitry is used to complete the microfluidic device. 
In conclusion, it is possible to vary the outlet lengths in order to tune the inner flow 
rate ratio at each bifurcations. However, the technique has its limitations as an 
increase in the outlet length reduces the flow rate in the last channels. 
4.4.3. Pull mode as an alternative strategy to influence the internal 
flow rate ratio 
Using two syringe pumps to pull the fluids out of the outlets instead of injecting the 
fluid through the single inlet (the push mode operation) is a practical, direct and 
flexible way to externally manipulate the internal flow rate ratios. This configuration, 
there onwards defined as the pull mode operation is shown in Table 4.6 (last row). The 
manipulation of the output length ratio, OLR, finds its limits when the flow rate of the 
last channels reaches zero and eventually becomes negative creating a back flow. 
Table 4.6 compares the three methods to influence the flow rate ratios once the chip is  
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 Main flow rate Channel flow rate Flow rate ratio 
OLR 1.45 
133.4 13.3 10 
111.2 11.1 10 
92.67 9.257 10 
77.23 7.72 10 
OLR 2 
135.5 12.22 11.1 
115.6 9.955 11.6 
99.62 8.01 12.4 
86.97 6.324 13.8 
OLR 9 
145.3 7.333 19.8 
135.7 4.801 
28.26 
130.9 2.389 54.79 
130.9 0.0181 723.20 
OLR 10 
145.8 7.077 20.6 
136.8 4.531 30.2 
132.6 2.095 63.3 
133.2 -0.3123 N.A. 
Table 4. 5: Comparison of the main channel and plasma channels flow rates , and 
flow rate ratios at each bifurcation in the optimised symmetrical model for an 
initial FRR=10.  
manufactured: the tuning of (1) the outlet length ratios in the push mode, (2) the 
outlet widths ratios in the push mode and (3) the external flow rate ratios in the case 
of the pull mode. The figures of comparison chosen are the rounded values of the 
ratios at which a backflow is introduced in the system and the values for which the FRR 
is doubled at the first bifurcation. From Table 4.6, it is impossible with the variation of 
the OLR to get a doubling of the FRR without having a backflow in the system. When 
varying the OWR it is possible to go far beyond a doubling of the FRR without having a 
back flow. The flow rates in the last plasma channels can be very slow however. Finally 
the last solution provides the easiest solution for the doubling of the FRR at the first 
bifurcation; the solution is however at the expense of rapidly decaying flow rates in the 
plasma channels. 
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Way to externally  
influence the 
internal flow rate 
ratios at each 
bifurcation 
Value from 
which a 
backflow is 
introduced in 
the system 
Value from 
which the first 
bifurcation FRR is 
doubled (from 10 
to 20) 
Parts of the design 
which varies 
Outlet lengths ratio  
end
end
RP
RM
L
L
OLR   
 
10 9 
 
Outlet width ratio  
end
end
RP
RM
W
W
OWR   
 
6 10 
 
Pull Mode - External 
flow rate ratio  
end
end
P
M
F
F
ExtFRR   
5 5 
 
Table 4. 6: Comparison between the different strategies of externally tuning the 
internal flow rate ratios in the chip. All the calculations are based on the 
optimised symmetrical model with an initial FRR=10.  
In conclusion, the separation efficiencies, directly linked with the flow rate ratios, are 
highly dependent on the network downstream in the separation module.  
CoventorWareTM can be used as a useful tool to model these types of passive 
microfluidic networks. The software can also directly be used to optimise the 
performance of the system and provide guidance over the safe usage of the device.   
4.5 Discussion 
High-level system modelling provides a system-oriented technique which can take into 
account the operation of complex networks. In this study an algorithm to calculate the 
geometries of a microfluidic network for passive blood separation has been 
demonstrated. The model is still incomplete due to the blood particulate behaviour, a 
feature absent from the modelling. However, the blood to be used in the device may 
be substantially diluted (up to 1:20). Therefore a Newtonian model may hold in certain 
cases. A numerical model of this network was subsequently built using the software 
package CoventorWare to (i) verify the validity of the analytical approach, (ii) and take 
into account subsequent changes to fluid path appearing during the experimental set-
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up and/or device operation after the chip has been manufactured. Nevertheless the 
model helps setting the correct flow rate ratios at each bifurcation and also allows to 
assess changes in geometry and behaviour of the entire system.  
The model is only valid for the analysis of simplex or complex microfluidic networks 
operated at low Reynolds number where the Hagen-Poiseuille law can be applied. In 
this model the viscosity is also independent of the flow rate ratios. The technique 
developed is simple and versatile. The strategy presented in this article is valid for any 
number of plasma branches. Zweifach-Fung law states that if a flow rate ratio better 
than 2.5 is achieved 100% separation can be achieved. However, very little has been 
written about the kind of geometries used, only that the size of the channel has to be 
comparable to the size of a cell. Therefore 100% efficiency is not guaranteed by these 
simulations. Nevertheless, the modeling ensures a precise control of the flow rate 
within the system and guidance over the limits to which the system can be used. 
The flow rate ratios have been shown to be independent of the entrance flow rate and 
the geometries of the entrance. In general, it was demonstrated that the flow rate 
ratios (in a push mode) are independent from any entrance parameter. It is worth 
noting that in this model the viscosity is also independent from the flow rate ratios.  
Once the chip has been manufactured, it is still possible to influence the internal flow 
rate ratios at each bifurcation by careful manipulation of the external parameters. It 
was demonstrated that back capillaries decrease the flow rate ratio, at the expense of 
the separation efficiency. The longer these capillaries are, the more the flow rate ratio 
decreases. This effect accounts also for the negative backflows found in the last plasma 
channels. However, back capillaries can also increase the separation ratio if the length 
of the plasma channel is larger than the length of the cell channel. Holistically, the 
design of a complete continuous separation system in-line with other modules, will 
require a separation module that can be operated independently of the further 
modules downstream independent will have to be developed. This can be achieved by 
a system of valves and reservoirs. In total, three external means of acting on the 
internal FRR have been simulated: output length ratios (OLR), Output Widths Ratio 
(OWR) and the External Flow Rate Ratio (ExtFRR). Amongst these, the last one is the 
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more direct and practical solution, albeit at the additional cost of additional valves or 
reservoirs.    
No blood damage modeling has been carried out in this present work. Reasonable flow 
rates (<20mL.h-1) should be used within the system to avoid dangerous shear rates 
leading to hemolysis.  
4.6 Conclusions  
In this chapter a modelling methodology to optimise the geometry of a microfluidic 
network for maximum separation efficiency of plasma from blood has been described. 
The analytical study permits to define the correct plasma channel lengths to get a 
constant flow rate ratio at each bifurcation, allowing for a more stable and reliable 
separation throughout the system. The analytical results were confirmed by the use of 
a numerical analysis tool, CoventorWareTM. Subsequently, CoventorWareTM was used 
on its own to highlight the general network behaviour and provide useful guidance 
over the use of such systems. It was further demonstrated that additional capillaries 
plugged at the back of the device can have a dramatic impact on the microfluidic chip 
separation efficiency. Generally, the separation device, as part of a modular system, 
can only be reliable if independent from downstream modules. Therefore a system of 
valves and reservoirs will have to be used to isolate this separation module from the 
rest of the system if a fully lab-on-chip system, as defined in chapter 1 is to be 
manufactured.    
An experimental study will have to confirm the results of the analytical and numerical 
study. To check for the flow rate in each bifurcating channels, it is suggested that 
Particle Image Velocimetry (P.I.V.) could be used. Two attempts at developing a PIV 
study are described in Chapter 8. The method developed in this study is applicable to 
many other microfluidic systems, sustaining a large range of different activities. Useful 
future developments include the implementation of a Non-Newtonian approach and a 
change of the blood viscosity along the network as more and more plasma is being 
directed to the plasma channels.  
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Chapter 5: Manufacturing routes and 
experimental set-ups 
5.1 Introduction  
The blood plasma separator is a versatile module aimed at producing high-speed and 
high-efficiency plasma separation to compete with conventional plasma extraction or 
CD-like platforms. The industrially-oriented product should therefore be manufactured 
using cheap material and low-cost techniques. To this end, different manufacturing 
methods have been implemented to decide on the best competitive one.   
The performance of the system is governed by the ratios of the channels widths and 
the length of the constrictions. The different designs present a number of engineering 
challenges such as tight arrays of relatively small channels and sharp edges. The 
designs provide a base for testing several manufacturing methods. 
The industrially-oriented product should have a set of desirable characteristic features 
such as: use of cheap biocompatible material and low-cost manufacturing techniques 
which allow rapid-prototyping. In this respect, different methods have been 
investigated and experimented upon the designs to determine the best one.  The 
challenge of the microfluidic chips manufacturing lies in the balance between the 
dimensional accuracy needed and the fast manufacturing response.  
The first part of this Chapter presents three different manufacturing routes taken by 
three different institutions to fabricate the microfluidic blood plasma separation 
system. Although the actual fabrication of the prototypes was carried out by other 
institutions, the following discussion and comparison of the results of these three 
different manufacturing approaches is original.  
In the second part the experimental set-up will be discussed in detail with an 
explanation of the major difficulties experienced. 
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5.2 Manufacturing routes 
5.2.1. Lamination  
Lamination is one of the 3D-Mintegration manufacturing philosophies as it permits the 
creation of truly 3D structures. Manufacturing layer by layer was undertaken with an 
EnvisioTEC Perfactory3 TM machine at the Cambridge Institute for Manufacturing [5.1]. 
As in a stereo-photolithographic process, the machine optically cures layers of liquid 
polymer. However, in the perfactory system the polymer is cured by means of a Digital 
Light Processing (DLP) projector from underneath the basin while the part is raised 
above the liquid polymer. The only material compatible with the process at the time 
was orange methalycrate. Figure 5.1 presents a cross-section view of the Envisotech 
Perfactory system. The main advantage of this technique is the speed of the process 
and the small footprint of the machine. The time response from the production of a 
design to the prototype is approximately one day and depends on the size of the 
device.  
 
Figure 5. 1:  Photograph of an EnvioTEC machine and cross -section view of the 
workbench [5.1]   
A prototype has been manufactured layer by layer in methalycrate by such a machine. 
A photograph of some prototypes is shown in Figure 5.2.  Various fabrication 
inclinations were tested from horizontal to vertical with angles of 0°, 10° and 20° to 
test the process capabilities of this manufacturing technology. Detailed scans showed 
that channels were either of a U- or V-shape. The roughness, Ra, varied from 170 to 
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570 nm. The horizontal inclination showed the best results. Although all samples 
showed acceptable shape for the main channels and the constriction, the definition of 
the plasma channels was poor as shown in Figure 5.3a, In figure 5.3b a section of the 
channel is shown when viewed with a white light interferometer. The channel widths 
were in general larger than expected. These prototypes were therefore not considered 
for testing. 
 
Figure 5. 2: Photograph of four samples with different manufacturing 
orientations. (Photograph Courtesy of Cambridge University)  
  
Figure 5. 3: (a)Microscope view of the device (b)White light interferometer view 
of a main channel. Photographs: Courtesy of Cambridge University  
In conclusion, although the lamination fabrication route offers an excellent  response 
time of a day or less, the technique was not applicable to our prototype. Nevertheless, 
lamination using the EnvisoTEC prototyping machine could be satisfactorily undertaken 
for a microfluidic device with structures in the x and y directions larger than 100µm. 
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5.2.2 Micro-injection moulding 
Microinjection moulding was considered at Cranfield University on a Battenfeld 
Microsystem machine to study the mass-manufacturability of the microfluidic system. 
Microinjection moulding is a fast replication method for the high volume production of 
polymeric parts. Micron-size features can be easily replicated in polymer and thus the 
precision depends on the mould itself. This mould has to be micro-milled. This 
preliminary step can hamper the rapid prototyping of components with this technique. 
Figure 5.4 presents the different steps involved in the preparation of microinjection 
moulded plastic parts. 
 
Figure 5. 4: Microinjection moulding process flow. Courtesy of Cranfield 
University 
After a preliminary study, the manufacturing of the prototype using microinjection 
moulding has been abandoned because of the difficulties in creating a metallic mould 
for the specific component geometries.  Indeed, sharp edges and tight small channel 
arrays as shown in Figure 5.5 cannot be milled by the currently available tools. Thus, 
the limits of micromilling have been reached in this particular design. In this example, 
the use of microinjection moulding is hampered by the preliminary milling step in the 
mould fabrication.  
108 
 
Figure 5. 5: Schematic of the challenging parts in the design  
Micromilling 
200-300µm slots Ok and safe 
100µm slots OK but needs further investigation 
20-30µm slots 
Under development but not close to 
application bespoke tools for 
micromilling 
Table 5. 1: Summary of the challenging parts in the design  
Microinjection moulding is a powerful high volume microfabrication technique [5.2]. 
However, due to the lengthy preparation of the tool and mould necessary for the 
replication, this technique was found to be unsuitable for our prototypes. However 
microinjection moulding is undoubtedly very useful for the manufacturing microfluidic 
parts at high production volume given that these parts have been carefully designed 
such as to accommodate the technique’s desirable features.  
5.2.3 Industrial photolithographic solution 
An industrial collaboration with Epigem Ltd., Redcar, UK lead to the rapid production 
of microfluidic chips [5.3]. At Epigem, conventional photolithographic technique is a 
cost-effective technique for the production of low and high numbers of components. 
The epoxy based negative photoresist SU8 is Epigem’s material of choice for the 
manufacturing of microfluidic chips. Among the reasons to use SU8 are its 
biocompatibility and the fact that high aspect ratios can be achieved with this material. 
Polydimethyloxane (PDMS) is another useful and flexible polymer with extremely 
simple processing capabilities. However, SU8 offers the advantage of highly defined, 
rigid and non-permeable channels unlike PDMS. Although widely used in microfluidics 
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prototyping, results using PDMS have been found to be unreliable and therefore not 
applicable to commercial chips [5.4].  
Design of masks for photolithography was carried out using AutoCAD (Autodesk Inc, 
USA). Electronic files of the masks were directly sent to Epigem in .dxf format. The 
masks were produced directly on-site at Epigem Ltd.  
 
Figure 5. 6: Photograph of the acetate mask used by Epigem to manu facture the 
blood plasma separation chip.  
For this separator device, a lid and base layer are produced in order to create the 
bonded chip laminate. The lid and the cover layers are composed of PMMA layers and 
a thin layer of SU8. The channel features are defined by the photolithography of an 
additional layer of SU8. Since the chips consist of several sandwiched layers of the 
negative photoresist SU8, thus ensures a “whole SU8” channel network. Having the 
same material on all four walls, helps to obtain better control and repeatability of the 
process. Layers are subsequently cleaned and layered together in bonding jigs, loaded 
and heated for a predetermined time period. The laminate is then chopped up into 
separate chips.   Figure 5.7 presents the main steps of the fabrication process flow.  
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Figure 5. 7: Fabrication process flow for the microfluidic chips  
Since the chip footprint is small (18mm x 23mm) a generic platform using the patented 
Fluence ferrule system presented in Figure 5.8 was also made from an assembly of 
PMMA and SU8. This system is used as a holder featuring standard microfluidic 
connections (Cheminert) as shown in Figure 5.9b. 
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Figure 5. 8: Illustration of the assembly technique of Epigem chip and 
breadboard, Courtesy of Epigem.   
    
Figure 5. 9: Photographs of the microfluidic chips manufactured by Epigem. (a) 
Microfluidic chip filled with blue ink sitting on a chip holder. (b) Close -up view 
of the thin channels microfluidic network.  
For analysis purposes a chip was cut in half along the main channel using a diamond 
saw. The cross-section obtained was observed and the geometries measured using a 
USB microscope (DinoLite, big C, USA). As shown in Figure 5.10 (a) and (b), the 
channels are well-defined and within 5% of the required dimensions (side channels 
20x20µm). 
 
Figure 5. 10: Microfluidic chip. (a)Cross-section view of the chip assembly. (b) 
Top view of a chip next to a British one pound coin. The red line corresponds to 
the cross-section in (a) 
The manufacturing route followed by Epigem is an established process. Sixteen chips 
with different geometrical variations were produced and mounted on microfluidic 
holders for testing. The chips were tested and no leakages were spotted. The channels 
are well defined and the roughness is very low. As compared to the first lamination 
technique presented, the manufacturing of the chips requires the fabrication of 
a b 
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photomasks after the design of the prototype. The response delay to changes is 
estimated at 1 to 2 weeks.  
5.2.4 Conclusions 
Three different manufacturing techniques for a particular design were tested. In this 
section, the advantages and drawbacks arising from these techniques are discussed in 
the form of a summary table.  
 Possibility of: 
Response 
time from 
design  to 
product-ion 
Cost for 
low 
volume 
Cost for 
high 
volume 
 
using bio 
compatible 
material 
 inserting 
dense 
arrays 
inserting 
narrow 
channels (<20 
μm) 
inserting  
sharp 
edges 
Layer by layer 
manufacturing 
yes medium low medium 1 day low medium 
Microinjection 
moulding 
yes low medium low 1 week medium low 
Lithographic 
lamination 
method 
yes high high high 1-2 weeks low low 
Table 5. 2: Summary of the fabrication methods  
Although all the proposed techniques allow the manipulation of cheap and 
biocompatible material, the photolithographic lamination method is the only 
manufacturing method able to reach the optimum system performances. The 
optimum system performances are defined in this case by the presence of dense 
arrays, narrow channels (<20μm) and sharp edges. The manufacturing response time 
from design to production of the methods tested was also evaluated. The response 
time from design to production indicates only a fair performance in that category for 
the photolithographic lamination.   
In this chapter, the designs of a microfluidic chip for blood plasma separation provided 
the basis for a study on the limits of some rapid prototyping and high volume 
manufacturing techniques. Back-side stereo-photolithography with the Perfactory 
machine showed the best response time from design to production of the prototype. 
However the technique did not prove appropriate for features below 20μm. Micro-
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injection moulding is a promising technique for high volume production of microfluidic 
components, although the tooling for micro-milling of tight structures is not available 
yet. Other methods such as Fused Deposition Modelling or laser ablation technique 
have been envisaged but have not been tested yet. Finally, the photolithographic 
manufacturing route is good although the response time to design changes ought to 
be improved. 3D-manufacturing techniques are likely to become strong contenders 
once these techniques become more mature.  
5.3 Experimental approach 
The ultimate goal of the experiments presented in chapter 6 is to characterize the 
efficiency of the plasma extraction, that is to say, how well the plasma is extracted 
from the blood using the microfluidic approach. Additionally, from these experiments 
some very useful  observations can also be made. 
The experimental approach used throughout this study is presented in Figure 5. 11. 
Firstly, a “solution” or “sample” was prepared with a  view to be separated in the 
microfluidic system. The different “solutions” or “samples” used for experimental 
purposes will be detailed in this section. Then the system itself was prepared, the chip 
was mounted onto its platform and capillaries were connected to the inlets and 
outlets. These capillaries were connected to tubes for the collection of the separated 
products. 
The experimental set-up will be discussed in further detail in the next section. A 
syringe was loaded and placed onto a syringe pump, this type of  pump  was  chosen 
for the experiments. A flow rate was selected on the syringe pump which will be the 
entrance flow rate of the solution in the system. Once the flow rate was selected, the 
pump was turned on and the observation of the separation behaviour was made 
possible through a microscope placed above the chip as shown in the experimental 
set-up. At the end of the separation, the products were collected for cell counting.  
Different types of experiments  and parameter variations were undertaken with the 
first and second generation devices in order to fully assess their performance. These 
parameters are presented in Figure 5. 12. With the first generation devices, 
streamlines and particle free zones in the devices were observed using milk and latex 
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beads. These results and observations were used to optimise the second generation 
devices. Blockages, cell population and cell viability could then be controlled in the 
second generation devices.  
 
Figure 5. 11: Overview of the experimental approach  in six steps.  
The efficiency of separation for different solutions were measured in both generation 
devices using different tools. The cell-free or particle-free zones are measured in 
micrometers and the efficiency is measured as a percentage using the following 
equation: 




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

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E 1
 
With cp, the concentration of cells in the plasma and cf, the concentration of cells in 
the inlet solution. In the experiments on the first generation device, the concentration 
corresponds to the number of “events” measured by the flow cytometer on a  volume 
unit. In the experiments on the second generation device, the concentration 
corresponds to the number of red blood cells measured by an automatic cell Coulter 
counter per volume unit. 
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The plasma yield is approximated by calculating the ratio of the volume of plasma 
extracted to the total volume of plasma. For example, a plasma yield of 40% means 
that over 1mL of blood with an absolute plasma volume of 55%, 0.22mL of plasma will 
be extracted. 
Throughout the experiments on the devices a range of solutions was used and the 
necessary information for these is  summarised  in table 5.3 . The preparation of these 
solutions is detailed in the next section. 
 
 Usage Particle size range 
Milk Streamlines observation 2-3µm  
Latex beads Particle free zone observation and experimental 
determination of Reynolds number range 
6.1µm 
Mussel 
haemolymph 
Efficiency characterisation   10-50µm 
Human 
blood 
Efficiency characterisation  RBCs: 5-7µm 
WBCs: 10-100µm 
Platelets < 2µm 
Table 5. 3: The different solutions used in the experiments on the first and 
second generation devices 
 
There are three main experimental variables, on top of the geometrical variables that 
vary from model to model (eg, plasma channel width): 
- The output capillary ratio 
- The entrance hematocrit (%) 
- The entrance flow rate (mL/hr) 
In the experiments on the first generation devices, these three experimental variables 
are used to produce different results. In the experiments on the second generation 
devices however, the focus was on the variations of the entrance hematocrit and flow 
rate as it was considered impractical to vary the output capillary ratio.  
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Figure 5. 12: Experimental controls in the two generation devices. Numbers 
refer to corresponding sections in Chapter 6.    
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5.4 Experimental set-up 
In this section are presented the main components of the experimental set-up for 
passive blood plasma separation, featuring the pumping system, the microfluidic set-
up, the video and image analysis system, particle counting apparatus and finally the 
sample preparation protocols.  
5.4.1 Pumping systems 
Although the final device in the prenatal diagnosis system should have an integrated 
pump, two types of external pumping systems were used for the first prototypes. 
A pumping system has to be chosen to inject the liquid into the microfluidic chip. A 
dual-piston pump system “Flash100” from LabAlliance (Figure 5. 13(a)) was used in the 
first tests as it was available in the Department.. The “Flash 100” is ideally designed for 
High Performance Liquid Chromatography and is quite a complex pumping system 
which includes: a prime purge valve, two pistons, and an outlet filter. The fluid is 
pumped and filtered through the system and arrives at the front panel of the pump 
where tubing must be connected to direct the fluid to the microfluidic chip. This results 
in a relatively long flow path in terms of microfluidic volume and is not suitable for 
pumping fixed volumes of fluid below 10mL to a chip. Indeed before entering the chip, 
the 10mL will be dispensed through the tubing of the pump and more fluid will be 
needed in the primary reservoir at the beginning of the flow path in order not to 
damage the pump by pumping air into the system. Although primary tests could be 
performed with the Flash100 pumping systems, a second solution had to be chosen for 
further tests.  
          
Figure 5. 13: (a) Flash 100 pumping system from LabAlliance 
(www.laballiance.com) (b) Aladdin syringe pump system from WPI (www.wpi-
europe.com) 
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Due to the inconvenience of the dual HPLC pump system, a second pumping system 
was chosen. A syringe pump offers a convenient facility for pumping small amounts of 
fluid to a microfluidic chip. A syringe pump is delivering a set flow rate using a step 
motor to push on a syringe. The fluid path is much reduced compared to the dual 
pump system. The selected syringe pump is the “Aladdin” from WPI (Figure 5. 13(b)) in 
which the syringe volume can range from to 60mL to 1mL. The syringes used are 
disposable plastic syringes from BD Plastipak. Different tips can be chosen from slip to 
luer-lock tip. The slip tip is a simple tip while the luer-lock tip offers the possibility to 
screw on the luer-adapter and therefore minimize leakage or the possibility of the tip 
coming off. 
It has been observed that in the microlitre range, the use of syringe pump might lead 
to long equilibration times and irreproducibility of the results [5.6]. Existing fluid 
handling devices are thus often inadequately adapted to the manipulation of small 
fluid volumes, however in this study the Aladdin syringe pump has been found to cope 
extremely well with the manipulation of 1mL biological samples at flow rates ranging 
from 1mL/h up to 30mL/h. 
The fast response of liquids to actuation in microchannels is a desirable benefit in 
Microsystems. For this reason, syringe pumps are suitable for most microfluidic 
applications. However, due to the various connections and tubing between the syringe 
and the microchannels, instantaneous flow actuation might be hard to obtain and has 
been shown to be relatively independent of the settings of the pump [5.6]. However, 
using the Aladdin syringe pump and semi-rigid tubing, equilibrium time have found to 
short, of the order of a few seconds, and the pump settings did correspond to the 
actual flow rate obtained. 
Moreover, the control of the pressure or the flow rate control may introduce different 
velocities in multiphase flows, such as blood [5.7]. Therefore different flow controls 
will have to be tested on the prototypes in the future.   
The tubing 1/16 inches Outer Diameter (OD) and 0,005 inches Internal Diameter (ID) 
delivered with the Epigem chips set the standard tubing dimensions of the microfluidic 
systems developed here. In the syringe pump system, the fluid path is reduced to that 
of the syringe barrel and tip, tubing, and the microfluidic chip, therefore only two 
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connections are needed. The first connection is linking the syringe luer tip (Slip or lock-
luer tip) and the piece of tubing. The connection solution chosen consists of two parts, 
the P659 and the F-120 from Upchurch. The P-659 is a female luer to female 10-32 
adapter shown in Figure 5. 14(a) and the F-120 is a fingertight fitting for 1/16’’ OD 
tubing shown in Figure 5. 14(b).  
 
Figure 5. 14: a) F-120 part from Upchurch. 10-32 Fingertight Fittings for 1/16" 
OD Tubing, b) P-659 Female Luer to Female10-32 Adapters     
(www.upchurch.com)  
5.4.2 Microfluidic set-up 
The first part of the tests was performed at Heriot-Watt University. The syringe pump 
was loaded with a 2.5mL disposable syringe (BD Plastipak). The fluid flow rates used 
ranged from 1mL/h to 30mL/h, although the chip could sustain a flow rate of up to 
100mL/h. The overall assembly of the experimental set-up is presented Figure 5. 15. A 
bead (b) was inserted in the syringe (c) and a magnet (a) was manually activated to 
agitate the fluid in the syringe and avoid sedimentation when the syringe was 
activated at low flow rates. The cellular and plasma samples were collected in 
eppendorfs via tubing connected at the outlets as shown in Figure 5. 15. In the first 
part of the tests both plasma samples were collected in the same tube and therefore 
no differentiation was made between the two samples. The flow was observed using a 
conventional microscope on which a digital camera could be mounted. 
 
Figure 5. 15:   Diagram of the experimental set-up for the tests on the first 
generation device . a) magnet, b) stainless steel ball, c) syringe, d) syringe 
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pump, e) holder inlet, f)&g) plasma outlets, h) chip, i) cell outlet, j)&k) 
eppendorfs for cell and plasma collection .  
The second part of the tests, involving the characterisation of the second generation of 
blood plasma separation chips, was performed at the division of pathway medicine 
(DPM), University of Edinburgh (Royal Infirmary of Edinburgh, Little France, 
Edinburgh). The chip was loaded onto the holder with microfluidic connections as 
shown in Figure 5. 16. The chip and holder assembly was maintained onto a custom 
made back-light apparatus under a microscope (DinoLite USB microscope, Big C, USA) 
to observe the flow and detect any obstacle to the flow path during each experiment. 
The flow was activated at flow rates ranging from 1mL/h to 10mL/hr by a syringe pump 
(Aladdin, WPI, USA). A syringe (BD Plastipak) with 1mL of blood was loaded for each 
experiment.  
For each single experiment, a 1mL disposable syringe filled with the sample was loaded 
on a syringe pump (Alladin, World Precision Instruments). The microfluidic devices 
were prefilled before each experiment with a 1% BSA-PBS buffer for at least 10mins to 
avoid cell adhesion during the separation process [5.7]. Despite this prevention, the 
microfluidic network tends to clog up after a number of experiments. However, the 
device is rarely clogged up during the first experiment. The cheap, plastic device is 
meant to be single-use and disposable to avoid contamination. However, at the time of 
the study a limited number of chips were accessible, and therefore chips were 
sometimes used several times but never more than 10 times. If a blockage was 
spotted, or if the efficiency of the chip seemed to drop, the chip was discarded and a 
new one was loaded on the holder. As shown in Figure 5.14, for the tests on the 
second generation device, the plasma collection was separated into two tubes.  
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Figure 5. 16: Photo of the experimental set-up at the DPM, University of 
Edinburgh, Royal Infirmary, for the second part of the tests.  
In Figure 5. 17, a close view of the chip is shown during the experimental tests. The 
flow of red blood cells, can be seen clearly in the main channel. A close-up on the cell 
free layer is shown.  
5.4.3. Video and Analysis 
In the first part of the tests a conventional microscope with a mounted digital camera 
was used for the video setting. For the second part of the tests an apparatus with a 
back-light system was manufactured in-house. 
The chip and holder assembly was mounted onto a custom made back-light apparatus 
under a microscope (DinoLite USB microscope, Big C, USA) to observe the flow and 
detect any obstacles to the flow path during each experiment that was carried out.  
Some of the experiments required image analysis, for this application the free 
software package Image J was used. The use of the software will be presented in the 
next section. 
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Figure 5. 17: The blood plasma separation chip (second generation) in use 
during experiment . Blood dilution 1:2.  
 
5.4.4 Sample preparation for the first generation device 
Experiments have been carried out on milk, mussel blood and human blood. Whole 
milk is injected into the separator as a blood simulator. Milk is a water-based 
suspension composed of fat globules. Cow’s milk fat globules size range from 1 and 
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10µm. However after homogenization, fat globules are reduced to a size range from 1 
to 2µm. Fat globules are surrounded by a phospholipidic membrane like cells. 
Although a milk skimming effect is observed after the constrictions in both designs, no 
separation of fat globule from the water base was observed. Several reasons can lead 
to these results. First of all, the size of the fat globules is much smaller than that of red 
blood cells. Due to this, fat globules may not be as deformable as RBCs and therefore 
do not experience a radial drift strong enough which would coerce them into entering 
into subchannels. 
Human blood was collected from healthy donors with a sterile lancet (Accu-check, 
Roche, Switzerland). The collected blood was suspended in 1mL of anticoagulant 
solution composed of Phosphate Buffered Saline (PBS) at normal strength and 10μL of 
ethylene diamine tetraacetic acid trypsin (EDTA-trypsin) (0.05M, Gibco).  
The immune cells of the blue mussel, Mytilus edulis, range from 5μm up to 25μm in 
diameter and were used to investigate the behaviour of larger deformable particles in 
our system. These immune cells are transparent and have a range of internal 
complexity. In order to investigate the influence of the buffer type on the purity 
efficiency, the mussel blood was suspended in two different buffers. The first buffer 
comprised formaldehyde, known to fix and harden the cells. To keep the cell 
characteristics as close as possible to the physiological conditions, the second buffer 
was free of fixing solution. Details of the mussel blood preparation are given in Table 5. 
4.  
5.4.5 Samples for second generation device 
Human blood was obtained in 500mL bags from the Scottish National Blood 
Transfusion Service, Lauriston Place, Edinburgh. Samples were used with the donors’ 
prior consent and ethical clearance was obtained from the SNBTS Sample Governance 
Committee. Blood was treated with oxalate and stored at 4°C upon the day of 
reception. The blood was used within a month. Ideally the blood should be separated 
on the same day, and the PCR performed within hours after the separation. However, 
this could not be achieved in the current situation. This delay has been taken into 
account when interpreting the results. During the length of the study two different 
blood samples were obtained. The blood samples were subjected to different dilutions  
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Buffer 
Preparation 
Preparation Note 
With  
Formaldehyde 
5 mussels of 4-5cm in length were bled 
using 2.5mL syringe filled with 1mL of 
fixing solution (3.6%formaldehyde in 3x 
TBS). The haemocyte suspension was 
centrifuged at 1000rpm for 10 minutes. 
The cell pellet was re-suspended in 1mL of 
methanol and 20μL of Wright’s stain pure 
solution. After 2 minutes, 10mL of TBS 
buffer was added to the suspension and 
centrifuged at 1000 rpm for 10 minutes. 
Finally the cell pellet was re-suspended in 
10mL of fixation solution and ready for 
use. 
The cell mixture was kept 
at room temperature 
before processing and used 
within two hours after 
bleeding 
Without 
Formaldehyde 
The mussel blood was collected in a saline 
solution (v:v) composed of 0.45M NaCl, 
0.1M glucose, 0.03M Tris-Sodium citrate, 
0.1M EDTA, 0.026M citric acid. The pH is 
adjusted at pH=8 with KOH 
The cell suspensions were 
kept on ice and used within 
following 2 hours from 
extraction. 
Table 5. 4: Table illustrating the preparation of two different buffer s for the 
mussel blood experiments 
using Phosphate Buffered Saline, (PBS, Sigma). The dilution levels ranged from zero to 
1:20. Dilution levels on different blood samples are biased by the intrinsic hematocrit 
of the blood donor at the time of the collection. Therefore, only resulting hematocrit 
levels truly reflect the different dilutions performed. Hematocrit level measurements 
and a full cell count were performed using a Beckmann Coulter Counter before each 
run. 
Around 50µL aliquots of each blood samples were placed in individual eppendorfs 
tubes for hematocrit level verification using a Beckmann Coulter Counter. 
The samples were loaded at entrance flow rate in the 2-10mL/h range. Once the blood 
samples filled the main channel, the separation process occurred at each bifurcation 
and the plasma flowed through the individual plasma channels and collection channel. 
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The cell-enriched mixture and the extracted plasma were collected in three individual 
eppendorf tubes and stored at 4°C until further processing.  
5.4.6 Particle counting 
After the first stage of collecting suspensions from the different outlets, the particles 
or cells contained in the different outlets must be counted to determine the efficiency 
of the separation. This section details the different techniques used to count the cells, 
their advantages and disadvantages of each method are explained.  
Disposable haemacytometer 
After the first stage of collecting suspensions from the different outlets, 10µL are 
pipetted from each of the collection beaker (cell and plasma). The 10µL are then 
inserted into a disposable haemacytometer from Labtech as shown in Figure 5.16.  The 
so called “C-chip” is normally used for manual cell counting under a microscope.  It 
consists of two surface-patterned enclosed chambers with two ports for sample 
injection. A standard grid pattern is used for counting the cells (Figure 5. 18(b)). 
Counting cells using a manual haemacytometer is very tedious, and time-consuming, 
and due to human eyes fatigue, can have a high error rate.   
   a     b 
c 
Figure 5. 18: Haemacytometer principles, Labtech website (www.labtech.com). 
(a) Photograph of a C-chip; (b) Neubauer pattern grid used for conventional 
cell counting; (c) haemacytometer  diagram.  
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Figure 5. 19: Photographs of hemacytometer counting grid  
Image processing 
Instead of counting the cells by eye, a photograph of the cells in the C-chip is 
processed with the free image analysis software known as ImageJ. In Figure 5. 20, the 
diagram shows the path of image processing to obtain a cell count from an image of 
the haemacytometer taken through a microscope.  
 
Figure 5. 20: Image processing flow to extract the cell count from a photograph 
of a cellular sample.  
Automated cell coulter counter 
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A Coulter counter is an automated apparatus to count cells. Fluid passes through a 
small aperture and the machine uses variations of the electrical conductance to 
calculate the number of cells passing through the tube. The concept which created a 
small revolution in the analysis of microparticles, was invented in 1947 by Wallace 
H.Coulter.   
Cell counting using a Beckmann Coulter counter was performed at the cardiovascular 
unit, at the Queen’s Medical Research Institute (QMRI) at the University of Edinburgh, 
Royal Infirmary. This apparatus is visible on Figure 5. 21(a). The external interface 
consists of metallic tip (Figure 5. 21 (b)) and a touch screen (Figure 5. 22). The metallic 
tip is directly placed in the tube prepared for cell counting as shown in Figure 5. 21(b) 
and the results are read on the touch screen (Figure 5. 22). This Coulter counter not 
only allows the reading of the population of red blood cells but also counts the white 
blood cells, platelets, haemoglobin level and other parameters.    
 
    
Figure 5. 21: Automated cell counting (a) Beckman Cell coulter counter (b) 
Blood sampling on the cell counter.  
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Figure 5. 22: Screenshot of the Beckman Cell coulter counter. WBC: White Blood 
Cells, RBC, HgB: Hemoglobin level, Hct: Hematocrit level, MCV: Mean 
Corpuscular Volume, MCH, MCHC, Plt: Platelets concentration.  
Flow cytometry  
A flow cytometric study was performed on several samples to get an in-depth 
knowledge of the separation of plasma from blood. Flow cytometry allows a very 
precise counting of particles in a fluid and, in this case, provides information on the cell 
population, such as cell lysis that may be caused by the high shear rates in the 
microchannels. Flow cytometry offers a higher level of sensitivity than can be achieved 
with a Coulter Counter.  
Flow cytometry was invented in the late 60s and is based on the principle that as 
different cells pass individually in front of a laser beam on an individual basis, they 
reflect back differently some of the light which can be analysed using a photodetector 
[5.10]. This technique, shown in Figure 5. 23, is also known as Fluorescence Activated 
Cells Sorting, (FACS). Although having inherent fluorescence, cells are often labelled 
using fluorescent tags for sorting purposes.   
Flow cytometry offers a higher level of sensitivity (error <1%) than can be achieved 
with a Coulter Counter (error >3-5%). As the ultimate goal of the plasma separation is 
to detect cfDNA in the plasma, it is crucial to prove that the cells are not damaged or 
destroyed during separation. Damaging the cells and causing lysis leads to more 
contamination of the plasma. In order to give useful biomedical information, the 
cfDNA detected in the plasma should be present in the blood prior to extraction and 
should not come from cell lysis as a result of sample preparation. 
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Figure 5. 23: Diagram of the Flow cytometry concept [5.8]  
The flow cytometer focuses individually the cells in a laminar flow of ultrapure water. 
The cells pass through a 488nm wavelength blue laser and 5 characteristics are 
measured: the relative size of the particles, their internal complexity (or granularity), 
and fluorescence at the three most common wavelengths (520nm, 590nm, 620nm).  
Two different flow cytometers were used. In the first part of the tests, mussel blood 
was analysed using a Partec Cyflow cytometer in the marine biology unit at Heriot-
Watt University. In the second part of the tests, counting was performed using a FACS 
scan instrument from the flow analysis department Flow Laboratory, Queen's Medical 
Research Institute, Edinburgh. The next two sections present in detail the experimental 
set up for each of the flow cytometers. 
Partec Cyflow 
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200μL of the sample collections (cell and plasma) were screened using a flow 
cytometer (FC) (Partec CyFlow® SL, Germany). A lower limit has been set up to exclude 
the particles smaller than 2- 3μm; this filtering allows the reduction of the size of the 
files stored on the computer. The flow cytometry data was acquired with the Partec 
FloMax® FCM software and analysed with the freeware WinMDI Version 2.9. For direct 
control of the cell content in the collection samples, 10μL of the cell and plasma 
collections were inserted into independent chambers of a disposable hemocytometer 
(C-Chip, Labtech International, UK) and manually inspected through a microscope. 
 
FACS Scan 
Staining of the blood sample was performed to label leukocytes and platelets. The R-
phycoerythrin (R-PE)-conjugated monoclonal antibody CD45 (PE Mouse Anti- Human, 
BD Biosciences) was used for leukocytes surface staining. The fluorescein 
isothiocyanate (FITC)-conjugated CD42 antibodies stained the platelets. Using these 
markers we were able to identify the leukocytes and platelets population. The RBCs 
were identified by being non-stained. Blood cell population analysis was carried out on 
a FACS Scan instrument (BD Biosciences, San Jose, USA) and results were analysed 
using Flow Jo software v7.5.3 (Tree Star, Ashland, OR, USA). Determination of the 
absolute cell count was achieved by the use of flow cytometric beads Flow-Check 
Fluorospheres (Beckman Coulter). 50μL of well-mixed beads mixture was added to the 
200μL of sample and mixed thoroughly. The flow cytometer was then calibrated to 
count a specific number of beads allowing a precise absolute count of the cells. 
Comparison of the different counting techniques used 
Four techniques have been presented for counting particles in the resulting collection 
after blood plasma separation. Advantages and disadvantages of each method are 
given in Table 5.5. 
 
 
 
 
 
131 
Counting technique Accuracy Advantages Disadvantages 
Disposable 
hemacytometer (eye 
count) 
+/- 20% Cost-effective  
Low accuracy, slow, 
tiring 
Disposable 
hemacytometer 
(digital count) 
+/- 10% 
Additional 
accuracy/repeatability 
compared to eye count 
Fairly long processing 
time 
Automated cell coulter 
counter 
+/- 5% 
Rapid, accurate, easy to 
use 
Fairly expensive to run 
(washing reagents) 
Flow cytometry +/- 1% Highly accurate 
Processing needed, 
Training needed, 
apparatus expensive to 
run 
Table 5. 5: Comparison of four cell counting techniques  
In conclusion, although the flow cytometer offers the best accuracy, the automated 
cell Coulter counter was found to be the best solution to rapidly and accurately count 
cell populations in the resulting collection and was used in the second part of the tests 
presented in Chapter6.  
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Chapter 6: Experimental results on 
flows and separation efficiencies  
6.1 Introduction 
This chapter presents the results obtained with the first and second generation 
microfluidic separators. On the one hand, the study focuses on the characterisation of 
the flow at the constrictions and bifurcations, and sheds lights on the different 
behaviour of biological particles in such microfluidic networks. On the other hand, 
separation efficiencies are extensively characterised as a function of a number of 
parameters including entrance hematocrit levels and flow rates. It is demonstrated 
that the forces acting upon the cells are of inertial origin and therefore linked to the 
flow speed. The two generations of devices are shown in Figure 6.1. From one design 
to another, the mean separation efficiency is increased by 30% approximately. The 
more efficient design was found to be the second generation design with the 10um 
width plasma channels, which gives purity efficiency of 99% with 45% entrance 
hematocrit level. However, this design also gives the lowest yield (<7%), while the 
second generation design with the 20 µm width plasma channels gave a yield of 
around 30%.   
This chapter is divided into two distinct parts. The first part focuses on the 
observations of the flow in the microfluidic network and investigates the reason for 
blockage in the system. The second part looks into the separation efficiencies on the 
two generation systems. Two independent flow cytometric studies are presented.   
Both generation devices have one outlet for the whole blood, two outlets for the 
plasma and one outlet for the cell collection. The first generation device, as shown on 
Figure 6.1 (a), features 15 plasma channels (also named daughter channels) which are 
20 µm in width, symmetrically arranged along the main channel. The main channel is 
100 or 200µm depending on the model and the entire structure has a depth of 20µm. 
A constriction (20µm by 100µm) is placed in the main channel before the separating 
network. In the second generation device, shown in Figure 6.1 (b), there are only four 
channels, 10 or 20µm in width and 1.4cm in length arranged asymmetrically on each 
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side of a main channel.  In this device the main channel is 100µm in width and 
constrictions are arranged before each bifurcation.   
  
Figure 6. 1: First (a) and second generation (b) of blood plasma separation 
systems 
6.2 Controls and observations on flows 
6.2.1 Discussion about the Reynolds number and the forces acting upon 
the cells.  
Although the results of the experiments are satisfactory in terms of purity efficiency as 
reported in the next section, the separation mechanisms happening at the cell level 
are not as yet fully quantified. In order to gain a better understanding of these 
mechanisms, it is of interest to present experimental observations of cell flow and 
compare them with work from other groups. To do so we define the dimensionless 
channel Reynolds number by Rc:  


 hc
DV
R
..
            
(6.1) 
Where ρ is the density of the liquid, μ the viscosity, V the mean velocity across the 
channel and Dh the hydraulic diameter. Faivre et al showed that, in their system, rigid 
spheres did not encounter an axial migration; in other words, the viscous forces 
overcame the inertial forces [6.1]. Indeed, the Reynolds number in Faivre was found to 
be 0.01. In [6.2] Yang et al the Reynolds number is less than 0.01, which also indicates 
that the system is in the tank-treading regime. In [6.3] however, Jaggi et al mention a 
higher Reynolds number of up to 5, and yet separation is observed. In these papers the 
assumption of a fully laminar regime dominated by viscous forces is made. In our case, 
a b 
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for typical flow conditions of 10mL/h, the channel Reynolds number was found to be 
0.69 (blood viscosity, of 4.10-2 Pa.s; width, 100µm; depth, 20µm; density of 103 kg.m-2). 
The flow pattern in the system can be easily identified using a milk mixture (data not 
shown). The regime is laminar but recirculating eddies appear after the constriction. 
Recirculation eddies are not turbulences but secondary laminar flows due to the back 
facing step. Recirculations have also been observed in [6.4] in the same circumstances 
and might have further extraction power when used carefully. Although the channel 
Reynolds number was found to be close to 1, it was observed that the constriction did 
not focus the cells as much as expected. This can be explained by the fact that the 
bifurcations create a force on the cells pulling them again towards the main channel 
walls. In order to compare the behaviour of deformable asymmetric particles with non-
deformable spherical ones, a mixture of 6.6µm latex spheres was dispensed into the 
system at varied flow rates. Particles were observed when they passed through the 
constriction using a microscope and videos were recorded. As shown in Figure 6.2, at a 
flow rate of 10mL/hr, the particle-free layer is more important with the latex spheres 
mixture than with the blood.  This proves that the inertial forces are dominating the 
viscous forces. With flow rates around 20mL/h, the latex beads followed however 
closely the streamlines. At these flow rates the blood cells are expected to focus well, 
however we observed only a slight focus much smaller than the 27.5µm predicted by 
Equation [3.4].    
The reason for this behaviour might be the effect of the plasma channels placed 
500µm downstream which act on the flow forcing the cells to travel closer to the 
channel wall. However, as spherical beads cannot experience a lateral force at low 
Reynolds number, it is therefore proved that inertial forces create this lateral drift 
[6.5], it is more likely that the inertial forces are present in the microchannel and 
overcome the viscous forces. It is a common mistake to state that inertial forces do not 
exist in microchannels [6.6], and blood plasma separation has been achieved both by 
using inertial separation [6.6] and viscous forces [6.1].  
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Figure 6. 2: (a) A photograph of 6.6 µm latex spheres passing through the 
constriction (25x300µm). The flow rate is 20mL/h. The flow is from left to right 
in all photographs. The focus is very visibl e at the end of the constriction (b). 
Superposition of photographs of 6.6 µm latex beads at a flow rate of 5µL/hr. 
Each sphere is following a flow streamline. (c) A photograph of red blood cells 
passing at 20mL/h in the constriction. The focus is less acce ntuated than in (a) 
and the cells retrieve their position near the walls only 150 µm after the 
constriction. (d) Superposition of photographs of red blood cells passing 
through the constriction at a flow rate of 5 µL/h. Here a focus of a few microns 
is visible after the constriction.  
In conclusion, depending on the flow rate used in this type of system, the potential 
exists to achieve two modes of separation. One mode would be better at separating 
hard spheres using the inertial lift force; while the other one would separate soft 
deformable particle using a viscous lift force. Consequently, the use of a lower flow 
rate for the full viscous mode would significantly reduce the plasma yield. In the rest of 
the present study, high flow rates (ranging from 2 to 10 mL/h) were used. 
6.2.2 Patterns and backflow problems in the microfluidic system 
Milk is a cheap and safe testing material alternative to blood. The solid and liquid 
phases of milk can be separated at high shear rate. Milk can be useful to observe the 
patterns and streamlines in the microfluidic network and rapidly detect backflow or 
other fluidic problems. In Figure 6.3, dyed whole milk was flowed into the first 
generation chip to observe the changes in patterns at low and high flow rates.  
a b 
c d 
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Figure 6. 3: Patterns in the milk stream in the plasma channels of the 
microfluidic structures. The flow is from right to left. The flow rate is raised 
from the first to the second picture. First picture, icon: zone of interest in the 
system. Second picture, icon: simulation of streamlines in the system are 
showing the same kind of patterns.  
In the first generation separator some backflows were observed in the system at high 
flow rates as indicated in Figure 6.4. The resistance in the collecting channel is higher 
than the resistance in the three last plasma channels, therefore a part of the fluid 
escapes back through the plasma channel to the main channel. In the second 
generation system no back-flow was observed. Backflows were avoided by the use of a 
high-level modeling, described in Chapter 5, to predict flow behaviour in the system. 
  
Figure 6. 4: Milk stream patterns in the plasma channels of the microfluidic 
structures. The flow is from right to left.  
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6.2.3 Blockages in the microfluidic network 
Blockage of the microchannels by dust particles or air bubbles is a common problem in 
Microfluidics. In these experiments, the syringe was loaded and carefully connected to 
the system to ensure minimum air bubbles. After priming, the air bubbles were easily 
removed from the microchannel separation network. Nevertheless it did not deter 
other particles to enter and block the channels. Dust particles are the primary first 
reason for channel blockage in the system. Figure 6.10 (a) illustrates a dust particle 
blocking the entrance of a constriction in the network. RBCs are still able to flow 
through the channel, but the dust particle creates a high shear stress zone which will 
encourage platelets aggregation. 
Platelets aggregation, as shown in Figure 6.10 (b) is the second most common reason 
for channel blockage in this system.  
These blockages can create serious disturbance to the normal operation of the system. 
Figure 6.11 (a) shows that platelets aggregation blocking the cell collection outlet. 
Figure 6.11 (b) illustrates a case where the combination of dust and platelet 
aggregation block the flow of RBCs in the main channel. The flow of RBCs is diverted to 
a plasma channel and pollutes the plasma collection. 
The system has originally been developed to allow plasma extraction as well as the 
recovery of cells for further analysis. If the recovery of intact cells is not necessary, a 
pillar structure upstream from the separation network could potentially reduce the 
occurrence of blockages. 
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Figure 6. 5: (a) Photograph illustrating the blockage of the main channel by 
dust. Platelets are aggregating easily around the dust particle blocking the 
channel. (b) Photograph illustrating another case of blockage in a 20m 
channel. Some entire cells are visible, while the channels are tainted with red. 
The high shear stress has resulted in the breakdown of a lot of cells, releasing 
thereby hemoglobin in the channels.  
  
Figure 6. 6: (a) Photograph illustrating platelets aggregation  (white shape) at 
the cell outlet. Some red blood cells are trapped in the platelets aggregate. (b) 
Photograph showing a large disruption of the blood flow due to a platelet 
aggregate blocking the main channel.  
a 
b 
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6.2.4 Formation of platelets aggregates under shear flow 
The formation of platelet aggregates was observed and is reported in this section. 
Although these observations were not studied systematically, links were made with 
existing theory and experimental observation, which allowed the understanding of the 
formation of platelets aggregates under specific circumstances. 
In vivo, the formation of platelet aggregates is triggered by a range of parameters, 
however, in vitro, as in these separation channels, aggregates are mainly due to the 
shear stress. Although aggregate formation is a problem in this system, it is still a 
fascinating event, and a subject of many studies. In this short section an account is 
given of our findings and compared with existing studies on the subject.  
Several biological mechanisms induce platelets aggregation in-vivo and in-vitro. A local 
zone of shear acceleration is one of them. Platelet aggregates formation in this system 
occurred mainly in the main channel before the first constriction. A small aggregate 
firstly forms of the vertical wall on the channel and is gradually expanded by the 
accumulation of platelets and red blood cells in its “tail” as shown in Figure 6.11.a. The 
tail could also be made out of fibrin clots. Yoshimura et al noticed that, despite large 
amount of heparin in blood, fibrin clots could still be formed in a microchannel and 
hinder the normal blood flow [6.7]. Figure 6.12.b presents a model for platelet 
aggregation in local shear flow. When comparing Figure 6.12 (a) and (b), we can 
hypothetically assume that part (1) creates the shear microgradient in the 
microchannel, part (2) is composed of discoid platelets and part (3) consists of 
platelets with restructured tethers.  
141 
  
 
Figure 6. 7: (a) Observed platelets aggregation in the main channel. Black 
arrows indicate red blood cells trapped in the platelet aggregate (b)  Diagram 
explaining the platelet aggregation mechanisms under local shear stress [6.8]  
Figure 6.13 presents the movement of a platelet aggregate in the main channel for 
duration over 12 seconds. As explained earlier tethers may restructure on the “tail” of 
the platelet aggregate. This is characterised by free movement of the platelets around 
a fixed anchor point [6.8].  
(1) (2) (3) 
a 
b 
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Figure 6. 8: Movement of platelets aggregate in channel over 12 seconds. (i) 
Core forming a local shear stress (ii) Platelet aggregation, possible tether 
formation (iii) Platelet aggregation, possible tether restructuring . 
6.3 Controls and measurements of the cell-free zones 
6.3.1 Cell-free layer and cell free zone observation 
A cell-free layer is created by the inertial forces pushing the cells centrally.  In Figure 
6.5, a cell-free layer can be seen to the right of the first bifurcation. This layer is just a 
few microns wide, comparable to the naturally occurring cell-free layer in blood 
vessels smaller than 300µm.  
As illustrated in Figure 6.6 (a) and (b), the lateral force can be more or less strong 
depending on the flow rate applied at the inlet and on the entrance hematocrit level. 
In Figure 6.6 (b) a cell-free layer larger than the layer of RBCs can be observed. This 
occurs with a high flow rate and low entrance hematocrit. As suggested in [6.1,4], at 
low hematocrit levels the interactions between the red blood cells are becoming 
minimal and does not prevent the lateral force acting on the cells.  
In the next section the influence of the flow rate and entrance hematocrit level on the 
cell-free zone will be detailed. 
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Figure 6. 9: Cell-free layer of a few microns as indicated by the black arrows. 
The chip has 20µm plasma channel, flow rate: 5mL/h, the blood is undiluted 
(Hct 33.3%). The white arrow indicates the flow direction.  
 
 
Figure 6. 10: (a) shows a very large lateral force for a chip with 20m channels. 
Chip 20µm, Hct 1.8%, 2mL/hr (b) Photographic evidence of high lateral force 
acting of the RBCs for a chip with 10m channel. The RBCs are clearly forced 
into the middle of the main channel and a large cell -free zone is created after 
the constriction.  
a 
b 
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6.3.2 Hematocrit and the cell-free zones 
The influence of the hematocrit on the cell-free zone at each bifurcation was observed 
independently of the flow rate. Figure 6.7 (a, b, c) shows the difference at bifurcation 
number 7 of the cell-free zone depending on the hematocrit level. The lower the 
entrance hematocrit level, the larger is the cell free zone. For low hematocrit levels 
(8.3% and 3.3%) and a relatively high flow rate (here 10mL/hr) a recirculation forms 
just after the constriction, while no recirculation is observed for a level of 16.8%. The 
lower the hematocrit level, the larger the recirculation will be. The recirculation 
doesn’t affect the separation, nor does it indicate the presence of turbulences.  
 
Figure 6. 11: First row: Effect of the entrance hematocrit level at bifurcation 7, 
constant flow rate 10mL/hr, (a) eHCT=16.8% (b) eHCT=8.3% (c) eHCT=3.3%. 
Second row: Effect of the flow rate at constant hematocrit level, 8.3% (d) 
2mL/hr (e) 5mL/hr (f) 10mL/hr.   
 
6.3.3 Flow rate and the cell-free zones 
In the same fashion, an effect of the flow rate on the cell-free zones was observed. As 
shown in Figure 6.7 (d,e,f), three separation experiments were carried out with the 
same entrance hematocrit of 8.3%. The flow was varied in each experiment from 2 to 
10mL/h. A difference of several tens of microns was observed at the bifurcation 
between each experiment. A flow rate rise leads to a higher purity at the risk of 
damaging the cells which encounters greater shear rate forces. 
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6.3.4 Cell-free zone along the main channel: an account of flow rate ratios 
Due to the difference in flow rate ratios, the cell-free zone dimension varies from 
bifurcation to bifurcation. For high hematocrit levels, this results in different purity 
efficiencies at each bifurcation. The plasma channels then join a common outlet 
channel on each side of the main channel. To observe the effect of the different flow 
rate ratios at each bifurcation, a number of observation windows were set-up as 
shown in Figure 6.8.  
 
Figure 6. 12: Observation windows on the second generation device  
Figure 6.9 illustrates the cell-free zone and the outlets in the main plasma channels 
corresponding to different bifurcations. In this experiment the hematocrit (Hct) was 
chosen deliberately high, 22.2%, to illustrate the dramatic changes in separation 
efficiency at each bifurcation in the 20µm channel device. On (a-1), (b-1), (c-1) and (d-
1), the cell-free zone broadens at every bifurcation along the direction of the flow. As 
flow rate ratios are getting higher and higher in the direction of the flow, the 
separation efficiency is increasing. In this experiment, red blood cell flow enters all 
plasma channels except bifurcations 6, 7, and 8. In the other channels, the flow of 
RBCs is reduced as the flow travels down the main channel. For example the flow of 
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RBCs is reduced from the plasma outlet 1 (a-2) compared to the plasma outlet 3 (a-3). 
This experiment demonstrates that the cell-free zone is different at each bifurcation, 
which in turn results to a different separation efficiency (plasma purity) at each plasma 
outlet. It could be argued that the change of viscosities along the separation channel is 
affecting the cell-free zone. However, the flow rate ratio is also changing dramatically, 
therefore these two effects combined are probably responsible for the difference in 
separation efficiencies at each bifurcation.  
 
Figure 6. 13: Photographs of a 20m blood plasma separation chip using a  flow 
rate of 5ml/hr, at Hct=22.2% (a)First and second bifurcations- bottom second 
bifurcation (b) third and fourth bifurcations (c) fifth and sixth bifurcations  (d) 
seventh and eighth bifurcations.   
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Getting identical separation efficiencies at each bifurcation would be possible by 
setting the length of each plasma channels independently. Plasma channels length can 
be calculated to set identical flow rate ratios at each bifurcation as proposed in 
Chapter 4. 
 
6.4 Measurements of separation efficiencies  
6.4.1 Separation efficiencies in first generation chips 
In this section experimental results and their analysis are presented to understand the 
influence of the different parameters on the efficiency of the separation system. The 
first section concerns the results obtained from the mussel blood separation. The 
second section presents human blood results. All the experiments in this publication 
have been carried out at large flow rates. 
6.4.1.1 Mussel blood plasma separation  
The study firstly focused on the influence of the buffer type and chip geometry. In 
Fig.6.13 the density plots obtained from the flow cytometry results of two separate 
experiments are given. The X axis corresponds to the forward scatter (laser light 
passing through the cell, FCS) which is proportional to the size of the cells. The Y axis 
corresponds to the forward Scatter (laser light being reflected by the cell) which is 
proportional to the granularity, or complexity of the cell. By placing each event on 
these two axes, the different populations (namely RBCs, WBCs, platelets) emerge. In 
this experiment, the cell populations have been depleted in the plasma outlet. The 
largest cells are the most depleted ones in this outlet. In both experiments, the main 
channel is 200μm and the flow rate 10mL/h. In Experiment 1, formaldehyde was used 
in the mussel cells buffer and the outlet length ratio, OLR, was kept to zero. In 
Experiment 2, however, no formaldehyde was used and the OLR was 4.5. The tuning of 
these two parameters, deformability of the cells (adjustable through the buffer type) 
and OLR, produces an enhancement of the separation effect.  
148 
The influence of the OLR on the separation efficiency can be studied independently of 
the other variable parameters. The OLR is varied as 1, 1.8 and 3 in three experiments in 
which the other parameters are kept the same. Figure .6.14a and Figure .6.14b show 
the results of these experiments. When the length ratio is increased 3-fold, the particle 
concentration in the plasma collection is still 70,000 events/mL as indicated in Figure 
6.14 (b). An event corresponds to a single particle being detected by the flow 
cytometer. This particle may be a dust particle, a fragment of cell or a cell. Areas of 
different cell types (depending on size and granularity) are assigned according to 
literature on the density plots with WinMDI functions. The percentage of each cell type 
on the total event count is extracted and compiled into Figure 6.15 (b). In the case of a 
length ratio of 3, more than 80% of the remaining particles are small particles or cell 
debris of the order of 3-4μm. The cellular content of the cell and plasma collection 
samples were also examined in a disposable haemocytometer under a conventional 
microscope. An eye check at 400x magnification confirmed these results. The purity 
efficiency of the device for mussel blood is 60% on average.   
  
Figure 6. 14: Density plot from the flow cytometry results illustrating the 
influence of the BT and OLR in two different experiments. In Experiment 1 the 
main channel width is 200μm, flow rate 10mL/h, BT with formaldehyde, OLR:1. 
In Experiment 2, the main channel width is 200μm, flow rate 10mL/h BT 
without formaldehyde, OLR:4.5. The difference in shape of the cellular fraction 
is due to the difference in buffer solutions.  
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Figure 6. 15:  (a) Graph illustrating the influence of the outlet length ratio on 
the number of events per mL. (b) Graph illustrating the influence of the outlet 
length ratio on the repartition of event types in the plasma coll ection. 
 
6.4.1.2 Separation of plasma from human blood 
The separation efficiency of cells in the plasma collection of human blood experiments 
is generally inferior to the result obtained with mussel blood. This can be partly 
explained by the difference in cell size. In the human blood the size of red blood cells is 
ranging from 7 to 8μm, which is very different from the size of the depth of the 
channels, and therefore the effect is not as clearly visible as for the larger mussel blood 
cells. 
Table 6.1 presents the results of two experiments to determine the influence of the 
flow rate. The OLR is 4.5 in both experiments, and the flow rate was varied from 5 to 
20mL/h. The results show a modest increase in efficiency of 7.6%. 
Experiment 
number 
Outlet 
length ratio 
Flow 
rate 
Number of events 
(feed) (/mL) 
Number of events 
(plasma coll) 
Purity 
efficiency (%) 
N13 4.5 5mL/h 1.9e5 1e5 49 
N12 4.5 20mL/h 6.6e5 8.3e4 56.6 
Table 6. 1: Table illustrating the influence of the flow rate on the pu rity 
efficiency in the human blood experiments.  
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6.4.1.3 Discussion of the results (first generation device) 
The results of these experiments have been compared to those published by other 
research groups. The present experiments have been carried out at an average flow 
rate of 10ml/h which is at least one order of magnitude higher than previously 
reported. For reference, the average flow rate in publications *6.1,6.2+ is 100μL/h. 
Plasma yield is approximately 40%, comparable to Ducree’s results [6.9], but it is not 
reaching the 95% of the common centrifugation technique. The purity efficiency is 
calculated as in Equation (6.1): 
p
f
c
c
Ef 1                                                                    (6.1) 
where cf is the concentration of RBCs in the feed collection and cp is the concentration 
of RBCs in the plasma collection. 
The purity efficiency found for the mussel blood is 60% on average, which is 
comparable to other groups. Results of the human blood experiments show an 
efficiency of 40% on average, which is slightly below the results reached by other 
groups. Generally, the hematocrit used in these experiments is low (3%) which means 
that the blood is heavily diluted before the experiments.  
6.4.2 Separation efficiencies in the second generation chips 
6.4.2.1 Influence of the entrance hematocrit and flow rate on the separation 
efficiency. 
The influence of the hematocrit on the separation efficiency was studied using 
different dilution levels. For the chip with the 20µm plasma channels, the 
corresponding hematocrit levels to the dilution levels were comprised between 3.3% 
and 31%. In the chip with the 10µm plasma channels, higher levels of hematocrit were 
studied, ranging from 9.4% to 45% (1:10 dilution to no dilution at all). The purity 
efficiency is given in equation 6.1.  
Figure 6.16 shows the different purity efficiencies obtained as a function of the level of 
hematocrit at the entry for the 20µm model. Some hematocrit levels have several 
experimental points (two or four). Two points are due to the independent collection of 
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data from each plasma outlet. Four points are due to two different experiments, each 
of them having two different experimental points. Two different flow rate were used 
(2mL/h and 5mL/h) and figure 6.16 also illustrates the influence of flow rate on the 
separation efficiencies. After the threshold of 9.4% hematocrit, the purity efficiency 
decreases sharply. The experimental points at 5mL/h and 10mL/h show a slight 
increase in purity efficiency, confirming the preceding results. The high hemoglobin 
levels results from the low purity efficiencies after the threshold. 
 
Figure 6. 16: Influence of the flow rate on the purity efficiency  of the 20µm 
microfluidic system  
Figure 6.17 details the results of the 10µm plasma channel chips. In these experiments, 
the only flow rate used was 2mL/h. Hemoglobin levels are indicated here to report on 
cell destruction, it can be seen that the hemoglobin level are increasing with the 
hematocrit. However it stays below the level reported to introduce interference in the 
downstream analysis = 5g/L [6.11].  The purity efficiency decreases very slightly 
towards hematocrit levels comparable to whole human blood. Generally, the 10µm 
design showed excellent plasma purity. However, this comes at the expense of low 
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yield (<7%).  Furthermore, the use of non-diluted blood increases the risk of clogging 
the separation chip within the few minutes of use. Nevertheless, this is an 
achievement as very few groups have reported the separation of non-diluted blood 
using passive microfluidic devices. 
 
Figure 6. 17: Influence of the flow rate on the purity efficiency of the 10 µm 
microfluidic system 
6.4.2.2 Control of cell population: a flow cytometric study 
A flow cytometric study was performed on several samples to get an in-depth 
knowledge of the separation of plasma from blood. As the ultimate goal of the plasma 
separation is to detect cfDNA in the plasma, it is crucial to prove that the cells are not 
damaged or destroyed during separation. Damaging the cells and causing lysis lead to 
more contamination of the plasma. In order to give useful biomedical information, the 
cfDNA detected in the plasma should be present in the blood prior to extraction and 
should not come from cell lysis as a result of sample preparation.  
Material and Methodology 
Staining of the blood sample was performed to label leukocytes and platelets. The R-
phycoerythrin (R-PE)-conjugated monoclonal antibody CD45 (PE Mouse Anti- Human, 
BD Biosciences) was used for leukocytes surface staining. The fluorescein 
isothiocyanate (FITC)-conjugated CD42 antibodies stained the platelets. Using these 
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markers we were able to identify the leukocytes and platelets population. The RBCs 
were identified by being non-stained. Blood cell population analysis was carried out on 
a FACS Scan instrument (BD Biosciences, San Jose, USA) and results were analysed 
using Flow Jo software v7.5.3 (Tree Star, Ashland, OR, USA). Determination of the 
absolute cell count was achieved by the use of flow cytometric beads Flow-Check 
Fluorospheres (Beckman Coulter). 50μL of well-mixed beads mixture was added to the 
200μL of sample and mixed thoroughly. The flow cytometer was then calibrated to 
count a specific number of beads allowing a precise absolute count of the cells. 
Three types of samples are analysed with the FACS scan instrument: 
- Feed samples (diluted whole blood) 
- Cell collection samples (concentrated feed samples) 
- Plasma collection samples (cell-depleted samples) 
A certain number of controls are necessary to make sure that the antibodies work and 
will allow the detection of all components. Table 6.2 details the different controls set-
up before the study. 
Type of sample Type of control 
Diluted WB 
Negative control, check background 
fluorescence 
Diluted WB + CD42 Check binding CD42 
Diluted WB + CD45 Check binding CD45 
Diluted WB + CD 42 + CD45 Antibodies Positive control 
Diluted WB + counting beads Check counting beads 
Diluted WB + CD42 + CD45 + counting 
beads 
Entire Positive control 
Table 6. 2: Flow cytometric controls using whole blood(WB) sampl es. 
 
Figure 6.18 shows the results of the flow cytometric data after processing. The 
horizontal axis represents the size of the cells (Forward scatter, FSC) and the vertical 
axis represents their granularity (Side Scatter, SSC). In the feed collection the 
population is mainly constituted of RBCs (95.62%), platelets (4.1%), leucocytes (0.28%), 
which corresponds to normal physiological conditions. Additionally the counting beads 
are present in the mixture, as well as the population identified as platelets aggregates 
and platelets-monocytes aggregates [6.7]. The platelets are located in the bottom-left 
quadrant of the diagram, as they are the smallest and least granular particles. In this 
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quadrant a large population of red blood cells is also present; these are either very 
small RBCs or RBCs debris present in the blood before separation. The presence of 
these debris can be explained by cell damage caused by the processing, transport and 
storage of the blood. Other RBCs, counting beads, monocytes and platelets aggregates 
can be found in the upper right quadrant. Linking these two quadrants is the “tail” of 
the healthy RBCs population, smaller or damaged RBCs. Little change is observed 
between the feed collection and the cell collection after separation. The tail does not 
show signs of growth which means that the cells either have not been through high 
stress or have resisted the stress. Looking at the plasma collection outlets, the plasma 
is not entirely devoid of cells, but has been strongly depleted by 250 times compared 
to the feed sample. Most of the RBCs debris has also been removed, which enhance 
the overall quality of the plasma. The population of platelets is the less depleted of all 
cell populations, confirming the results from a previous study by Sollier et al. [6.12]. 
Additionally, a measurement of the concentration of potassium ions could be used as a 
marker of cell death to assess global cell damage. This has not been carried out in this 
study. 
In conclusion, the flow cytometric investigation has shown that the cells are not 
damaged through the system. Additionally, the plasma is not entirely devoid of cells as 
the cell Coulter counter suggests, but the RBC population in the plasma collection has 
been reduced 250 times compared to the feed sample. Finally, the system also 
removes the cell debris, rendering the plasma even purer. 
Although cytometric studies have also been carried out by other research groups 
looking at blood plasma separation, this flow cytometry study has provided the most 
in-depth analysis so far [6.6].  
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.  
Figure 6. 18: flow cytometer results for each of the four collections. Both plasma 
collections are largely depleted from red blood cells and white blood cells. No 
noticeable cell damage by separation method was observed.  
 
6.3.2.3 Control of cell viability  
The flow cytometric study does not indicate fully if the cells are dead or not. It only 
shows the amount of debris and cell population present in the different collections. A 
flow cytometric study can be completed by a study of the cell viability. Cell viability can 
be observed using a trypan blue exclusion test. 
Trypan blue test is based on the principle that living cells have strong cell membrane 
impermeable to certain dyes such as Trypan blue. On the other hand, in dead cells the 
membrane becomes permeable to all sorts of chemicals. [6.13]. Both dead red blood 
cells and dead white blood cells can be detected in a blood sample using this method. 
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The white blood cells, which are whitish/transparent of a clear background will appear 
blueish if they are permeable to the trypan blue. The red blood cells which already 
have pigmentation due to their iron content, will appear purple. 
The trypan blue test is a simple procedure where the sample is diluted about 10 times. 
A volume of 1 to 4 of 0.4% trypan blue is added to the cell mixture, gently agitated and 
allowed to stand for 15 minutes at room temperature. A disposable haemacytometer 
can be used for cell observation. The sample chosen for this test was a sample of the 
cell solution. Figure 6.19 shows a photograph of the haemacytomter fill with a cell 
mixture containing trypan blue. The arrow points out to the only blue cell visible in the 
area. 
In conclusion this short cell viability study confirmed the results obtained with the flow 
cytometry. The process is relatively safe for the cells and it can be envisaged to use the 
cell from the concentrated outlet for an analytic purpose. 
 
 
Figure 6. 19: Evidence of cell viability. Cells dyed with Trypan blue. Here only 
one colored cell is spotted (black arrow). Size of square is 250µmx250µm.  
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6.4 Conclusions  
Table 6.3 gives a summary comparison between the two types of devices that were 
made for this study and other publications in blood plasma separation. A maximum of 
40% improvement in the purity efficiency has been realized from the first device type 
to the second. This was possible at the expense of the plasma yield.  
Separation of plasma out of diluted whole blood in a passive microfluidic device was 
demonstrated and characterized in this chapter. The mean separation efficiency from 
the first generation device to the second generation device was found to be better 
than 30%. Generally the cells were found to be unharmed by the separation, and no 
cell debris was found to be produced from the separation. This study demonstrates an 
efficient and disposable way to extract at high flow rate cell-free plasma from whole 
blood at different dilution levels. The purity efficiency reached 100% even with the use 
of relatively large channels (20μm) which are suitable for mass manufacturing.  
Difficulties related to the processing of large difficult biological samples such as whole 
blood samples were also presented and the reasons of their presence were proposed.  
In the next chapter, biological characterization of the separation will be carried out. 
Influence of the separation efficiency and of the entrance hematocrit level on 
polymerase chain reaction will also be studied.  
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*plasma yield definition varies depending on the research group.  
Table 6.3: Table illustrating the comparison between different blood plasma separation microtechniques and the common 
centrifugation process. The behaviour of the RBCs is also indicated with reference to Table 3.5 in Chapter 3.    
 Ducrée 
[6.9] 
Faivre 
[6.1] 
Jaggi 
[6.3] 
Blattert 
[6.10] 
Yang 
[6.2] 
Common 
centrifugation 
This work 
First generation 
This work  
Second 
generation 
Flow rate 15µL/min 3,3µL/min 5mL/min 1,2mL/min 0,167µL/min batch 10mL/h 5mL/hr 
Hematocrit 45% 16% 4.5% 5% <25% 45% 3% Up to 45% 
Counting method 
Optical (colour 
recognition) 
NC Auto cell counter Auto cell counter 
Optical (image 
analysis) 
FC FC 
Auto cell counter 
Regime used 
Centrifugation on 
a CD 
A C 
Small centrifugal 
force + C 
(predominant) 
A Centrifugal force C  C 
Plasma Yield* 40% 18% 2.5% 3% 19% 95% 40% 5 to 30% 
Purity Efficiency 99% 100% 30% 90% 100% 99% 60% Up to 100% 
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Chapter 7:  Biological validation of the 
extracted plasma by biomarkers 
detection 
7.1 Introduction  
7.1.1 Motivations 
The quality of the plasma has already been assessed by cell counting and flow 
cytometry as shown in the previous chapter. One other interest in this study is the 
subsequent recovery of cell-free DNA from the plasma after blood plasma separation 
on-chip. As seen in Chapter 2, several applications demand the screening of cell-free 
DNA present in the plasma or serum of the patient. Briefly, this includes the 
assessment of rejection levels in the monitoring of transplantation and the detection 
of fetal DNA in the case of prenatal diagnosis.    
To truly assess the quality of the plasma extracted on-chip and its use in a common 
biological reaction, PCR on house-keeping genes (GAPDH, ALU and β-actin) has first 
been carried out using the product of the separation. The goal of this biological study is 
to prove that cell-free DNA can be extracted in plasma obtained by the on-chip 
separation method proposed in this study. It has been suggested that dilution level 
prior to separation could alter the recovery of biomarkers. In order to answer this 
question, the influence of the pre-dilution on the PCR efficiency has been studied in 
this chapter. Additionally to characterise the limits of this separation method, the 
influence of the separation efficiency on the PCR efficiency has been studied.  This 
study will assess wether 100% pure plasma is required to achieve successful 
amplification of house-keeping or gender-specific genes. As it is not always easy to 
extract 100% pure plasma from passive microfluidic device, it is interesting to know if a 
lesser level of purity would suffice for some types of analysis.  
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7.1.2 Polymerase Chain Reaction (PCR): a brief introduction 
Polymerase Chain Reaction was developed in 1983 by K. Mullis. This powerful 
technique allows the amplification of DNA strands from a few copies to millions of 
them.  
A number of reagents are necessary in the PCR process: 
- Primers are oligonucleotides that are complementary to the beginning and end 
of the targeted DNA strand (forward and reverse primers). These sequences, 
about 10 to 20 base-long, “prime” the PCR. 
- Polymerase is the enzyme catalysing the replication of DNA. Under the 
polymerase activity the complementary bases assemble along the DNA strand. 
The most common PCR polymerase is Thermus Aquaticus (Taq). The 
polymerase cannot start the replication of the DNA without primers 
preliminary binding. 
- Bases, the bases are the deoxyribonucleotides forming the backbone of DNA. 
The term dNTPs relates to the four bases, Adenine (A), Guanine (G), Thymine 
(T) and Cytosine (C). 
- Buffer Solution, a buffer solution is required to provide a salted solution 
necessary for the optimisation of the PCR. 
- Magnesium-chloride MgCl2 is used to regulate the number of cations necessary 
to the reaction, it is usually used at a molar concentration of 3mM. 
- Template nucleic acid, this is the target of the amplification, the DNA to be 
amplify. Templates added to the PCR reaction can be in various forms. For 
example, pure genomic content in water-based solution is used for positive 
controls. In this case the template are in high concentration and often relatively 
easy to amplify. In this study, the templates are generally in low concentration, 
dispersed in unpurified plasma. In the case where there are multiple templates, 
the PCR is called a multiplex-PCR. 
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As shown in Figure 7.1, the PCR is composed of 5 distinct steps. The first and last steps 
occur only once in the procedure, whilst the three middle steps are repeated over a 
number of cycles ranging from 20 to 40 cycles.  During the first initialisation step, the 
polymerase is activated by temperature ranging from 90 to 95°C for 10 minutes.  
During denaturation, the first step of the PCR cycle, the double helix is separated into 
two strands under high temperature. It usually takes place at 94°C step for 20 to 60 
seconds. The primers are then bonded to the DNA strands during the annealing step 
which occurs at lower temperature (50-60°C). The polymerase is then attracted to the 
primer-strand bonding sites and the extension step can begin when temperatures is 
raised to 72°C. The polymerase enzyme travels along the strand to assemble the 
complementary oligonucleotides. Generally, the cycle of denaturation-annealing-
extension is performed about 30 times before the efficiency of the polymerase seems 
to drop. After these cycles a final extension is performed for 10 minutes, this step 
ensures the full extension of the single DNA strands. PCR is an exponential reaction, 
after n cycles, the number of copies will reach 2n. In theory, PCR can be achieved from 
a single DNA copy, however, in practice a more substantial amount of DNA is often 
necessary to start off the reaction.  
 
Figure 7. 1: Polymerase Chain Reaction (PCR) steps  
In conventional PCR the detection and quantification of the amplified product occurs 
after the process is finished. Gel electrophoresis is the most common post-PCR 
analysis. When the PCR is finished the samples may be purified using common QIAGEN 
PCR purification kit. The sample containing the amplified product is then loaded in an 
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Agarose gel upon to which is applied a voltage which separates DNA molecules by size. 
The DNA material has been stained using fluorescent probe such as Ethidium bromide 
or SYBRsafe. The DNA bands are visualised using UV radiation and analysed. More 
details on the gel electrophoresis procedure can be found in Appendix B. 
PCR analysis can be affected by contamination by volatile nucleic acids present in the 
laboratory environment. Cross-contamination can also arise between samples [7.3]. 
Contamination can be relatively severe in the case where house-keeping genes are 
amplified. In this particular study, anti-contamination measures had to be set-up to 
prevent contamination. Preparation of the PCR was carried out under laminar flow 
hood, in a dedicated room. Surfaces, pipettes and gloves were cleaned using DNase-
Zap (Ambion) previous to the preparation of the PCR mix. Appendix C summarises the 
different steps generally taken to avoid contamination.  
7.2 Recovery of cell-free DNA by Conventional PCR  
Theoretical aspects of PCR has been treated in the previous section. In order to make 
the entire process faster and in the future outlook of implementing a microPCR 
module directly downstream from the separation module, the common purification 
step of the DNA before PCR was omitted. The protocol used is shown in Figure 7.2. 
Three house-keeping genes have been chosen in this study. ALU is a very abundant 
gene (redundant) in the human genome. Its redundancy makes it a gene of choice, for 
example, in the recovery of human DNA in forensic science [7.4]. However, because of 
ALU redundancy, a PCR with this gene is more susceptible to contamination. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a gene responsible for the 
enzyme catalising glucose for energy supply in the cell. β-actin is another house-
keeping gene, encoding a cytoskeletal protein. β-actin levels are known to be very 
stable, and is often used as control measures in diverse biological protocols.   
     
165 
 
Figure 7. 2: Generic protocol for the extraction of DNA from plasma obtained 
on-chip.  
7.2.1 Amplification of house-keeping genes in the cell-free DNA 
population present in the serum extracted on-chip. 
The amplification primers for the GAPDH gene (Forward primer 5’- GAA GGT GAA GGT 
CGG AGT CA-3’, reverse primer 5’ GAC AAG CTT CCC GTT CTC AG) were purchased 
from Metabion International AG. For the PCR with the GAPDH gene, each reaction 
aliquot contained 0.4µM forward primer, 0.4µM reverse primer, 0.1µM dNTP (Sigma), 
0.1µM dCTP (Sigma), 2.5U Taq DNA polymerase (QIAgen HotStarTaq DNA Polymerase 
kit), 2.5µL PCR buffer (HotStarTaq DNA Polymerase kit), 4mM MgCl2 (QIAgen  
HotStarTaq DNA Polymerase kit), 9µL DNA free water. For each reaction, 5µL of serum 
was added to 20µL of the PCR master mix.    
In order to determine whether GAPDH gene could be amplified directly in whole blood 
a negative control consisting of untreated blood (as received from the blood bank) has 
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been introduced in the protocol. In the same fashion, to determine if GAPDH gene was 
present in the buffer solution, a negative control consisting of the 1% BSA PBS solution 
was used in the PCR on the GAPDH gene (data not shown). ALU primers were also used 
primarily, however, ALU being a highly repetitive human genomic sequence; it makes 
the test very sensitive to contamination. It was found, in agreement with ref [7.4] that 
contamination cannot be avoided, and therefore GAPDH sequence, shorter and less 
repetitive was more appropriate for the detection tests.   
The human genomic control was obtained from Promega in 210ng/µL concentration, 
and was diluted 10x, 100x and 1000x. 1µL of the dilution was added to the 20µL 
mastermix, with 4µL of DNA-free water to get a total of 20, 2 and 0.2 ng of DNA per 
reaction.   
Thermal cycling was initiated with a 10min denaturation at 95°C, followed by 40 cycles 
of 1min denaturation at 94°C, 1min primer annealing at 68°C, 1min extension at 72°C. 
The final extension step consisted of a further 5min cycle at 72°C and the samples 
were kept on hold at 10°C until further processing. 
The PCR product was purified using the QIAgen PCR purification kit using the 
procedure specified by the manufacturer. The purified DNA product was eluted in 30µL 
Elution buffer. 10µL of this product was then stained with 2µL of loading buffer for a 
gel electrophoresis analysis. The 2% agarose gel was made with 100mL TAE buffer and 
2µL of ethidium bromide (10mM/µL). The gel was loaded in the tank and run at 80V for 
60min. A gel electrophoresis picture was subsequently taken using a CCD camera in a 
BioRad UV transluminator and analysed using GelDoc-ItTM software.   
7.2.2 Influence of the dilution of whole blood previous to on-chip 
separation 
A PCR was performed on the GAPDH gene in the plasma samples extracted on-chip. 
Samples were isolated after the separation experiment and stored in 1mL eppendorf 
tubes at 4°C. The separation efficiency was characterised by a Coulter counter as 
described previously. In order to assess the influence of the pre-dilution of the PCR 
efficiency, six samples (S1 to S6) with approximately the same separation efficiency but 
different pre-dilution levels were chosen as shown in Table 7.1. The same separation 
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efficiency can be achieved through the use of different flow rates and the two chip 
models (10µm or 20µm width plasma channels).   
 
Code 
Separation efficiency 
of sample (%) 
Entrance hematocrit 
level (%) 
Plasma 
Samples 
series 1 
S1 100 3.3 
S2 100 6.2 
S3 100 7.0 
S4 100 14.9 
S5 100 17 
S6 100 33.7 
Positive 
controls 
G1 Genomic control 1 – 1:10 
G2 Genomic control 2 – 1:100 
G3 Genomic control 3 – 1:1000 
Other 
controls 
WB Whole blood  
W Ultrapure Water 
Negative 
control 
C 
Plasma sample extracted by gentle 
centrifugation (3000 rpm, 10 min) 
Table 7. 1: Characteristics of the samples and controls used in the blood  dilution 
influence experiment   
Three human DNA controls (G3041, Promega, Madison, WI, USA) were prepared at 
dilution levels (G1 to G3). Samples of whole blood, ultrapure water and plasma 
extracted by centrifugation were collected.   
PCR and gel electrophoresis were performed on these samples, as shown in Table 7.1, 
following the protocol presented in the previous section. The on-chip extracted 
samples were doubled. A 1000bp ladder was used in the first column of the gel.  
The amplified products of the plasma samples are shown in Figure 7.3. In all columns 
but the negatives samples a clear 200bp band is present, showing the amplification of 
the GAPDH gene fragment. The intensity of the bands varies from sample to sample. 
Within the duplicates, the intensity does not vary. For the samples series 1, all PCR 
products show a relatively strong amplification. Interestingly, a gradient in the 
fluorescent signal can be noted from S1 to S6, excluding S5 which stands out and 
shows a lower amplification. The presence of a gradient confirms that the PCR 
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amplification efficiency is depending on sample dilution. Additionally, the presence of 
an amplification band in the sample with the highest dilution (corresponding 
hematocrit level 3.3%) demonstrates that PCR can be achieved on diluted samples.  
All the other controls, including the negative controls show no amplification. In line 
WB, and C, the PCR has been inhibited by the presence of Immunoglobulin G present 
in the whole blood and in the plasma sample extracted by centrifugation.  
 
Figure 7. 3: Ethidium bromide-stained agarose gel of PCR products obtained 
with GAPDH primer and unprepared plasma samples  obtained by microfluidic 
extraction. The first lane is a molecular weight marker  (1000-bp ladder).  
7.2.3 Influence of the separation efficiency on the PCR efficiency. 
As demonstrated by Figure 7.3, PCR can be achieved on cfDNA in plasma extracted on-
chip for purity efficiency of 100%. Further study was carried out to assess the limits of 
the PCR capability on cfDNA in untreated plasma sample. In that respect, plasma 
aliquots from samples with similar entrance hematocrit levels and with different purity 
efficiencies were collected after separation and stored at 4°C. The different samples 
used in this experiment are presented in Table 7.2. The separation efficiency of the 
samples ranged from 65.1% to 100%. The amplified products of this experiment are 
shown in ethidium bromide-stained agarose gel in Figure 7.4. A clear gradient of band 
intensity through samples S1 to S5 can be observed. No PCR product could be 
amplified from S5 (purity 65.1%), whole blood and water lanes. The band from S4 
(purity 84%) is visible but faint.  
This experiment demonstrates that the PCR efficiency depends on the separation 
efficiency, and most importantly shows that at the high separation efficiencies which 
are standard for our device, PCR can be routinely performed. Moreover these 
experiments have successfully shown that the plasma extracted on-chip is pure 
enough to perform amplification without further purification steps as routinely done 
after centrifugation today, reducing thereby reagent costs, material waste and 
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processing time. For more difficult cfDNA targets such as cffDNA, this step might still 
be necessary.  
 Code Separation efficiency 
(%) 
Hematocrit level (%) 
Plasma samples 
S1 100 14.9 
S2 97.8 12.3 
S3 94.9 12.3 
S4 84 16 
S5 65.1 16 
Positive controls 
G1 Genomic control 1– 1/10 
G2 Genomic control 2 – 1/100 
G3 Genomic control 3 – 1/1000 
Other control WB Whole Blood 
Negative control W Water 
Table 7. 2: Characteristics of the samples and controls used in the experiment  
on separation efficiency influence  
 
Figure 7. 4: Influence of the separation efficiency on the detection of the GapDH 
house-keeping gene in the on-chip extracted plasma. The first lane is a 
molecular weight marker (50bp ladder).  
One final and important point to consider is the effect of the time delay between draw 
and processing of blood which has been shown to be a factor in the quantification of 
cfDNA. Lysis of intact cells caused by a delay in blood processing would result in 
increased concentrations of cfDNA (caused by ex-vivo processing) which might lead to 
misleading results especially if cfDNA is used as a biomarker in cancer, prenatal and 
post transplant care. Integrating the process of blood plasma separation and PCR 
analysis onto a single chip will overcome this limitation for the routine use of cfDNA 
analysis in clinical settings. 
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7.3 Detection of biomarkers via real-time quantitative PCR (qPCR) 
7.3.1 Introduction to qPCR and goal of this study  
Real-time quantitative PCR, or qPCR is one of the most powerful techniques in 
molecular biology. Like PCR it allows the amplification of specific sequences within 
DNA. However, unlike conventional PCR where the sequences are detected at the end 
of the PCR process via a purification, staining and gel electrophoresis, qPCR allows the 
measurement of the amplified product at the end of each cycle via real-time 
fluorescence monitoring. Therefore by comparison it is possible to determine the 
initial concentration of product in each sample.  
In this study it is particularly interesting to use qPCR to quantify the differences in 
amplification between the different samples. As shown in the previous part, it is 
possible to observe these differences on a gel, but difficult to quantify them. Real-time 
PCR is also attractive to detect low levels of target DNA in samples. Additionally, in 
qPCR the amplification and the detection are combined which saves manipulation time 
and prevent post-PCR contamination. Finally qPCR presents advantages for on-chip 
integration, as it combines amplification and detection at the same time, and therefore 
greatly reduces the assay time, as well as the possible manual intervention. The 
realisation of truly integrated qPCR devices has been branded as a “bottleneck” [7.5]. 
Nevertheless, a number of examples of qPCR integration on microfluidic chip can be 
found in the literature [7.6]. In the 1990s, many microfluidic PCR examples used silicon 
as a substrate material [7.5,7]. However in the recent years, PDMS and PMMA have 
been used to build PCR module.  
7.3.2 Materials and methods 
Reaction mix and samples 
The qPCR was carried out on a Stratagene MX300P. The 25µL reaction contained 12.5 
µL of 2X SYBR Green jump start Taq ReadyMix (Sigma), 0.4 µL of 10uM of each primer, 
5.5µL distilled H2O, and 5uL of sample containing the input DNA. The parameters used 
for qPRC on B-actin is given in Table 7.3. The reaction samples were pipetted into 
microplate (ABgene plate, ThermoScientific) wells and the plate was spun at 1000rpm 
for 30s prior to the amplification to ensure a homogenous reaction in each well. Both 
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β-actin and GAPDH genes were used as target DNA in these experiments. The positive 
controls consisted of human genomic DNA at different concentrations.  
   [Start] [Finish] 
Volume per 
reaction 
Master Mix 
SYBR Green jump 
start Taq ReadyMix 
2x 1x 12.5µL 150µL 
Forward primer 10µM 0.4 1µL 12µL 
Reverse Primer 10µM 0.4 1µL 12µL 
Water N/A N/A 5.5µL 66µL 
Sample N/A N/A 5µL N/A  
Total Volume    25µL  
Table 7. 3: Mastermix parameters for qPCR on β-actin 
Figure 7.5 presents the thermal profile of the qPCR as designed on Stratagene MxPro 
QPCR software of the Mx3000p qPCR machine (Stratagene). The optimised real-time 
quantitative PCR temperature consisted of a 10min hot start at 95°C (segment 1, 
Figure 7.5) followed by 45 cycles of 30s denaturation step at 94°C, 15 seconds of 
annealing step at 64°C and 30 seconds elongation step at 72°C (Segment 2, Figure 7.5). 
The annealing step was purposefully set at high temperature and short duration to 
avoid primer-dimer formation. In the last step the dsDNA present in the wells is 
denatured once again, then gradually cooled to a “melting temperature” (Tm) (based 
on the primers Tm value) followed by a last increase in temperature to 95°C (Segment 
3, Figure 7.5).  This last step produces the dissociation curve or melting curve and is 
specific to SYBR green qPCR.     
7.3.2.2. Plate occupation  
A qPCR plate has 64 wells. A plate can be divided into different parts for different tests 
and be run at different times. It is a cost effective method but may bring cross-
contamination if the wells are not carefully closed. 
For each run the samples may be run in duplicate to cancel out artefacts. Genomic 
controls at different dilution levels may be used to produce standard curves. Figure 7.6 
shows a typical plate occupation. 
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Figure 7. 5 : Thermal profile of the quantitative PCR   
 
Figure 7. 6 : Plate setup for qPCR experiment  
 
7.3.2.3. Dissociation and Standard curves 
Dissociation curves are used to control the presence of primer-dimers or non-specific 
product formation in each well. Dissociation curves are also known as « melting 
curves » from the way this curve is produced. The samples are first denatured at 95°C, 
followed by an annealing step and a gradual increase in temperature, while the 
fluorescence levels are recorded. The primer-dimers exibit a lower melting 
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temperature than the amplified product and therefore can be easily detected on this 
type of curve. Figure 7.7 shows a normal dissociation curves with a single peak. The 
dissociation curves of the genomic controls are only present in this particular graph. 
Figure 7.8 shows the dissociation curves of several samples. While some of the curves 
have a single peak, others have two peaks, revealing the presence of primer-dimer 
formation. The conventional PCR method have not shown any non-specific product 
formation, therefore these peaks confirm the presence of primer-dimer formation.  
 
Figure 7. 7: Dissociation curves of a serial dilution of genomic controls.  
 
Figure 7. 8: The dissociation curve of the samples. It provides information about 
the presence of primer-dimers 
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A standard curve can also be established to obtain further information on the reaction. 
On a standard curve, the initial concentration of DNA in the sample is plotted against 
the threshold cycle value for each sample as shown in Figure 7.9. The information that 
can be obtained from the strandard curve, includes : 
- The absolute quantification of DNA present in the solution  
- The PCR efficiency : the sample points must be as close as possible from the 
ideal slope of -3.32 corresponding to an efficiency of 100%3  
Standard curves for absolute quantification, are obtained using dilution series of 
known template [7.3]. In one experiment, four positive controls of serially diluted 
solutions of human genomic DNA were used to build the standard curve. The Human 
Genomic DNA initially comes at a concentration of 210ng/mL. The dilutions used were 
1 :10, 1 :100, 1 :1000 and 1 :10,000. 5µL of solution was used in each well with 20µL of 
master mix solution. Therefore the theoretical quantity of DNA in the first genomic 
control (1 :10) can be calculated as 105ng, the second (1 :100) 10.5ng, the third 
(1 :1000) 1.05ng and the fourth (1 :10,000) 0.105ng. In Figure 7.9, these quantities 
match with the standard curves results.     
 
Figure 7. 9: Standard curve based on the standard points of the genomic 
controls.  
                                                     
3
 The concentration of DNA doubles at each PCR cycle if the efficiency is 100%, therefore the slope of 
the curve is -1/log10(2)=-3.32  
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7.3.3 Results 
A typical amplification curve for a series of unpurified plasma and four dilutions of 
genomic controls is shown in Figure 7.10. The fluorescent signal level is low during the 
first cycles of the real-time PCR, this is called the baseline. The threshold of the 
reaction is set when a statistical increase in the fluorescent signal is detected. In theory 
the threshold can be set at any point of the exponential curve, but is usually set up 
automatically at “10 times the standard deviation of the fluorescent value of the 
baseline” [7.3]. The value at which a curve cross the threshold is called the threshold 
cycle (Ct) and corresponds to the number of cycle necessary to reach a given threshold 
fluorescence. The four positive controls with serial dilution values of 1:10, 1:100, 
1:1000 and 1:10000 show the lowest Cts, respectively Ct(G1), Ct(G2), Ct(G3), and 
Ct(G4). As the Ct is inversely proportional to the initial quantity of template DNA 
present in the sample, it means that the genomic controls have the highest quantity of 
DNA, as expected.  
From Figure 7.10 it can be observed that the unpurified plasma samples have high or 
no Cts. The whole blood control and negative control do not show any amplification at 
all (no Ct). 
 
Figure 7. 10: Typical amplification curves from qPCR on B-actin gene from 
genomic controls and unpurified plasma samples  
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The amplification curve, however, cannot be analysed without verifying if primer-
dimer formation have occurred from the dissociation curves. In Figure 7.11, the 
amplification curve and dissociation curve of four samples (unpurified plasma) show 
that the Cts from S3 and S4 are due to the formation of primer-dimer in the well. In 
conclusion, an amplification curve, does not necessarily mean a positive results: this 
might be due to primer-dimer formation only. Additionally, an amplification curve can 
be given by a non-specific product that will also have a different dissociation curve. 
The dissociation curve should therefore be verified for each sample, after each real-
time PCR. This has to be taken into account for the operation of a future integrated 
qPCR device onto a lab-on-chip. Alternatively, the analysis can be based on the Cts 
only, given that primer-dimer formation generally do not occur before 30 or 40 cycles. 
This solution would be at the expense of small or difficult product amplification which 
necessitates a higher number of cycles.   
 
Figure 7. 11: Amplification curve and dissociation cur ve of four unpurified 
plasma samples.  
In Figure 7.12, the data of six samples and two controls are analysed using the 
amplification and the dissociation curves.  
All of these samples have 100% purity efficiency, but dilution levels are varied. S1 and 
S2 have a 1:20 dilution level. S3 and S4 have a 1:10 dilution level, and S5 and S6 have a 
1:5 dilution level. On the amplification curve, S3, S4, S5 and S6 show relatively 
significant amplification with Ct values between 30 and 40. S1, S2 and the two controls 
show no or little amplification. However, the dissociation curve reveals that only S3 
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and S6 have real “product” amplification, with a distinct curve. A small peak due to 
primer-dimer formation can be observed on S5 dissociation curve. However, given that 
the product peak is more than twice the height of the the primer-dimer peak, the 
product can be considered to have been amplified. S4 show a dissociation curve with a 
primer-dimer peak higher than the product peak. Although it has been showed that 
cfDNA in plasma can be amplified using this technique, the presence of primer-dimer 
formation jeopardizes the quantification of DNA levels in each sample.    
 
Figure 7. 12: Amplification curve of six unpurified samples. Inset: dissociations 
curves for the same six samples. Note: the colours be tween the two graphs do 
not match. (Data on genomic controls not shown).  
In another experiment, the influence of purification on the detection of cell-free DNA 
via real-time PCR was studied. DNA was extracted from four plasma samples (1:9 
dilution) with 100% purity efficiency using QIAGEN blood mini kit following the 
manufacturer instructions. A real-time PCR was carried out on the 8 samples. Figure 
7.13 presents the amplification curve obtained. From Figure 7.13, it is clear that the 
amplification of purified sample gives high Cts (between 20 and 25), comparable to the 
levels of the positive controls, while unpurified samples have very low Cts. The 
dissociation curves were checked, and showed that only the product was amplified in 
the purified samples.    
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In conclusion, it was shown that fluorescent PCR could be performed on unpurified 
plasma samples obtained on-chip. From the present results, it has been difficult to 
repeat the amplification of unpurified sample. One explanation for this effect might be 
that the real-time PCR might be more sensitive to remaining inhibitors.   
Nevertheless, the amplification of gene in non-purified samples might be possible with 
the fine tuning of reagent and temperature cycles, an optimization process which has 
not been carried out in this study.  
 
Figure 7. 13: Amplification curve of purified samples and unpurified samples  
7.3.4 Conclusions 
A qPCR study was carried out using the plasma samples extracted on-chip. It is 
envisaged that qPCR might be more sensitive to the remaining hemoglobin levels 
present in unpurified plasma samples. No significant data was extracted from the qPCR 
carried out on unpurified samples. Nevertheless, DNA template was successfully 
amplified from positive controls, purified samples and some unpurified samples and 
might be optimised.     
As highlighted at the beginning of this section, real-time PCR is the best choice for on-
chip integration. In this small study, it has been shown that the amplification of house-
keeping gene via real-time PCR on unpurified sample is not impossible but difficult. The 
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usefulness of the dissociation curve to analyse if the fluorescence comes from the 
product amplification or primer-dimer was demonstrated. Dissociation curves should 
therefore be integral part of on-chip analysis as they are at the moment in macro-sized 
tools.  Despite the difficulties of the physical integration of qPCR on-chip, as well as its 
operation on difficult samples, this solution will probably be used more and more in 
the future in LOC modules.     
7.4 cffDNA extraction from maternal plasma  
7.4.1 Motivations and ethical approval 
One attractive application of blood plasma separation and cfDNA detection is the 
possibility of detecting foetal genes in the maternal blood early on during the 
pregnancy. Several studies have shown the possibilities of using foetal cell-free DNA 
levels as biomarkers for chromosomal abnormalities such as Down syndrome or 
pregnancy-associated diseased such as preeclampsia [7.8,9,10].  
In the previous section we have shown that it is possible to detect house-keeping 
genes in plasma extracted on-chip. However, redundant house-keeping genes are 
relatively easy to detect, extracting cffDNA from maternal blood is a more challenging 
task. Figure 7.14 presents the typical protocol set-up for this study. The research 
project and proposed protocol was approved by the Lothian Research Ethics 
committee and the Lothian NHS Research and Management committee. The letters of 
approval can be read in Appendix D1 and D2.  
Pregnant women in their first and third semester were recruited at the maternal unit 
of Edinburgh Royal Infirmary and presented with an information sheet. Signed consent 
forms were obtained from patients aged between 18 and 45. Information sheets  and 
consent forms can be read in Appendix D3 and D4. All women gave a sample at a single 
point only.  
A closed blood collection system, S-MonovetteTM (Sarstedt) as shown in Figure 7.15, 
was chosen to extract from 2 to 4mL of blood from patients. The S-Monovette blood 
collection system contains sufficient anticoagulant (Potassium EDTA), but causes  
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Figure 7. 14: Generic protocol for fetal sex detection via fluorescent PCR on maternal plas ma samples.  
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minimum dilution of the sample. Samples were subsequently stored at 4°C awaiting for 
collection within 12 hours. 
 
Figure 7. 15: S-Monovette (Sarstedt) blood transfusion tubes prefilled with 
EDTA are used for blood collection at the Simpson Institute for Reproductive 
Health.  
7.4.2 Material and methods  
Figure 7.14 presents a generic protocol for the fetal sex detection via a normal 
fluorescent PCR on maternal samples. The microfluidic chips used in this study have 
the same design as the second generation device with 15µm width plasma channel. 
Using this methodology, the separation will be efficient and the channel will not be 
clogged up by SU8 material as it could sometimes occurred in the 10µm design. 
Additionally, the plasma channels have been moved about 20µm upstream to fit 
exactly in the corner of the constriction. The chips are provided by Epigem and are 
solely used for this clinical study. A single microfluidic chip is used per sample to avoid 
cross-contamination. Furthermore, the platform is also changed and the fluid adaptors 
are autoclaved between each sample.    
Whole blood samples were carefully diluted at 1:3, irrespectively of their intrinsic 
hematocrit level. Aliquots of each whole blood samples each diluted samples were 
placed in individual eppendorfs tubes for hematocrit level verification. A Beckmann 
Coulter Counter was used to obtain the hematocrit level of each whole blood and 
individual samples as described earlier.     
2mL of 1:3 diluted blood samples was loaded in a disposable syringe (BD Plastipak) and 
loaded on a syringe pump (Alladin, World Precision Instruments). The samples were 
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loaded at a 5mL/h entrance flow rate. Once the blood samples filled the main channel, 
the separation occurred and the plasma was extracted through the microfluidic 
network. The cell-enriched mixture was collected in an eppendorf tube for disposal. 
The ~0.3mL of extracted plasma was collected in a 1mL eppendorf and stored on ice 
until the cell counting was performed within 6 hours. After the cell counting, the 
serum samples were stored at -20°C until further processing.    
DNA Extraction from serum samples 
In a previous experiment, it was shown that cell-free DNA in human serum could be 
detected directly in serum. In this experiment, fetal DNA is to be extracted from 
plasma containing maternal and fetal DNA. Without a study of the paternal genome, 
only genes from the Y chromosome of male foetus can be detected among the 
maternal plasma. Genes from the Y-chromosome such as SRY or DYS14 will be 
amplified and will confirm the sex of the foetus. Furthermore, a house-keeping gene 
will be amplified and will act as a positive control for the efficiency of the PCR for each 
sample.  
In this experiment, the total number of DNA copies is low, and therefore to minimize 
the risk of negative outcome, the fetal and maternal DNA could be purified from the 
serum samples using the Qiagen Blood minikit. However, this was not carried out in 
this particular study. 
Good primer design is important, especially in multiplex PCR, to avoid primer-dimer 
formation. As shown in Table 7.4, the melting temperatures of the primers chosen are 
within 5°C of each other.    
Name Sequence                  Tm°C nt A T C G 
GAPDHFOR gaaggtgaaggtcggagtca      61.45 20 6 3 2 9 
GAPDHREV gacaagcttcccgttctcag      61 20 4 5 7 4 
SRYREV   ccccctagtaccctgacaatgtatt 62.85 25 6 7 9 3 
SRYFOR   tggcgattaagtcaaattcgc     59.2 21 6 6 4 5 
Table 7. 4: Oligo concentration :  0.25µM, salt concentration:   100mM,  
primerdigital.com/tools  
A single PCR and multiplex PCR were designed. The PCR master mix for the single PCR 
is shown in Table 7.5, it is in essence similar to the PCR master mix developed in the 
first part of this study.   
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 [Start] [Finish] Volume /rxn 
Forward primer 10µM 0.4µM 1µL 
Reverse primer 10µM 0.4µM 1µL 
10xTaq buffer 10x 1x 2.5µL 
dNTP 2.5mM 0.1mM 1µL 
Polymerase 5U/mL 0.2U/mL 1µL 
MgCl2 25mM 4mM 4µL 
Water N/A N/A 8.5µL 
Sample N/A N/A 5µL 
Total reaction volume   25µL 
Table 7. 5: Start concentration, final concentration and volume per reaction for 
the single PCR on GAPDH and SRY sequences.    
Another master mix is created for the multiplex PCR as shown in Table 7.6. This time, 
four primers are present for the amplification of both GAPDH and SRY in the same 
tube. The concentrations vary slightly, for example, the GAPDH primers concentration 
is now divided by two and the SRY primer concentration is twice that of the GAPDH 
primers.  
 [Start] [Finish] Volume /rxn 
Forward primer (SRY) 10µM 0.4µM 1µL 
Reverse primer (SRY) 10µM 0.4µM 1µL 
Forward primer (GAPDH) 10µM 0.2µM 0.5µL 
Reverse primer (GAPDH) 10µM 0.2µM 0.5µL 
10xTaq buffer 10x 1x 2.5µL 
dNTP 2.5mM 0.2mM 2µL 
Polymerase 5U/mL 0.2U/mL 1µL 
MgCl2 25mM 4mM 4µL 
Water N/A N/A 7.5µL  
Sample N/A N/A 5µL 
Total reaction volume   25µL 
Table 7. 6: Start concentration, final concentration and volume per reaction for 
the multiplex PCR on GAPDH and SRY sequences.    
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In this experiment, thermal cycling was initiated with a 15min denaturation at 95°C, 
followed by 40 cycles of 30s denaturation at 94°C, 20s primer annealing at 62°C, 1min 
extension at 72°C. The final extension step consisted of a further 10min cycle at 72°C 
and the samples were then kept on hold at 8°C until further processing.  
The samples used in one experiment are detailed in Table 7.7. In total 7 single PCR and 
5 multiplex PCR were carried out with the same temperature cycle. The aim of this 
experiment is to compare the efficiency of single and multiplex PCR, relative to the 
detection of foetal DNA. 
PCR sample content 
Normal S1 hgDNA(ctrl+) 
Normal S2 hgDNA(ctrl+) 
Normal S3 water(ctrl-) 
Normal S4 Unpurified plasma from LOC5p2 
Normal S5 Unpurified plasma from LOC5p2 
Normal S6 Unpurified plasma from LOC7p2 
Normal S7 Unpurified plasma from LOC7p2 
Multiplex S8 hgDNA(ctrl+) 
Multiplex S9 water(ctrl-) 
Multiplex S10 Purified plasma LOC7 
Multiplex S11 Centrifugated and purified LOC5 
Multiplex S12 LOC7p2 
Table 7. 7:  Characteristics of the samples and controls used in the fetal DNA 
detection experiment  
 
7.4.3 Results 
Expected results for a single and multiplex PCR are presented in a schematic, Figure 
7.16, for clarity.  
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Figure 7. 16: Expected foetal sex detection results on a single PCR and a 
multiplex PCR 
A photograph of the resulting gel electrophoresis is presented in Figure 7.17. The 
detailed analysis of each lane of the gel is carried out in Table 7.8. Generally, both 
single and multiplex PCR have been successfully carried out. In single PCR the bands 
are clear while in the multiplex PCR the bands are faint, indicating that the multiplex 
PCR could be further optimized. 
 
Figure 7. 17: SYBRsafe-stained 3% agarose gel of PCR products obtained with 
GAPDH and SRY primers and unprepared plasma samples obtained by 
microfluidic extraction. The first and last lanes are a molecular weight marker 
(Ultra-low range DNA ladder, PeqLab). 
 
 
 
 
 
GAPDH 
SRY 
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PCR sample 
Presence of 
SRY band? 
Presence of 
GAPDH 
band? 
Comments 
Normal S1 Yes n.a. Control ok 
Normal S2 n.a. yes Control ok 
Normal S3 Yes n.a. Contamination with 
SRY 
Normal S4 Yes>conta n.a. 
BOY? 
Normal S5 n.a. yes 
Normal S6 Yes>conta n.a. 
BOY? 
Normal S7 n.a. Yes 
Multiplex S8 yes yes Control ok 
Multiplex S9 yes yes contamination 
Multiplex S10 yes yes Confirms S6 and S7 
Multiplex S11 yes yes Confirms S6 and S7 
Multiplex S12 no no Dilution too high? 
Table 7. 8: Detailed analysis of the gel electrophoresis results  
The following conclusions can be drawn relatively to the PCR efficiency and the fetal 
sex detection from Table 7.8: 
- Both the single and multiplex PCR are working (positive controls S1, S2, S8) 
- Slight contamination is observed in the negative controls of the normal PCR 
and the multiplex PCR 
- Successful amplification has been achieved on the sample LOC 5 and LOC 7 
that were randomly for this experiment 
- From the presence of two bands in Lanes S4, S5, S6 and S7, the foetal 
gender of samples LOC 5 and LOC 7 should be male, unless contamination 
has been greater than expected. 
 
Furthermore, to investigate the influence of the sample purification and the dilution 
three controls as followed, all were amplified in the same way (multiplex PCR).  The 
conclusions relatively to the method of extraction are presented in the Table 7.9.  
In conclusion, the experiments on the extraction of cffDNA from maternal blood are 
on-going work. Preliminary results suggest that it is possible to amplify cffDNA from 
maternal plasma extracted on-chip. Eradicating contamination from the PCR 
experiment will confirm these results. Demonstration of cffDNA extraction from 
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maternal plasma will be a great achievement and will pave the way towards 
developing integrated tool for on-site prenatal diagnosis. 
PCR 
Sample 
name 
Sample 
reference 
Protocol on the 
sample 
Results 
S10 LOC7 Microfluidic separation 
(dilution 1:3) 
 
Both bands amplified 
Although this sample has diluted 
substantially, both bands can be 
seen very clearly 
S11 LOC5 Centrifugation 
separation (no dilution) 
And Purification  
Both bands amplified 
Bands unclear 
Although this sample is the ideal 
sample (no dilution, purified) it 
does not give better results, 
indicating that dilution should not a 
problem in further testing 
S12 LOC7 Microfluidic separation 
(dilution 1:3) 
No purification 
No band 
Multiplex PCR might have failed 
because of the lack of purification   
Table 7. 9: Analysis on the extraction methods.  
7.5 Conclusions 
In this chapter, detection of genomic sequence from on-chip extracted plasma has 
been carried out with success, therefore showing the high quality of the plasma. 
Several PCR techniques, such as single and multiplex conventional PCR and real-time 
PCR have been used to analyse and quantify the presence of genomic sequence. Single 
conventional PCR has proven in this study to be the most reliable and robust technique 
to amplify genomic sequences from unpurified plasma. However, optimisation of the 
multiplex, conventional PCR and real-time PCR will also undoubtedly demonstrate that 
these methods can also be used for DNA detection for specific cases.  
Other biomarkers may be also detected in the plasma such as proteins or microRNA. 
MicroRNA detection in plasma is relatively new and is particularly useful for cancer 
diagnostics. Protein detection in on-chip extracted plasma has been performed by Fan 
et al [7.1] and Sollier et al [7.2]. Sollier et al has shown that a passive microfluidic 
extraction did not reduce the number of major proteins present in the blood and 
furthermore verified the integrity of these proteins.  
188 
7.6 References 
[7.1] Rong Fan, Ophir Vermesh, Alok Srivastava, Brian K. H. Yen, Lidong Qin, Habib 
Ahmad, Gabriel A. Kwong, Chao-Chao Liu, Juliane Gould, Leroy Hood, and 
James R. Heath, Integrated barcode chips for rapid, multiplexed analysis of 
proteins in microliter quantities of blood, Nat Biotech 26, 1373 - 1378 (2008). 
[7.2] M. Cubizolles E. Sollier, Y. Fouillet, J.L. Achard., Fast and continuous extraction 
from whole human blood based on expanding cell-free layer devices, biomedical 
microdevices (2010). 
[7.3] Invitrogen, Real-time PCR: from theory to practice. (undated). 
[7.4] E. Buel J.A. Nicklas, Development of an Alu-based, Real-Time PCR Method for 
quantitation of Human DNA in Forensic samples, J. Forensic. Sci 48, 1-9 ( 2003). 
[7.5] Jinliang Xu Chunsun Zhang, Wenli Ma, Wenling Zheng, PCR microfluidic devices 
for DNA amplification, Biotechnology advances 24 (3), 243-284 (2006). 
[7.6] Scott Stelick Nathanial C. Cady, Madanagopal V. Kunnavakkan, Carl A. Batt, 
Real-time PCR detection of Listeria monocytogenes using an integrated 
microfluidics platform, Sensors and Actuators B 107, 332-341 (2005). 
[7.7] Se Ho Park Dae-Sik Lee, Haesik Yang, Kwang-Hyo Chung, Tae Hwan Yoon, Sung-
Jin Kim, Kyuwon Kim, Youn Tae  Kim, Bulk-micromachined submicroliter-volume 
PCR chip with very rapid thermal response and low poser consumption, Lab On 
Chip 4, 401-407 (2004). 
[7.8] P. Ernault J.M. Costa, Automated Assay for Fetal DNA Analysis in Maternal 
Serum, Clin Chem. 48, 679 (2002). 
[7.9] Y.M.D. Lo, Recent Advances in Fetal Nucleic Acids in Maternal Plasma J. 
Histochem. Cytochem 53, 293 (2005). 
[7.10] D. W. Bianchi and J. Hanson, Sharpening the Tools: A summary of a National 
Institutes of Health workshop on new technologies for detection of fetal cells in 
maternal blood for early prenatal diagnosis, Journal of Maternal-Fetal & 
Neonatal Medicine 19 (4), 199–207 (2006). 
 
 
189 
Chapter 8 – Conclusions and Outlook 
8.1 Conclusions 
This thesis has described using eight chapters, the design, test and biological validation 
of microfluidic systems for the separation of plasma from blood. 
Following on from the motivation and layout of the thesis as presented in the first 
chapter, an extensive literature survey on recent developments of cell separation 
techniques was carried out and presented in the second chapter alongside the main 
applications of cell separation.    
The blood flow, and in particular, the flow of red blood cells was studied in the third 
chapter. The various physical effects associated with the morphology of the cells, the 
complex fluid dynamic of the blood have allowed an empirical understanding of the 
complexity of flow of red blood cells. Particularly, it was highlighted that both inertial 
and laminar forces can produce lateral forces on the cells in a laminar flow situation. 
Using the concepts presented, two generations of microdevices for blood plasma 
separation were designed. 
Following on from the modelling of the microfluidic system as a network of electrical 
equivalent lumped elements, an analytical and numerical study presented in the fourth 
chapter of this thesis provided insight into the network behaviour. It was clearly shown 
that the separation network can be influenced by external features such as the 
platform channels or the capillaries plugged at the back of the system. Using the 
example of the blood plasma separation device, it was demonstrated that a more 
generic design methodology can be implemented for microfluidic network that can 
accommodate the influence of external fluidic circuitry onto the critical functional 
performance of the network. For the first time, a “design for packaging” solution was 
presented for microfluidic applications.  
Following the design of a microfluidic chip for separation of plasma from blood, several 
manufacturing techniques carried out by several partners from the 3D-Mintegration 
project were presented. The data gathered, suggested that although it has a large turn 
around time from design to manufacture, a manufacturing process based on 
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photolithography is for the moment the most reliable technique for microfluidic 
manufacturing.  
The separation of plasma from whole blood at different dilution levels was extensively 
characterised for two different designs in chapter 6. An increase of 30% in the 
separation efficiency was found in the second generation device. For this generation, 
100% separation efficiency was achieved even with the use of relatively large channels 
(20µm), thereby allowing the mass-manufacturing of the device via micro-injection 
moulding for example. The blood flow was observed in the microchannels and the 
particular behaviour of the platelet aggregation described.    
To characterise the extracted plasma biologically, PCRs were carried out on the cell-
free DNA present in the plasma outlet. Cell-free GAPDH sequences were successfully 
amplify in plasma samples of varying dilution and purity, thereby demonstrating the 
integrity of the biomarkers during separation. For the first time, a study of the 
influence of the on-chip extracted plasma purity on the amplification of a house-
keeping gene was presented.  
8.2 Various technical issues encountered in this study 
Amongst the problems encountered, cell counting has been an issue from the start. At 
the beginning cells were counted using disposable hemacytometer, however this 
method was found extremely tedious and inaccurate. This technique was found 
unsuitable for the repetitive measurements needed in this study. A more automated 
counting technique was employed that makes use of image analysis software and 
photos taken from the disposable cell counter. The technique, albeit better, was still 
too laborious and unreliable for the counting of cells in a high number of samples. An 
informal collaboration with the Department of Marine Science at the School of Life 
Science allowed the use of a flow cytometre which offers a complex and precise 
screening of the cells and plasma samples. When the study moved to the Division of 
Pathway Medecine, Edinburgh University, an automated cell coulter counter was 
found in the Cardio-vascular department which provided the best cell characterisation 
technique. This technique is fast, relatively accurate and does not require any kind of 
sample preparation apart from dilution if the hematocrit level is too high. Cell counting 
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using the Coulter counter is best when completed by an in-depth flow cytometric 
analysis which is picking up small discrepancies overlooked by the Coulter counter. 
Therefore, an additional flow cytometry study was set-up in the Flow lab of Edinburgh 
University, Royal Infirmary [8.1].    
Micron-resolution Particle Image Velocimetry (µPIV) is a much sought after tool for the 
characterisation of flow in microfluidic systems [8.2]. In µPIV, fluorescent 
microparticles are tracked using a high-speed camera via a microscope objective and 
the different points are mapped to create a velocity vector field. The microfluidic 
system was first of all modified to allow the µPIV inverted microscopy system to be 
focused on the top surface of the chip. Figure 8.1 shows a cross-section view of the 
device before and after the modification.  
 
Figure 8. 1: Illustration of the chip and platform assembly for µPIV 
measurement. The chip is represented in orange.   
Two collaborations were started to apply µPIV to characterise the flow rates in the 
system and provide data feed in the different simulation models. The first 
collaboration with Loughborough University provided vector field images of the flow in 
the second generation device, as shown in Figure 8.2. In this experiment the flow was 
seeded with 1µm fluorescent particles and the actual flow was measured using 
holographic µPIV. Qualitatively, the creation of a cell-free “slow” zone can be observed 
at the corner of the constriction and the flow escaping to the plasma channel comes 
from this zone. Unfortunately, no formal analysis of these images against CFD or high-
level modelling data was pursued due to a lack of time. It would have been very useful 
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to extract flow rates from this data and correlate the flow rate ratios with the 
efficiency obtained. This could be part of some future work.  
a  
Figure 8. 2: PIV vector field in the blood plasma separation device. Courtesy of 
Andrew Wormald and Prof Jeremy Coupland, Loughborough University  
In the second collaboration with Dr John Christy from Edinburgh University, the 
apparatus comprised a LEICA CT R4000 laser system and a Dantec Dynamic Nanosense 
MKII camera. The data was recorded and analysed via the Flow Manager software 
from Dantec. Figure 8.3 shows the area of interest in this PIV study and a photograph 
with raw data. In the photograph, one can see a number of 1µm fluorescent particles, 
some of them agglomerated. Some of the 1µm particles have entered the plasma 
channels, which raise the question about the type of particles to be used in this PIV 
study. Larger particles might be more suitable to study the flow of RBCs in this 
particular network.  
However it was later determined that the flow speed of interest was too high for the 
system. Additionally, glitches on the photographs induced by a problem on the camera 
hindered the compilation of the vector fields. The data produced could not be used 
and the time for this study was very limited. 
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Figure 8. 3: Micron-resolution PIV experiment. Left: the second bifurcation 
entrance is the area of interest in the system. Right: Raw uPIV data of the area 
of study. (i) Fluorescent microparticles (1µm) can be observed in the main 
channel (ii) An agglomeration of 1µm particles (iii) Particles entering the 
plasma channel.   
In the future, the system could greatly benefit from a full extensive uPIV analysis. As 
suggested elsewhere, fluorescent particles might be encapsulated in deformable 
vesicle that would mimic RBC behaviour.   
8.3 Limitations of the system and future work 
8.3.1 Processing time 
The system has been shown to accommodate flow rates considerably higher compared 
to other research groups who studied separation of plasma from blood. The time 
needed for separation remains however high. For a 1mL syringe content, the 
separation speed can range from thirty to three minutes for dilution levels ranging 
from nil to 1:10, using the second generation device. At high levels of dilution levels 
(1:20), the separation time can be quicker and of the order of hundreds of seconds; 
however, this dilution level introduces another problem with the concentration of 
analytes for subsequent analysis. A trade-off has therefore to be found between the 
required minimum concentration of analytes to allow detection and the speed 
required for the separation process. This will depend on the application. For example 
i 
ii 
iii 
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in plasma viscometry, there is no concentration of analytes to be accounted for, 
therefore the separation speed can be higher.  
One solution to overcome the problem of the separation speed is to put two devices or 
more, in parallel. This introduces more complexity in the system but allows for lower 
process time. In this case the footprint is not necessarily larger as the devices are 
stacked. The geometries chosen for the blood plasma separation system allow an easy 
“stacking configuration”, as shown in Figure 8.4. 
 
Figure 8. 4: Conceptual stacking configuration for a high -throughput blood 
plasma separation 
8.3.2 Blockage 
Blockages have sometimes been a problem for the smooth operation of the blood 
plasma device. Pre-filtration of the blood off-chip can be time-consuming and would 
defeat the idea of sample preparation on-chip. It is proposed to integrate a pre-
filtration module that would be placed in the main channel of the blood plasma 
separation device but before the plasma channels as shown in figure 8.5. The pre-
filtration module is composed of a number of posts located in columns with a lateral 
pitch from each other. The aim of this pre-filtration module is to capture any particle 
of dust or platelets-cells aggregate with an approximate diameter over 30µm. The fact 
that cells of interest can be trapped in this module can be a disadvantage if the some 
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cells need to be analysed. However, the separated plasma portion is only to be 
studied, then this might a simple, yet effective way to remove unwanted large particles 
before the fine separation. A plug of cells might form over a certain period of use, if 
the device is to be employed several ties.  Characterisation of this filtration technique 
needs to be carried out. 
  
Figure 8. 5: An integrated pre-filtration module featuring arrays and columns of 
30µm pillars.  
8.3.3 Pumping system 
In this study, a non-integrated syringe pump was used to activate the flow in the 
microfluidic chip. Syringe pumps have the advantage to be a common sight in 
hospitals, they are a familiar tool not only for the doctors but also for the nurses. 
However, syringe pumps are quite bulky and can have a foot print about 200% the size 
of the chip itself. In the future, an integrated pumping system could be envisaged. The 
integrated system will have to produce a continuous, high speed flow. The continuity is 
foreseen to be especially difficult to achieve, but could be possible using micro-sized 
peristaltic pump with microfluidic diodes to smooth the flow.  
8.3.4 Integrability 
The platform associated with the microfluidic chip developed in this study is a totally 
passive platform solely useful for handling the fluid.  
An active type of platform could be envisaged from the present study as a useful 
example of future work to be carried out. This platform would allow the smart 
interconnection of disposable microfluidic chips. Broad microfluidic features could be 
built into the platform while the thin features such as the separation network could be 
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placed in the disposable polymeric chips. The blockages are more likely to be found in 
the thin features, hence the disposability of the polymeric parts featuring the thin 
network.  Additionally, this platform could have active actuators such as heaters and 
sensors. This concept, presented in Figure 8.6, has several advantages: it allows the 
user to discard the parts more likely to be blocked (single-use) while retaining the 
expensive parts such as heaters and sensors for repeated usage.  
 
Figure 8. 6: Conceptual LTCC platform for microfluidic function integration  
As a proof of concept, a LTCC platform has been manufactured using the LTTC facilities 
at Heriot-Watt University, as shown in Figure 8.7 (a,b). Ferrules, as in the Fluence 
system as describe in Chapter 5, are used to connect the fluidic path from the platform 
to the microfluidic chip. Different cavities have been manufactured in the LTCC stack to 
allow the positioning of a heater and three thermocouples to monitor the temperature 
inside the LTCC channel. Attempts have been made to manufacture integrated Joule 
heaters directly onto LTTC layers as shown in Figure 8.7 (c). 
This platform could serve as a demonstrator for PCR on a LTCC substrate in connection 
with the use of a polymeric blood plasma separation system. 
   
Figure 8. 7: (a) LTCC platform without plastic microfluidic chi, (i)Nanoport TM 
connectors for fluidic access, (ii) Ferrule to link fluidic path between the 
platform and the chip, (iii)Holes for screws to tighten the chip onto the 
platform, (iv)Cavities for thermocouples to monitor the temperature in the 
a b c 
i iii ii 
iv 
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LTCC channels (b) LTCC platform with plastic microfluidic chip (c) Integrated 
heater on LTCC, Courtesy of Yves Lacrotte, Heriot -Watt University    
8.4 Future Outlook 
In this study, passive continuous blood plasma separation using polymer microfluidic 
chip has been shown to be a valuable technique to extract cellular and plasma portion 
out of whole blood.  Extensive characterisation has shown that this technique does not 
harm the cells and produces clear plasma that can be readily processed for other 
analysis steps.  
Such a separation module could be integrated to other lab-on-chip modules such as 
PCR and detection analysis for the manufacturing of an entire integrated NIPD system 
as shown in Figure 8.8. 
 
Figure 8. 8: Current development status of a portable and modul ar system for 
non-invasive prenatal diagnosis at Heriot -Watt University, May 2010.  
This platform has been conceptualised as a modular entity, therefore each component 
might be used on its own, or part of a different system. As demonstrated throughout 
this thesis, applications for blood plasma separation microdevices are numerous and 
can be found summarised in Table 8.1. More importantly the miniaturisation of this 
strategic preliminary step in a clinical context is expected to help to produce more 
efficient and practical lab on chip systems.      
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Clinical context Targeted analyte/parameter in plasma 
Cancer MicroRNA 
Prenatal diagnosis Cell-free foetal DNA 
Myeloma Plasma viscosity 
Transplantation Levels of donor cfDNA in host plasma 
Table 8. 1: Summary of application where blood plasma separation is a primary 
step  
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